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Abstract 
Small nuclear and nucleolar RNAs are transcribed by RNA polymerase II as precursors, 
whose 5’ ends either undergo combined endo- and exonucleolytic processing by Rnt1 and 
Rat1, respectively, or remain unchanged. In turn, their extended 3’ ends are trimmed by the 
exosome/Rrp6, following cleavage by Rnt1 or transcription termination by the ncRNA-
specific transcription termination Nrd1/Nab3/Sen1 (NNS) complex. In this work showed that 
the interaction between Nrd1/Nab3 and the cap binding complex (CBC) bound to the m7G cap 
of sn/snoRNA precursors is a key element of the mechanism linking their 5’- and 3’ end 
processing. I demonstrated that CBC binds to the m7G cap at the early step of transcription 
but remains associated with snoRNAs and snRNA genes, also for snoRNAs processed by 
Rnt1, until the termination and is dependent on RNA. Moreover, in the absence of the CBC 
complex Nrd1 recruitment to sn/snoRNA genes is decreased. I also showed that co-
transcriptional recruitment of Rnt1 to snoRNA genes processed at their 5’ end occurs at late 
stages of transcription. Surprisingly, in the absence of Rnt1, 5’ end unprocessed box C/D pre-
snoRNAs do not possess mature 3’ ends but carry oligoadenylated extensions, which 
indicates a defect in their 3’ maturation. These data strongly suggest that processing of both 
snoRNA termini is coupled, probably via the CBC-NNS interaction, that prevents premature 
5’ end processing by Rnt1 and delays it until transcription termination. This link probably 
contributes to the error-free and timely synthesis of mature snoRNA molecules.  
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Streszczenie 
Małe jądrowe i jąderkowe RNA (sn/snoRNA) są transkrybowane przez polimerazę RNA II 
(Pol II) jako prekursory, których końce 5’ ulegają obróbce endo- i egzonukleolitycznej z 
udziałem nukleaz Rnt1 i Rat1, lub pozostają niezmienione. Z kolei wydłużone końce 3’ 
powstałe w wyniku cięcia katalizowanego przez Rnt1 lub terminacji transkrypcji zależnej od 
specyficznego dla niekodujących RNA (ncRNA) kompleksu Nrd1/Nab3/Sen1 (NNS) są 
skracane z udziałem jądrowego egzosomu/Rrp6. W pracy wykazano, że oddziaływanie NNS z 
kompleksem wiążącym m7G kap (CBC) obecny na końcu 5’ prekursorów sn/snoRNA jest 
kluczowym elementem mechanizmu łączącego dojrzewanie końców 5’ i 3’. CBC wiąże kap 
na wczesnych etapach transkrypcji genów sn/snoRNA i pozostaje z nim związany aż do 
terminacji transkrypcji, również w przypadku snoRNA, których koniec 5’ jest cięty przez 
Rnt1. Ponadto, w nieobecności CBC, rekrutacja Nrd1 do genów sn/snoRNA jest obniżona lub 
opóźniona. Pokazano również, że asocjacja Rnt1 do genów snoRNA ciętych na końcu 5’ 
zachodzi ko-transkrypcyjnie ale na późnych etapach transkrypcji. Co ciekawe, w 
nieobecności Rnt1, prekursory snoRNA klasy box C/D, które zostały przecięte na końcu 5’, 
mają niedojrzały, wydłużony i oligoadenylowany koniec 3’, co sugeruje defekt jego obróbki. 
Dane te silnie wskazują na związek między dojrzewaniem obu końców sn/snoRNA, 
prawdopodobnie poprzez oddziaływanie CBC-NNS, które zapobiega przedwczesnemu cięciu 
Rnt1, opóźniając je aż do momentu terminacji transkrypcji. Opisany mechanizm jest 
prawdopodobnie istotnym elementem kontroli jakości i synchronizacji dojrzewania pre-
sn/snoRNA. 
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1. INTRODUCTION 
According to recent studies up to 90% of eukaryotic genome is transcribed, but protein 
coding genes comprise only a small proportion (2-3%) (1). The majority of the transcriptome 
is untranslated and consists of noncoding RNAs (ncRNAs), which are no longer considered as 
“transcriptional noise”, since there is accumulating evidence that many of them have 
important biological functions. The best characterized examples of ncRNAs are small nuclear 
and small nucleolar RNAs (sn/snoRNAs) that, like protein coding mRNAs, are synthesized by 
RNA polymerase II (Pol II). Although our knowledge of Pol II transcription and co-
transcriptional processing is extensive for protein coding genes, much less is known about the 
biogenesis of Pol II transcribed ncRNAs. The subject of this PhD thesis is the maturation of 
the 3’ and 5’ ends of sn/snoRNAs in yeast Saccharomyces cerevisiae.  
1.1 Coordination of co-transcriptional events 
All eukaryotic RNAs are synthesized as precursors and their processing provides an 
important level of regulation of their expression. Most processing factors as well as 
components of mature ribonucleoprotein particles (RNPs) are recruited co-transcriptionally in 
a tightly regulated manner. Even assembly of factors that act at the latest stages of 
transcription (e.g. 3’ end processing machinery) or post-transcriptionally often occurs much 
earlier during transcription. The transcription cycle and transcription related events are 
organized by post-translational modifications of the C-terminal domain (CTD) of Pol II (2–5). 
Additional mechanisms such as transcription elongation rate tuning, Pol II pausing and the 
complex network of interactions between transcription and processing factors also contribute 
to the synchronisation of these processes (6).  
1.1.1 Pol II C-terminal domain 
The C-terminal domain of the largest Pol II subunit Rpb1 is a distinctive feature of this 
polymerase (2–5). It is dispensable for Pol II activity in vitro, and its partial deletion can be 
tolerated, although deletion of the entire CTD in mice, Drosophila or yeast is lethal (2). CTD 
orchestrates Pol II transcription and transcription related events serving as a scaffold for 
signalling between the transcription machinery and multiple auxiliary factors. It was shown to 
be involved in regulating transcriptional rates, chromatin modifications, RNA co-
transcriptional processing, including capping, splicing and 3’ end formation, transcription 
termination and finally RNA export, as well as in DNA replication and maintenance of 
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genomic stability. CTD is composed of multiple tandemly repeated heptapeptides with the 
consensus sequence Y1S2P3T4S5P6S7. The number of repeats varies among different species 
and correlates with the organism developmental level (from 26 repeats in yeast to 52 in 
humans) and deviations from the consensus (2, 5). Another important feature of the CTD, at 
least in humans, is the presence of the Rpb1-stabilizing 10-amino- acid non-consensus motif 
following heptad 52 (3). Due to such a composition, CTD possesses a huge structural and 
functional plasticity. This long and flexible tail can reach different elements of the actively 
transcribed chromatin (3). The reach of the CTD as well as its affinity to particular factors is 
further regulated by post-translational modifications. The phosphorylated tail could be 
extended even six times, being four times longer than the Pol II surface diameter (7). In 
theory, each residue can be modified, with 5 of them being phosphorylated. Additionally 
either of the two prolines can exist in a cis or trans conformation. This so-called “CTD code” 
was extensively studied over the last decade (2–5).  
The best characterized CTD modifications are these of the three serine residues: Serine 5 
(Ser5-P), Serine 2 (Ser2-P) and Serine 7 (Ser7-P) (2–5). The pattern of these modifications 
dynamically changes during the transcription cycle, which governs the association of stage-
specific factors (Fig. 1A and B). High-throughput studies, mainly using chromatin 
immunoprecipitation (ChIP) techniques, established characteristic Ser5-P, Ser2-P and Ser7-P 
profiles along genes and intragenic regions. Generally, Ser5 phosphorylation seems to be 
higher at the beginning of the transcription cycle and becomes reduced towards the end, 
whereas Ser2 phosphorylation increases towards the end of the transcription unit (Fig. 1A) 
(8–10). This pattern is important for synchronizing transcription of all Pol II transcribed 
genes, whereas the far less understood Ser7 phosphorylation seems to play a more specific 
function. However, it is noteworthy, that recent studies, using novel native sequencing 
technology for elongating transcripts, showed significant differences in CTD phosphorylation 
profiles across mammalian protein coding genes. Particularly most Ser5-P was detected not 
over the transcription start site (TSS) region of the gene, but in the gene bodies, where it is 
associated with actively spliced exons (11). There are several other differences between yeast 
and higher eukaryotes, and the description below is focused on the situation in S. cerevisiae. 
At the beginning of the transcription cycle Ser5 is phosphorylated by Kin28 (CDK7 in 
higher eukaryotes) (Fig. 1A). In vitro, Ser5 has been shown to be phosphorylated also by 
mammalian CDK8, a subunit of the generic transcription regulator complex, that can 
phosphorylate Ser2 (12). However, yeast CDK8 homologue, Srb10, does not contribute to 
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CTD phosphorylation in vivo. During transcription elongation Ser5-P is removed by Ssu72 
and Rtr1 phosphatases (Fig. 1A) (7, 13).  
Rtr1 associates with genes at the point where Ser5-P levels drop and Ser2-P starts to 
increase, and its inactivation leads to elevated Ser5-P across the coding region. Its human 
homologue, RNA Pol II associated protein 2 (RPAP2), is essential for efficient transcription 
and 3’ end processing of snRNA transcripts. In turn, Ssu72 which is the component of the 
APT (associated with Pta1) subunit of the cleavage and polyadenylation factor (CPF) is 
stimulated by Pta1, associates with the elongating complex (EC) at both the promoter and 
more robustly at the 3’ end region, and its depletion results in increased Ser5-P towards the 3’ 
end (14–16). The main role of the Ser5-P modification, demonstrated specifically in 
Schizosaccharomyces pombe, is the recruitment of the capping enzyme (Fig. 1B) (see 1.2.1) 
(17). However, also other important factors require the Ser5-P mark for association with the 
transcription machinery, including the Set1-COMPASS histone methyltransferase, Rtr1, the 
histone deacetylase Rpd3S and the termination factor Nrd1 (Fig. 1B) (see 1.3.2) (2). 
Also Ser7 phosphorylation takes place early during the transcription cycle, and is 
performed by Kin28, but also by Ser2-P kinase Bur1 during transcription elongation (2, 9). 
Accordingly, Ser7-P profiles generally resemble those of Ser5-P at the beginning of yeast 
genes, but in contrast to Ser5-P, Ser7-P level remain high until transcription termination (Fig. 
1A) (9, 10). Ser7-P profile is similar on protein coding and noncoding Pol II transcribed genes 
(Fig. 1A) (8, 9). Ser7-P mark is removed by the Ser5-P Ssu72 phosphatase, but not by Rtr1, 
immediately after cleavage and polyadenylation, contributing to the reconstitution of the 
hypo-phosphorylated state of Pol II (Fig. 1A) (14, 15, 18, 19). Ser7-P may be important for 
elongation, as high levels of Ser7-P are detected on highly transcribed genes (8, 9). Genome-
wide studies in yeast showed that Ser7-P profile often colocalize with Nrd1 at the 3’ ends of 
cryptic unstable RNAs (CUTs) and stable unannotated transcripts (SUTs) and within introns 
encoding snoRNAs, however the meaning of this correlation is not clear at the moment (8). In 
humans, Ser7-P is required for the expression of snRNA genes by facilitating the interaction 
with the snRNA-specific 3’ end formation complex, the Integrator (20). Ser7-P also facilitates 
the recruitment of the CTD Ser5 phosphatase RPAP2, associated with a catalytically inactive 
subcomplex of the Integrator, to snRNA promoter regions (21). RPAP2 dephosphorylates 
Ser5-P while Ser2 is phosphorylated, creating a ‘double mark’ composed of Ser7-P on one 
repeat and Ser2-P on the following repeat, which is then specifically recognized by Int11 (22). 
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Serine 2 phosphorylation varies the most between different transcription units, but in 
general it is significantly lower on noncoding genes (8, 9). Phosphorylation is carried out by 
two Ser2 kinases, Bur1 and Ctk1, that are essential for normal growth of yeast cells, with the 
latter playing a major role during Pol II elongation (Fig. 1A) (2, 23, 24). Besides CTD 
phosphorylation, the main role attributed to Bur1 is stimulation of elongation and suppression 
of aberrant initiation by phosphorylation of other transcription factors like Spt5, that contains 
a C-terminal repeat domain (CTR) similar to that in CTD (9, 24–26). Bur1 is recruited to the 
EC through Ser5-P CTD and Ser2 phosphorylation by Bur1 at promoter proximal regions 
further stimulates phosphorylation by Ctk1 (24). In higher eukaryotes, Cdk9, a subunit of the 
positive transcription elongation factor b (P-TEFb), phosphorylates both Spt5 and Ser2 (27). 
Additional CTD Ser2 kinases Cdk12 and Cdk13 have been identified recently in higher 
eukaryotes, with Cdk12 contributing the majority of Ser2-P during transcription elongation 
(28, 29). Also a bromodomain protein Brd4 is an atypical Ser2-P kinase, involved in P-TEFb 
recruitment, which phosphorylates Ser2 while P-TEFb is inactive (30). Yeast Ctk1 and Bur1 
and human P-TEFb was recently shown to interact with cap binding complex (CBC), which 
stimulates their recruitment and thus Ser2 phosphorylation (see 1.2.2) (31–33). At the end of 
the transcription cycle Ser2-P mark is removed by Ser2 specific phosphatase Fcp1 (Fig. 1A) 
(7, 15), enabling the polymerase recycling. Although Fcp1 travels with Pol II along the gene 
and can dephosphorylate both Ser2-P and Ser5-P, it prefers Ser2-P (3). Ser2-P and Ser5-P are 
additionally dephosphorylated by phosphatase Cdc14 during mitosis to repress transcription 
(34).  
The role of Ser2-P in Pol II elongation is not fully understood, but this modification was 
shown to be important for splicing, transcription termination and 3’ end formation (see 1.3) 
(2). Consistently, Ser2-P is placed downstream from the promoter and its level increases 
towards the 3’ end of genes (Fig. 1A) (8–10). CTD phosphorylated on both Ser2 and Ser5 
recruits numerous transcription and RNA processing factors as well as histone modification 
enzymes, including splicing factors Prp40 and U2AF65, export factor Yra1, H3K36 
methyltransferase Set2, the RNA binding factor Ssd1, the mitotic kinase Hrr25, and the 
RecQ5 genome stability helicase (Fig. 1B) (2). On the contrary, elongation-associated 
proteins, Npl3 and Spt6, as well as CTD-interaction domain-containing (CID) termination 
factors, Rtt103 (together with the 5’-3’ exonuclease Rat1) and Pcf11, associate with the CTD 
phosphorylated on Ser2 alone (Fig. 1B) (2, 3). Both termination factors, Rtt103 and Pcf11, 
bind cooperatively to neighbouring Ser2-P repeats, which ensures that they are efficiently 
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recruited only when many repeats have Ser2-P (35). Also Sen1 helicase, another Pol II 
termination factor, binds to the Ser2-P CTD (36, 37). Conversely, termination factors can also 
affect CTD phosphorylation, as was shown for exonuclease Rat1 (see 1.2.4.2) (38).  
 
Figure 1. The carboxyl-terminal domain (CTD) phosphorylation pattern across yeast genes. (A) Average 
profiles of Tyr1-P, Ser2-P, Thr4-P, Ser5-P and Ser7-P along typical protein coding genes (continuous lines) or 
snoRNA genes (dashed lines) visualized by ChIP experiments in S. cerevisiae according to (39). Known kinases 
and phosphatases responsible for establishing and eradicating these marks are indicated above and below the 
diagram, respectively. Transcription start site (TSS), polyadenylation signal (PAS) and transcription termination 
site (TTS) are indicated on the x axis. (B) Selected factors binding specifically to the differentially-modified CTD 
(CTD code readers) at different stages of the transcription cycle. Termination factors are coloured in green and 
red. Description in the text. 
Although Ser2-P level at short sn/snoRNA genes is low, this modification plays important 
role in the Nrd1/Nab3/Sen1-dependent termination (see 1.3.2), as deletion of the CTK1 gene 
leads to extensive transcriptional readthrough of these genes (40). It can be partly explained 
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by the altered elongation kinetics caused by the disturbed recruitment of elongation factors 
and histone modifiers. However, according to recent studies proper Ser2-P level at the 3’ end 
of noncoding transcription units is needed for the association of Pcf11 and Sen1 (Fig. 1B), 
which seems to be vital for the termination pathway mediated by the Nrd1/Nab3/Sen1 (NNS) 
complex (37, 41). 
Much less is known about the significance of Thr4 phosphorylation that is limited to the 
gene body, where it may impair the recruitment of termination factors (Fig. 1A) (42). Lack of 
Thr4-P is not lethal in yeast but it is vital for transcription elongation in mammalian cells 
where its profiles overlap with Ser2-P with a slight shift towards the 3’ end (43). Different 
results were obtained in chicken cells, where Thr4-P was shown to play a role in processing of 
non-polyadenylated histone mRNAs (44). Also the identity of the kinase that phosphorylates 
Thr4 is not entirely clear, either Ser2 kinase Cdk9 or Plk3 (Polo-like kinase 3) were implied 
to be involved, depending on the system, chicken or human, respectively (43, 44), whereas S. 
cerevisiae Thr4 kinase has not been identified yet. 
Phosphorylation of Tyr1 was demonstrated in humans almost two decades ago, but only 
recently this modification and its function was analysed in yeast (42, 45). Tyr1-P is present at 
all active genes and its level correlates with the Ser2-P mark, increasing downstream of the 
TSS but dropping before reaching the polyadenylation signal (PAS) (Fig. 1A) (42). Tyr1-P 
was shown to inhibit the association of termination factors to the EC that probably serves to 
prevent premature termination. Therefore, termination factors peak upstream the highest 
Tyr1-P level (Nrd1) or further downstream, after Tyr1-P dephosphorylation (Pcf11, Rtt103) 
(Fig. 1B). Tyr1 kinase has not been identified yet, whereas APT subunit phosphatases Glc7 
and Rtr1 were shown to remove the Tyr1-P mark (46, 47).  
Proline isomerization, performed by proline isomerases Ess1 in yeast and Pin1 in 
mammals, contributes to the association of numerous factors and is particularly important for 
transcription termination in yeast. Pcf11 specifically recognizes the repeats with Ser2-P and 
prolines in the trans configuration (48), which is a dominant isomer in equilibrium (49). In 
contrast, Nrd1 and Ser5-P phosphatase Ssu72 bind CTD with Ser5-P and the downstream 
proline in the cis configuration (49, 50). It was shown that proline isomerization by Ess1 
activates Ssu72, facilitating Ser5-P dephosphorylation (49, 51, 52). In turn, CTD 
phosphorylation state is important for the activity of Ess1 (53). In yeast, Ess1 mutation causes 
readthrough of many snoRNA genes, probably due to the disturbed recruitment of Nrd1 and 
Pcf11 (41, 51). 
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In higher eukaryotes not all CTD repeats have the consensus sequence. For instance, the 
mammalian CTD contains 31 non-consensus repeats, located mainly in the C-terminal region 
(2). They predominantly differ at position 7 where serine is often replaced by lysine, a 
potential substrate for acetylation, methylation, sumoylation and ubiquitination (2, 4). These 
repeats can be additionally, specifically modified and may contribute to specific CTD 
functions. For instance, the arginine in position 7 of repeat 31 (R1810) can be methylated 
during transcription, which probably serves to inhibit general transcription of sn/snoRNA 
genes (54). 
Individual CTD modifications influence each other and these connections may enable the 
general transcription machinery to distinguish between “coding” and “noncoding” 
transcription mode. Several genome-wide Pol II ChIP studies in yeast demonstrated that 
usually longer genes have phosphorylation patterns more consistent with the general model, 
with Ser5-P high at the beginning and increasing Ser2-P towards the end (8–10, 14, 15). 
Shorter transcription units, most often noncoding, are characterized by higher levels of Ser5-P 
and lower levels of Ser2-P, probably due to the crossover of Ser5-P to Ser2-P occurring 450 
nt downstream from the TSS (Fig. 1A). The meaning of this difference is underscored by 
different requirements for the recruitment of the coding versus noncoding termination factors 
(see 1.3). The association of the cleavage and polyadenylation (CP) machinery is Ser2-P 
dependent, whereas Nrd1 binds Ser5-P CTD (3). However, appropriate level of Ser2-P 
phosphorylation is also required for ncRNA transcription termination, as it contributes to 
Pcf11 and Sen1 recruitment (41). Additionally, it was proposed that a low level of Ser2-P and 
high level of Ser7-P serves as a CTD gene-type specific signal for noncoding transcription 
units (Fig. 1A) (2). The balance between Ser2-P and Ser7-P is also emphasized by the finding 
that mutating all Ser7 residues can bypass a gene-specific requirement for Lsk1-mediated 
CTD Ser2 phosphorylation in regulation of meiosis in S. pombe (17, 55). In turn, Ser5-P was 
shown to be important for subsequent phosphorylation of Ser2 (24, 56). Ser5-P is also tightly 
connected to Ser7-P, as these marks share a common kinase Kin28 and phosphatase Ssu72. 
CTD is not required for Pol II catalytic activity, but its deletion is lethal and at least 50% of 
the natural numbers of heptads are necessary for cell viability (3). In yeast, eight heptads of 
total 26 repeats are sufficient for viability but 13 are required for wild-type growth (57). 
Although deletion of the CTD has no effects on transcription, it is required for efficient 5’ 
capping, splicing, and 3’ processing (58, 59). Also mutations of CTD residues that undergo 
modification, for instance substitution of all Tyr1 residues to phenylalanine (Phe) or of Ser2 
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or Ser5 to alanine (Ala) in S. cerevisiae, are lethal (17, 57). In turn, in S. pombe only Ser5 is 
absolutely essential and it can be compensated by tethering the capping enzyme to the CTD 
(17). Thr4 or Ser7 substitution with Ala are viable in both yeast species, but human and 
chicken cells harbouring Thr4 to Val mutation, or Ser7 to Ala in humans are lethal (17, 43, 
44, 60, 61). In contrast, substitution of Ser7 by the phospho-mimic amino acid glutamate is 
inviable in both human and yeast cells (14, 61). Also insertion of additional amino acids 
between single heptads is lethal in S. cerevisiae, while insertion after a di-heptad is tolerated 
suggesting that it is the minimal functional unit of the CTD (62, 63). 
1.1.2 Other mechanisms coupling transcription-related processes 
Pol II transcription is a highly regulated process, comprising sequentially occurring steps 
that include transcription preinitiation, initiation, promoter clearance, promoter-proximal 
pausing (in higher eukaryotes), elongation, termination, and reinitiation. These events and 
RNA processing are interconnected in a bidirectional manner (6). For example, initiation is 
necessary for efficient pre-mRNA capping, which in turn influences downstream transcription 
and processing steps via the action of Capping enzymes (CEs) as well as CBC (see 1.2.1 and 
1.2.2). Such proteins with dual function, involved in transcription and co-transcriptional 
processing, are the key players in coordination of these events. On the other hand, RNA 
processing steps depend also on the promoter structure, which is mediated through the 
recruitment of different factors and through alterations of the Pol II transcription rate (6). 
The rate of transcription impacts co-transcriptional processes, which in turn can affect 
transcription. Pre-mRNA splicing, especially in higher eukaryotes, is regulated by the speed 
of the elongation complex (6). Especially, the suboptimal splicing signals require Pol II to 
slow down within the exon to be efficiently recognized by the spliceosome. Multiple factors 
modulate Pol II kinetics including regulatory DNA elements or phosphorylation status of the 
CTD. Pol II can be slowed down or even paused to give time for processing apparatus to 
perform their tasks (64).  Pol II pausing was shown to play a key role in capping and 
transcription termination, where it acts as an especially important factor for the choice 
between alternative PASes (see 1.2.1 and 1.3.1). Also NNS-dependent termination is sensitive 
to Pol II kinetics (see 1.3.2). 
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Figure 2. m7G and TMG cap: structure and synthesis. (A) Capping reaction: RNA dephosphorylation catalysed 
by Cet1 (1). Ligation with the inverted GMP molecule catalysed by Ceg1 (2). Added guanosine methylation at 
N7 position catalysed by Abd1 (3). (B) Cap recognition by CBC, composed of Cbp20 and Cbp80 subunits; m7G 
dimethylation at the N2 position catalysed by Tgs1 (4). (C) Low affinity of CBC to the TMG cap. Lines with 
arrowheads indicate catalysed reaction, lines with barheads - inhibition. RNA is drawn as a black ribbon. 
Description in the text. 
Another factor that imposes a strong impediment to transcription elongation kinetics is 
chromatin structure, regulated by numerous highly conserved proteins. These proteins include 
chromatin remodeling enzymes, histone modification enzymes and histone chaperones and 
are also often recruited by the properly modified Pol II CTD (65). Elevated histone 
acetylation level can alter the rate of Pol II elongation in yeast cells with mutations in the Paf1 
complex (polymerase-associated factor 1) that are deficient in H3 K4 and K36 methylation 
(66, 67). Dysfunction of Paf1 was also shown to lead to transcriptional readthrough at several 
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snoRNA genes, as Paf1 seems to facilitate Nrd1 recruitment, in addition to its role in histone 
methylation (67–69). Other transcriptional regulators, such as Rad6 required for 
monoubiquitination of histone H2B K123, and Set2 methyltransferase that trimethylates H3 
K36, can affect NNS-dependent transcription termination in a locus-specific manner (69). 
Also Set1 is an important regulator of the NNS recruitment, it affect Pol II kinetics in early 
elongation by modulating histone acetylation (70). In turn, chromatin remodelers such as Isw1 
and Chd1, were shown to prevent readthrough of PAS on mRNA genes (71, 72). 
1.2 Capping and 5’ end maturation 
1.2.1 m7G cap formation 
m7G cap, that is a unique feature of all Pol II primary transcripts, is synthesized co-
transcriptionally at the early stage of transcription (73, 74). This substantial modification has 
been shown to be required for viability in different organisms, reflecting its fundamental role 
in many cellular processes, including translation initiation. Three-step capping reaction is 
initiated when the 5’ end of the nascent transcript emerges from the Pol II RNA exit channel 
and is completed before the growing RNA chain reaches 100-150 bp (33). In the first step, 
terminal γ-phosphate group is removed from the 5’ triphosphate end by RNA triphosphatase 
Cet1 (Fig. 2A) (74). Resultant diphosphate is then ligated with the inverted GMP moiety by 
guanylyltransferase Ceg1 forming a unique 5’-5’ triphosphate bridge (Fig. 2A). Finally, the 
cap methyltransferase Abd1 specifically methylates the added guanine in the N7 position, 
using S-adenosylmethionine (AdoMet) as a donor (Fig. 2A). In yeast S. cerevisiae, all three 
reactions are catalysed by separate enzymes, whereas in metazoans first two reactions are 
performed by a bifunctional capping enzyme.  
Capping is not only an important processing reaction, its completion serves as a signal for 
initiation-elongation transition of Pol II (6). It is therefore precisely synchronized with the 
transcription cycle. Capping enzymes are recruited to Ser5-P CTD and recent studies in 
yeast showed that this process occurs in a consecutive manner (33). Cet1-Ceg1 heterodimer 
is bound first and it dissociates shortly after the 5’-5’ triphosphate linkage synthesis. The 
subsequent recruitment of Abd1 is also mediated by Ser5-P CTD. In turn, Abd1, Ser5-P 
and cap methylation itself stimulate recruitment of Ser2 kinases Ctk1 and Bur1. 
Additionally, S. cerevisiae capping enzymes can also bind the Rpb1 ‘‘foot domain’ (75). The 
mammalian capping enzyme interacts not only with Ser5-P but also with Tyr1-P of the next 
CTD repeat (76). CTD Ser2-P promotes release of capping enzymes and facilitates events 
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leading to the assembly of the productive elongation complex. In addition, Cet1 was shown 
to promote this transition, independently of its mRNA capping activity or cap-mediated 
recruitment of CBC, as it decreases the accumulation of Pol II towards the promoter 
proximal site (77). On the other hand, Cet1 inhibits reinitiation which appears to provide 
sufficient time for capping and may serve as a quality control mechanism (78). Additional 
surveillance mechanism that ensures proper Pol II transcripts capping involves decapping 
by Rai1 and exonucleolytic degradation by Rat1 (see 1.2.4.2 and 1.2.5) (79, 80). 
1.2.2 m7G cap and CBC functions 
Immediately following its synthesis, m7G cap is recognized by the nuclear cap binding 
complex (CBC), a heterodimer composed of Cbp20 that directly binds the cap structure and 
Cbp80 that facilitates this interaction (Fig. 2B) (81–83). Neither Cbp20 nor Cbp80 can bind 
alone to the capped RNA, and moreover Cbp20 is unstable in the absence of Cbp80, but the 
opposite is not the case (84–87). CBC is recruited directly to the capped transcript through the 
highly specific interaction with the m7G base, but it also interacts with the RNA chain through 
the RNA recognition motifs (RRM) in Cbp20 and Cbp80 (33, 86–88). 
CBC binding stabilizes m7G capped RNAs and is involved in regulation of co-
transcriptional pre-mRNA maturation, its nucleocytoplasmic export and transcription itself 
(Fig. 3) (reviewed in (73, 74)). It enhances the rate of recognition and splicing of the cap-
proximal intron in higher eukaryotes and is necessary for co-transcriptional spliceosome 
assembly at intron-containing genes in yeast (81, 89–92). Cbp20 was identified as a 
component of the yeast commitment complex stabilizing binding of U1 snRNP to the 5’ 
splice site and Mud2 to the intron branch point (Fig. 3) (84, 91, 93). In higher eukaryotes, 
CBC also regulates pre-mRNA 3’ end formation and its depletion from HeLa cell nuclear 
extract reduces the endonucleolytic cleavage step during this process (90, 94). 3’ end 
processing of capped noncoding and coding RNAs, including histone mRNAs, was 
demonstrated in humans to be stimulated also by a larger CBC-containing complex, CBCA, 
that additionally comprises ARS2 (arsenic-resistance protein 2) (95, 96). The interaction of 
ARS2 with transcription termination or 3’ end processing factors, such as CLP1, NELF-E, 
SLBP15 or FLASH, enables CBCA to facilitate recruitment of these factors (see 1.3) (95, 96). 
Also yeast CBC contributes somehow to mRNA 3’ end formation by impeding recruitment of 
cleavage factors complex CF IA to weak terminators and reducing termination and poly(A) 
addition at these sites (Fig. 3) (86). 
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Figure 3. CBC functions in yeast. CBC interacts with a spectrum of factors mediating RNA metabolism and 
stability, Pol II CTD phosphorylation, transcription termination and reinitiation. Lines with arrowheads indicate 
either activation, catalysed reaction or interaction (arrowheads at both ends), while lines with barheads indicate 
inhibition. Circles on the Pol II tail (CTD) indicate phosphorylated residues and are colour-coded as on Figure 
1. RNA is drawn as a black ribbon, important sequences are coloured in grey (intron), green (Nab3 binding 
sites) and red (Nrd1 binding site). DNA template is drawn as a black line, red line indicates promoter region. 
Description in the text. 
CBC is also important for transcription itself. In yeast it interacts with Mot1 (modifier of 
transcription) that is recruited to gene promoters and enhances the formation of the 
preinitiation complex (PIC) in the subsequent rounds of transcription initiation (Fig. 3) (97). 
Recent studies showed that CBC facilitates Pol II CTD Ser2 phosphorylation (see 1.1.1) and 
thus contributes to proper Pol II elongation and alternative splicing, through its interaction 
with P-TEFb in mammalian cells or Bur1/2 and Ctk1/2/3 complexes in yeast (Fig. 3) (31–33). 
Another cellular process that involves CBC is RNA degradation. In mammals, CBC is 
important for the recognition of the premature stop codon (PTC) in specialized mRNA quality 
control mechanism, Nonsense-mediated Decay (NMD), via direct interaction with a major 
NMD effector, Upf1, and stimulation of its binding to Upf2 (98). CBC is also a key 
component of the mRNA degradation pathway in the nucleus (DRN). The lack of Cbp80 
stabilizes mRNAs, that are retained in the nucleus due to abnormal physiological conditions 
and are normally rapidly degraded through the pathway involving also Rrp6, exosome and 
Rat1 (Fig. 3) (99–101). 
24 
 
Recently a human CBCN complex, composed of CBC, ARS2 (that forms the CBCA 
subcomplex), ZC3H18 and the Nuclear Exosome Targeting (NEXT) complex, was described 
to link CBC to the 3’-5’ RNA degradation, acting as a platform for exosome recruitment (95, 
96). This complex was suggested to be important for the suppression of noncoding RNA 
transcription in human cells (see 1.3.2). The CBCN complex was also demonstrated to take 
part in biogenesis of human telomerase RNA (hTR) that contains a box H/ACA motif. This 
process is supposed to entail a kinetic competition between RNA processing and degradation 
by the exosome (102). Functionally similar CBC connection to the exosome may also exist in 
yeast S. cerevisiae, where CBC copurifies with the ncRNA-specific NNS transcription 
termination complex and the exosome (Fig. 3) (103). Similarly to human CBCN and its 
subcomplex CBCA, CBC-NNS connection can be involved in ncRNA transcription 
termination and 3’ end formation. 
CBC activity is regulated by interaction with importins that is probably mediated by 
growth factors and is important for temporal and spatial coordination of cap-dependent 
processes such as mRNA translation (74). In vertebrates importin-α binds Cbp80 through its 
N-terminal region and the CBC-importin-α complex stimulates the release of capped RNA via 
displacing Cbp20 from its contact with Cbp80 (104). This tuning of CBC-cap interaction is 
regulated by GTPase Ran that while bound to GTP disables the interaction of CBC-importin-
α with importin-β. Thus, CBC-importin-α remains attached to the capped RNA in the nucleus, 
where the concentration of Ran-GTP is high, and is released in the cytoplasm where Ran-GTP 
level is low. CBC-importin-α-importin-β can be then imported back to the nucleus and reused. 
CBC interaction with importin-α is stable within the nucleus through multiple stages of RNA 
processing and is well conserved among eukaryotes (74).  
Despite CBC important roles in diverse biological processes, yeast CBC is not essential for 
viability, and deletion strains show moderately reduced growth phenotype (84). Because only 
the heterodimer have a cap-binding ability, cbp20Δ and cbp80Δ show similar phenotypes, but 
surprisingly, the double cbp20Δ cbp80Δ mutant grows better than single deletion strains, 
which suggests that expression of either CBP80 or CBP20 alone have a dominant negative 
effect. The lack of CBC causes synthetic lethality with deletion of U1 snRNP components or 
other splicing factors, in agreement with the role of CBC in splicing (84, 105). Synthetic 
lethal interactions with CBC were also described for CBF5 and NOP58, encoding 
components of H/ACA and box C/D snoRNPs, respectively, although the meaning of this 
genetic interaction is not known. CBC mutants show rRNA processing defects, possibly as a 
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result of splicing defect of a subset of ribosomal protein pre-mRNAs (84). Moreover, 
hypomorphic mutations of Cbp20 cap binding pocket (as cbc2-N∆42) are synthetically lethal 
or sick with null mutations of factors involved in early spliceosome assembly and severely 
impede yeast sporulation and meiosis, as CBC is especially important for splicing of 
meiotically-expressed MER3 and SAE3 mRNAs (106). Another hypomorphic mutation, cbc2-
Y24A, that attenuates CBC affinity for m7G cap, completely suppresses the cold sensitivity of 
the tgs1∆ mutant (see 1.2.3) (107).  
1.2.3 TMG cap 
The m7G cap of snRNAs, some snoRNAs and telomerase RNA component TLC1 is further 
dimethylated by Tgs1 to the 2,2,7-trimethylguanosine cap (TMG) (Fig. 2B) (108–110). Tgs1 
is a conserved protein that catalyses two successive methyl transfers from AdoMet to the N2 
position of m7G. Its activity is strictly dependent on prior N7 methylation, which provides 
modification of properly capped RNA (111). Although Tgs1 catalytic activity does not require 
additional cofactors (111), Tgs1 is recruited to its substrates through interactions with 
sn/snoRNP specific proteins SmB and SmD1 (snRNA), Cbf5 (box H/ACA snoRNA) and 
Nop58 (box C/D snoRNA) (108). Another binding partner of Tgs1 that is involved in snRNA 
and U3 snoRNA cap trimethylation, acting as a Tgs1 specificity factor is Swm2 (112). 
In mammals, snRNP cap hypermethylation occurs in the cytoplasm (74, 109). The m7G 
cap bound to CBC acts as an export signal, recognized by the snRNA-specific export adaptor 
protein PHAX and transported to the cytoplasm via the export receptor CRM1. Following the 
Sm-core assembly, cap hypermethylation and 3’ end trimming in the cytoplasm, snRNPs are 
imported back into the nucleus using the TMG cap and Sm-core as the nuclear localization 
signal and Snurportin-1 and the survival motor neuron (SMN) complex as adaptors (see 1.5) 
(109, 113). Cap hypermethylation of those mammalian snoRNAs that retain this structure is 
believed to occur in Cajal bodies (see 1.5), whereas in yeast m7G cap of both snoRNAs and 
snRNAs is probably modified in the nucleolus, although it was not conclusively shown, 
despite Tgs1 localization in this structure (108, 114). TMG-capped RNAs do not further bind 
CBC whose affinity to 2,2,7- trimethylguanosine is much lower than to m7G (Fig. 2C) (115). 
Mammalian TMG cap of mature snRNPs is essential for their nuclear localisation, but 
yeast sn/snoRNPs do not transit through the cytoplasm during their biogenesis (109) and 
neither their TMG cap nor Tgs1 are required for cell viability (107, 108). The composition of 
sn/snoRNPs in the absence of TMG cap is only slightly altered, with CBC still attached to 
their m7G (107). S. cerevisiae tgs1Δ mutant shows a cold-sensitive splicing phenotype, related 
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to the retention of U1 snRNA in the nucleolus, which is suppressed by the mutation in the 
cap-binding pocket of Cbp20 (cbc2-Y24A) (107). TGS1 deletion causes synthetic lethality 
with genes encoding pre-mRNA splicing factors such as Mud2 and Nam8, and a weaker 
synthetic growth defect with a number of genes coding proteins involved in snRNP function 
and spliceosome assembly, including Brr1, Lea1, Ist3, Isy1, Cwc21, and Bud13 (116). This 
suggests that TMG cap is involved in spliceosome assembly and is functionally redundant 
with proteins that assist U1 and/or U2 snRNP recruitment to the pre-mRNA. Although Tgs1 
is not essential for splicing in mitotically growing yeast, it is required for yeast sporulation, 
promoting splicing of meiotic pre-mRNAs PCH2 and SAE3 with non-canonical splicing 
signals (117).  
It was also suggested that TMG cap may play some role in snRNA 3’ end processing, 
because of a strong synthetic sick interaction between TGS1 and TRF4, encoding a catalytic 
subunit of the TRAMP complex that cooperates with the exosome in sn/snoRNA 3’ end 
formation (see 1.3.3.3) (116). A synthetic sick phenotype was described for TGS1/LSM1 and 
TGS1/PAT1 pairs. Lsm1 and Pat1 are both involved in RNA decapping that may contribute to 
5’ end processing of some snoRNAs (see 1.2.5).  
Tgs1 is also required for pre-rRNA processing and for maintaining nucleolar morphology 
(118) and in addition its absence is associated with changes in telomere length and structure, 
resulting in shorter replication lifespan and premature aging (110).  
1.2.4 Endo- and exonucleolytic 5’ end processing 
Part of snoRNA precursors, more commonly of the box C/D class, undergo further 5’ end 
processing that removes the cap structure and thus also CBC from pre-snoRNPs. 5’ end of 
these pre-snoRNAs is extended and contains a steam-loop structure that is recognized and 
cleaved by Rnt1 endonuclease (119, 120). This provides an entry site for further 
exonucleolytic trimming catalysed by Rat1 and Xrn1 nucleases (see 1.5). 
1.2.4.1 Rnt1 
Rnt1 belongs to the RNase III endonuclease family that specifically cleaves a double-
stranded RNA (dsRNA) introducing two staggered cuts on each side of the RNA duplex 
(121). It is composed of dsRNA binding (dsRBD) and nuclease domains conserved among 
bacterial and eukaryotic RNase III family, and the N-terminal domain that promotes enzyme 
homodimerization and increases the accuracy and efficiency of its catalytic activity (122, 
123). Rnt1 substrate comprise a hairpin structure capped with a tetraloop containing the 
A/uGNN consensus sequence that is important for the recognition by the enzyme and defines 
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cleavage sites 14–16 base pairs from the tetraloop (Fig. 4) (123–125). Although the second 
nucleotide of the tetraloop is universally conserved and its mutation significantly reduces 
binding and blocks cleavage, AAGU tetraloop of snR48 is also recognized and cleaved by 
Rnt1 with a comparable affinity due to cooperative conformational changes in both the RNA 
and the enzyme (126–128). 
 
Figure 4. Rnt1 substrate recognition and cleavage site determination. (A) Rnt1 dimer interacting with the stem 
terminated with the AGUC tetraloop, adapted from (123). Protein is illustrated as a molecular surface, RNA is 
shown in grey for the tetraloop (guanine residue is highlighted as a ball-and-stick illustration) and in blue and 
red for the stem. (B) Secondary structure prediction of RNA sequences found upstream of box C/D snoRNAs, 
adapted from (120). The distance to the mature snoRNA sequence is indicated on the 3’ end of the structure. 
Cleavage sites mapped in vitro are indicated by black triangles and cleavage sites mapped in vivo are indicated 
by grey triangles.  
The A/uGNN tetraloops are commonly found in yeast snRNA, snoRNA and rRNA 
precursors processed by Rnt1 (119, 120, 129–132). In the case of pre-rRNA, Rnt1 co-
transcriptional cleavage downstream of the mature 25S is strongly linked to transcription, as 
Rnt1 is recruited to the nucleolus in the presence of actively transcribed rRNA genes and 
physically interacts with RNA polymerase I (Pol I) (132, 133). In contrast, the co-
transcriptional or post-transcriptional nature of Rnt1-mediated processing at the 3’ end of 
yeast snRNAs or 5’ end of snoRNAs has not been explicitly demonstrated. However, the role 
of Rnt1 in pre-sn/snoRNA processing was reported to be facilitated by its physical 
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interactions with snoRNP proteins Nop1 and Gar1 or termination factors Sen1 and Nrd1 (see 
1.3 and 1.5) (36, 103, 134, 135). 
Rnt1 also contributes to the degradation of some unspliced pre-mRNA precursors by 
cleaving intronic stem-loops present in unspliced precursors and lariat introns (136). In the 
case of rare yeast genes with two introns, such as a modulator of sex-specific gene expression 
MATa1, Rnt1 eliminates pre-mRNAs folded in a manner that promotes the skipping of the 
second exon (137). Rnt1-dependent nuclear degradation is involved in regulation of 
expression of specific mRNAs under distinct environmental conditions, including telomerase 
subunit EST1 mRNA, mRNAs encoding iron uptake and iron mobilization proteins or cell 
wall integrity associated mRNAs (138–140) In addition, Rnt1 cleavage of nascent transcripts 
mediates fail-safe transcription termination (see 1.3.3) (141, 142). 
Independently of its endonuclease activity, Rnt1 is required for cell cycle progression and 
nuclear division. Rnt1 resides in the nucleolus in G1 and S phases and its cell cycle-dependent 
relocation to the nucleoplasm contributes to the exit from the G2/M phase (133). This cell 
cycle regulated control of Rnt1 localization could be responsible for the degradation of the 
telomerase EST1 or cell wall integrity associated HSL1 mRNAs in the G2/M phase.  
Surprisingly, RNT1 gene is not essential, although its deletion causes severe growth defect 
due to a globally disturbed metabolism of ncRNAs (143). Biogenesis of rRNA and many 
sn/snoRNAs is strongly disturbed in a temperature sensitive rnt1∆ strain, however, the level 
of some snoRNAs processed at their 5’ end (e.g., snR52) appears to be hardly affected (120). 
RNT1 deletion also impacts the accuracy of Pol I termination (144, 145) and reduces rRNA 
transcription, at the same time increasing the number of transcriptionally poised rRNA genes 
(146). The growth defect in the absence of Rnt1 is also related to impaired cell cycle 
progression due to abnormal nuclei positioning (133). Moreover, upregulation of mRNAs 
associated with morphogenesis and cell wall integrity in cells lacking Rnt1 leads to stress 
response attenuation (140). Consistently, RNT1 deletion shows strong synthetic sickness or 
lethality with cell wall integrity pathway related genes, and these phenotypes can be partially 
rescued by increased osmotic strength of the growth medium. 
1.2.4.2 Rat1 and Xrn1 
Cap structure contains a triphosphate bridge that is atypical for nucleic acids and cannot be 
cleaved by exonucleases. Therefore, maturation of extended precursors requires additional 
endonucleolytic cleavage or decapping steps that provide monophosphate 5’ end as a 
substrate for 5’-3’ exonucleases. Two major yeast 5’-3’ exonucleases, nuclear Rat1 and 
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predominantly cytoplasmic Xrn1, participate in 5’ end processing of different RNA species, 
with a more prevalent role of the nuclear Rat1 (147–151). The two enzymes are functionally 
equivalent and are fully interchangeable when targeted to the non-native cellular compartment 
(152–154). However, RAT1 is essential for growth and rat1-1 phenotypes are not rescued by 
XRN1 overexpression, whereas XRN1 is nonessential and elevated expression of RAT1 
partially restores growth and RNA turnover defects of xrn1 mutants (152, 155–157) ). While 
the main role of Xrn1 is in cytoplasmic mRNA turnover, Rat1 functions in the nuclear 5’ end-
processing of ncRNAs and quality control of aberrant or inefficiently processed RNAs (158–
160).  
Rat1 in yeast interacts with a Rai1 cofactor that stabilizes and enhances its activity, assists 
in degrading structured RNAs and provides the access to monophosphate 5’ end when 
necessary (80, 154, 161). Besides the 5’ end formation of many snoRNAs, Rat1 is required 
for the maturation of the 5’ end of 25 S and 5.8 S rRNAs and it is involved in Pol I rRNA 
transcription and co-transcriptional cleavage by Rnt1 (158). Another important function of 
Rat1 is in transcription termination of Pol I and Pol II, at least partly by contributing to co-
transcriptional degradation of nascent RNA in a so-called torpedo mechanism (see 1.3.1) 
(162, 163). Moreover, Rat1 enhances recruitment of 3’ end processing factors (164) and 
influences the phosphorylation levels of Pol II CTD (38). Rat1/Rai1 associate with the Pol II 
EC, partially through the interaction with the Ser2-P-CTD binding protein Rtt103, from the 
very beginning of the active transcription unit, peaking at the 3’ end (162). Rat1/Rai1 is also 
involved in premature termination of Pol II engaged in the production of uncapped or 
improperly capped RNAs as a part of cap-related quality control mechanisms that prevent 
incomplete mRNAs from being transported and translated (see 1.2.5) (79, 80). In fact, 
Rat1/Rai1 is the major component of prominent nuclear ncRNA surveillance pathways, 
responsible for the identification and degradation of aberrantly processed pre-rRNAs, 
antisense RNAs (asRNAs) and structurally compromised mature tRNAs as well as normal 
mRNAs retained in the nucleus (159). In addition, Rat1 associates with telomerase and 
degrades telomeric repeat-containing ncRNA TERRA, thus promoting telomere elongation 
via a mechanism mediated by the repressor-activator protein Rap1 and its interacting proteins, 
Rif1 and Rif2 (165, 166). Rat1 is also involved in promoting proper replication fork 
progression (165).  
The rat1-1 temperature-sensitive allele was identified in a screen for factors involved in 
the export of poly(A) mRNA from the nucleus, although this phenotype was not observed for 
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another RAT1 allele (152). It was also shown to cause the accumulation of the ncRNA 
TERRA that inhibits telomerase activity due to RNA/DNA hybrid formation (165). This 
defect results in telomeres shortening and can be overcome by RNaseH overexpression. The 
rat1-1 mutation causes elevated CTD phosphorylation, altered Pol II distribution and, most 
importantly, transcription termination defects (38). These phenotypes are rescued by 
overexpression of the CTD phosphatase Fcp1. Moreover, the rat1-1 allele is responsible for 
increased Pol II transcription kinetics and therefore is synthetic lethal with a mutation in Rpb1 
that increases Pol II speed and suppressed by mutations slowing polymerase down (38, 79). 
On the other hand, rat1-1 rescues Pol II processivity defect. Interestingly, rat1-1 is also 
synthetic sick with a mutation in guanylyltransferase Ceg1 due to the toxicity of uncapped 
mRNAs. (167). 
1.2.5 Decapping  
Decapping by cap-specific pyrophosphatases (decapping enzymes) is an important step of 
all RNA degradation pathways for Pol II transcripts (160, 168). Especially, as mentioned 
above 5’-3’ exonucleolytic decay requires prior hydrolysis of the pyrophosphate bond.  
The major cellular decapping enzyme engaged in these processes is Dcp2 from the Nudix 
pyrophosphatase family that acts within a dimeric complex with Dcp1 that is required for cap 
hydrolysis in vivo (169, 170). The Dcp1/Dcp2 complex preferentially acts on longer RNA 
substrates, at least 12 nucleotides long (171–174). Dcp2 Nudix pyrophosphatase domain is 
flanked by conserved boxes A and B that interact with Dcp1 and RNA substrate, respectively 
(172, 175, 176). Dcp1 stimulates Dcp2 activity, affecting reaction chemistry but not substrate 
binding, and serves as a bridge between the enzyme and decapping activators and inhibitors 
that regulate its activity in vivo (173, 175–177). In higher eukaryotes additional factors are 
required to stabilize the interaction between Dcp1 and Dcp2 such as Edc4/Hedls/Ge-1 
(VARICOSE in Arabidopsis) (178, 179). Moreover, multiple enhancers, including yeast 
Dhh1, Pat1, the Lsm1-7 complex or Edc1-3, and inhibitors of decapping, such as eIF4E or 
poly(A)-binding protein Pab1, are involved in this process (169, 170). Some of them act as 
general factors inhibiting or facilitating the assembly of the decapping machinery or 
influencing Dcp2 enzymatic activity, and some are RNA-specific. Although active decapping 
machinery is localized mainly in cytoplasmic foci termed P-bodies it was shown that cap 
hydrolysis can occur co-translationally and the exact function of these foci remains unclear 
(171, 180–183). Decapping enzymes compete with cap binding proteins for the access to the 
cap structure, and binding of different cap enhancers leads to formation of the decapping 
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machinery and its association in P-bodies probably by interfering with translation initiation 
factors (160).  
Although Dcp1/Dcp2 is primarily cytoplasmic it was shown to shuttle into nucleus where 
it can be involved in numerous RNA surveillance decay pathways that engage 5’-3’ RNA 
degradation (see 1.2.4.2) (184, 185). Nuclear decapping is stimulated by the Lsm2-8 complex 
and it plays an important role in utilization of nucleus-restricted mRNAs (184) and in 
regulation of expression of lncRNAs that are degraded either by the Xrn1-dependent pathway 
in the cytoplasm or by Rat1 in the nucleus (186). The latter has further impact on 
transcriptional activity of inducible genes such as GAL regulon (186, 187). Yeast and human 
Dcp1/Dcp2 complex cleaves not only m7G but also TMG and unmethylated capped RNAs 
and it was recently shown to be involved in the quality control of U1 snRNA in human and 
yeast cells (188–190). There is some evidence that Dcp1/Dcp2 as well as Xrn1 are present in 
the nucleus and associate with the chromatin to promote transcription (191). It is therefore 
possible that RNA decapping may occur co-transcriptionally in degradation of aberrant 
transcriptional products or 5’ end exonucleolytic processing of snoRNAs. Moreover, it was 
recently shown to function in premature termination of human Pol II together with the Rat1 
homolog, Xrn2, suppressing promoter bidirectionality (192). 
Besides Dcp1/Dcp2 there are other less studied decapping enzymes responsible for 
hydrolysis of a subset of RNAs. Nudt16, initially identified in Xenopus laevis as a nucleolar 
enzyme involved in decapping of U8 snoRNA (193, 194), in mammalian cells is localized in 
the cytoplasm, where it contributes to mRNA decapping (195). In turn, the cofactor of Rat1 
exonuclease, nuclear Rai1 has a decapping activity preferentially towards the unmethylated 
cap (GpppG) and also a pyrophosphatase activity, acting as an important player in RNA cap 
quality control (80, 161). Another decapping enzyme engaged in this process is Rai1 homolog 
Dxo1, that primarily resides in the cytoplasm and can degrade RNAs with an unmethylated 
cap single-handedly as it has both decapping and 5’-3’ exonuclease activity (196). The 
mammalian homolog of these enzymes, DXO, performs all three activities and eliminates 
both uncapped substrates and RNAs with the unmethylated cap (197). In contrast to Rai1, 
which shows only minimal decapping activity on properly capped RNAs, Dxo1 and DXO 
efficiently hydrolyse m7G structure (196, 197). Moreover, DXO also has a decapping activity 
towards TMG-capped RNAs, and may therefore be involved in degradation or processing of 
mammalian sn/snoRNAs (197). Recent studies identified six additional mammalian Nudix 
pyrophosphatases, namely Nudt2, Nudt3, Nudt12, Nudt15, Nudt17, and Nudt19 and the yeast 
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Nudt3, as decapping enzymes hydrolysing m7G and unmethylated caps (189). Another cap 
specific pyrophosphatase conserved among eukaryotes is the decapping scavenger enzyme 
DcpS that acts on a free cap and short-capped RNAs that arise from 3’-5’ mRNA degradation 
by the exosome (198). The important role of this enzyme is the utilization of free cap 
structures that sequester cap binding complexes from their RNA substrates (199). 
Both Dcp1 and Dcp2 are not required for yeast viability, probably because their function 
overlaps with other decapping enzymes and the 3’-5’ RNA degradation machinery. However, 
both dcp1∆ and dcp2∆ strains grow extremely slowly at all temperatures due to RNA decay 
defects (200, 201). Consistently, dpc mutants are synthetically lethal with mutations in genes 
involved in 3’-5’ RNA degradation (202, 203). 
1.3 Transcription termination and 3’ end formation 
The last step of the transcription cycle, termination, is tightly coupled to RNA 3’ end 
processing and both processes are essential for the release of Pol II and the transcript from the 
template and each other (reviewed in (204–207)). However, transcription termination is also 
vital for general expression of the genome, as it hinders Pol II from interfering with 
downstream transcriptional units and prevents from formation of asRNAs that could interfere 
with the synthesis of normal cellular RNAs. This is particularly important in the light of 
recent evidence that eukaryotic genomes are promiscuously transcribed and this 
transcriptional traffic, as well as the fate of resulting products, must be tightly regulated (207). 
It was shown that defective termination may affect splicing efficiency and at the same time 
increase RNA degradation (208). Recent findings demonstrate that transcription termination 
and 3’ end processing also impact initiation of the next round of transcription (209). This is 
connected with so called gene looping that brings promoter and terminator regions together, 
which in yeast is mediated by the interaction between TFIIB and CTD Ser5-P phosphatase 
Ssu72. Finally, as several yeast genes have been shown to undergo premature termination, 
this process may contribute to overall regulation of gene expression. Pol II termination is a 
dynamic process and can occur within, upstream or downstream of the transcription unit. 
Therefore, the timing of Pol II release influences the length of the final transcript, affecting its 
stability, localization and functionality.  
Pol II termination can proceed through different mechanisms, depending on RNA 3’ end 
processing signals and termination factors present at the end of the gene (205). The best-
studied pathways are the poly(A)dependent termination, utilized in the case of protein coding 
genes, and mechanism employed mainly in ncRNA transcription in yeast that depends on the 
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complex of two RNA binding proteins Nrd1 and Nab3 and helicase Sen1 (NNS complex). 
Both mechanisms involve shared factors and are probably utilized as the main or fail-safe 
pathways, depending on the terminator and the context of other cis- and trans-acting factors 
(206, 207, 210). All events described below are highly regulated and coordinated through 
transcription cycle by binding and release of multiple factors that specifically recognize 
different elements in the Pol II complex. The coordination of these processes, especially by 
Pol II CTD modifications, is described in another chapter (see 1.1.1). 
1.3.1 Protein coding genes: Cleavage and polyadenylation  
Pol II termination downstream of most protein coding genes is mediated by the cleavage 
and polyadenylation (CP) machinery and the poly(A) signal (PAS) that acts as a 3’ end 
processing and transcription termination site (Fig. 5A) (205–207). Human PAS consists of a 
highly conserved AAUAAA sequence and other less conserved elements, while S. cerevisiae 
PAS consensus is less conserved and in the case of most gens is composed of an adenine-rich 
efficiency element (EE, TAYRTA, where Y is any pyrimidine and R any purine), an A-rich 
positioning element (PE, AAWAAA, with W being adenine (A) or thymine (T)), located 30 
nt upstream of the cleavage position, and an uridine-rich element spanning the cleavage and 
poly(A) site (206).  
Transcription through the PAS followed by Pol II pausing allow for the 
endoribonucleolytic cleavage of the nascent transcript, subsequent polyadenylation of the 
upstream cleavage product and degradation of the downstream RNA (205–207). The strength 
of the PAS and the presence of many trans-acting termination factors influence the efficiency 
of termination. The machinery that carries out this reaction comprises more than 20 proteins 
in yeast and over 80 in mammals, which are grouped in three complexes (Fig. 5B): cleavage 
and polyadenylation factor (CPF) and cleavage factors IA (CF IA) and IB (CF IB) (205, 206). 
They are recruited to the Pol II complex via multiple interactions involving Pol II body, CTD 
and the nascent transcript, bound by termination factors at the moment PAS is transcribed by 
elongating Pol II (206). In yeast, binding of Rna15 (CF IA) to the PE and Hrp1 (CF IB) to the 
EE defines the cleavage site (Fig. 5B). Other components of CF IA, Rna14, Pcf11 and Clp1, 
are essential for termination and 3’ end processing and provide the scaffold for the CPF 
recruitment. CPF is a large complex consisting of few subcomplexes: CFII (Pta1, Yhh1/Cft1, 
Ydh1/Cft2, Ysh1/Brr5), PFI (Mpe1, Pfs2, Fip1, and Yth1) and Pap1, forming the so called 
“core CPF” that dynamically associates with the APT complex (Pti1, Swd2, phosphatases 
Glc7 and Ssu72, Ref2, and Syc1) through the interaction with Pta1 (211). The latter is 
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considered to be a fine-tuner of the 3’ end processing reaction (206). CPF associates with Pol 
II CTD via Ydh1 and Yhh1 that also interacts with RNA, and CF subunits, and binds the 
nascent transcript downstream of the cleavage site. Two CPF subunits, Ydh1 and Ysh1, 
contain βCASP family endonuclease domain, although only that of Ysh1 has been shown to 
be functional (212). The major yeast poly(A) polymerase Pap1 is recruited to the PAS 
through the interactions of Yth1 with Fip1 or directly with Pta1 (Fig. 5B and C) (206). 
Polyadenylation of pre-mRNA is regulated by poly(A) binding proteins Nab2 and Pab1 in 
yeast or PABII in mammals that adjust the poly(A) tail length to around 70 or 200 nt, 
respectively. 
 
Figure 5. Polymerase II transcription termination at protein coding genes in yeast S. cerevisiae. (A) CPF/CF 
binding sites: the AU-rich efficiency element (EE), the A-rich positioning element (PE) and U-rich regions (UE) 
surrounding the cleavage site (upstream and downstream UE), the cleavage site is indicated by a red arrow and 
is located within the A-rich region (Py(A)n). Polyadenylation signal of CYC1 mRNA is shown to exemplify the 
low conservation of yeast CPF/CF-dependent terminators. According to (206) (B) Suggested stoichiometry and 
organisation of the CPF/CF complex on mRNAs, adapted from (206). Sub-complexes are colour-coded: blue-
purple – CPF with APT (light purple), PFI (purple) and CFII (blue) subcomplexes, green – CF I A and red – CF 
I B (Hrp1). (C) Unified allosteric-torpedo model of Pol II transcription termination at protein coding genes, 
based on (207). Lines with arrowheads indicate either activation or complex dissociation, while lines with 
barheads indicate inhibition. Circles on Pol II CTD tail indicate phosphorylated residues and are colour-coded 
as on Figure 1. RNA is drawn as a black ribbon, terminator elements and termination factors are coloured as on 
the schemes presented above. DNA template is drawn as a black line. Description in the text. 
Although Pol II transcription termination is tightly coupled to 3’ end processing and 
mutation of many processing factors as well as mutation in the PAS cause termination 
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defects, Pol II continues transcription after cleavage to finally dissociate from DNA even up 
to several hundred bases downstream of the PAS (206). Transcription of the PAS reduces Pol 
II association with the template probably by decreasing the speed of the EC (Pol II pausing) 
and destabilising the RNA:DNA hybrid within polymerase catalytic centre (206). The 
cleavage reaction per se is important for Pol II release, but the exact mechanism of 
polymerase dissociation from the DNA template is not fully understood and two models of 
termination were proposed (207). According to the ‘torpedo’ model, a free monophosphate 5′ 
end generated by the 3’ end processing reaction is recognized and rapidly degraded by Rat1 
that quickly catches up with Pol II and promotes its release from the template, possibly via 
direct collision (213). On the other hand, a second mechanism, known as the allosteric or anti-
terminator model, attributes polymerase release to allosteric changes in the EC that decrease 
Pol II processivity and destabilize its interaction with the DNA template (214). These changes 
are caused by dissociation of some elongation factors and/or association of termination 
factors. There is some evidence that these mechanism are not mutually exclusive, as the 
torpedo action of Rat1/Rai1 is not sufficient to terminate Pol II and mutations of several CP 
factors, including Rna15, Rna14, Pcf11, Yhh1, Ysh1, and Ssu72, result in readthrough at the 
3’ end of protein coding genes (164, 212, 215–217) . A complete termination mechanism 
more likely reflects a combination of both strategies in a unified allosteric-torpedo model 
(Fig. 5C) (164, 218–220). 
There are conflicting data concerning the role of the exonuclease activity in transcription 
termination. It seems not to be sufficient for Pol II release as the nascent transcript 
degradation by Xrn1 redirected to the nucleus does not promote termination (164). In 
addition, catalytically inactive Rat1 (rat1D235A) is able to dismantle the EC in vitro upon 
addition of Rtt103 (221). On the other hand, recent findings demonstrate that Rat1/Rai1 is 
sufficient to terminate Pol II in vitro in the presence of nucleoside triphosphates (222). Rat1 
exonuclease activity is essential for this process, as the rat1 catalytic mutant fails to terminate 
Pol II, regardless of the presence of Rtt103 (222, 223). The termination action of Rat1/Rai1 is 
attributed to Pol II pausing caused by NTP misincorporation that provides time to degrade 
nascent RNA and ‘torpedo’ the polymerase. Recent studies in human cells also suggest that 
the kinetic competition between Pol II and Rat1 homologue Xrn2 is important for proper 
transcription termination on most human genes (224). It transpires that Xrn2 dominant 
negative catalytic mutation delays Pol II termination genome-wide, whereas Pol II with 
altered elongation rate (slow/fast) accordingly impacts the occurrence of termination 
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(early/late). On the other hand, mammalian native elongating transcript sequencing (mNET-
seq) showed, that Xrn2 is involved in termination of sense and antisense promoter-associated 
non-productive transcripts and its depletion does not cause general termination defects (11). 
In line with the latter, PAS-dependent termination of mammalian Pol II was shown in vitro to 
involve only PAS recognition leading to Pol II pausing followed by at least two 
conformational changes, but not to require RNA cleavage or 5’-3’ exonuclease activity (225). 
However, cleavage-dependent and independent torpedo mechanisms are not mutually 
exclusive and can operate in parallel. 
Specific interaction between Rat1 and Pol II, possibly aided by Rtt103, was proposed to 
assist in the transmission of the termination signal (221, 222). Nevertheless, the role of Rat1 
in Pol II termination seems to be far more complicated than proposed in the ‘torpedo’ model 
as it also impacts the CTD phosphorylation status and Pol II kinetics (see 1.2.4.2) (38, 79). 
Binding of many protein factors to the elongating Pol II makes it competent for termination 
(204–207). The most important for efficient termination is Pcf11, a CF IA component that 
associates with Ser2-P CTD and is involved in the cleavage reaction (226–228). 
Independently of this function, it seems to bridge the CTD to pre-mRNA and dismantle the 
elongation complex thereby coupling 3’ end processing to termination (227, 229). 
Interestingly, in vitro studies and uncoupling of these two steps in pcf11 mutants in vivo 
showed that CTD binding is in fact important for proper termination but not for 3’ end 
formation (215, 223, 227, 230). Moreover, depletion of human Pcf11 reduces the efficiency of 
Pol II termination stabilizing the 3’ cleavage product, suggesting its role in Xrn2-dependent 
degradation of the nascent transcript (231). In addition to Pcf11-CTD interaction, Pcf11/Clp1 
subcomplex associates with the polymerase body through a flap loop domain of Rpb2 which 
is important for transcription termination of short genes (see 1.3.2) (232). In yeast, Pcf11 and 
Rat1 appear to act in a cooperative manner in facilitating reciprocal recruitment to the 
elongation complex (164). 
Dissociation of other factors, so called anti-terminators, also influences EC conformation, 
thus favouring Pol II termination. Paf1C and the TREX/THO complex, implicated in 
coordination of mRNP biogenesis and maintenance of genome integrity, are associated with 
the transcription machinery throughout genes and their level is reduced past the poly(A) site 
(204). Yeast Sub1 and its human homologue PC4 have a conserved anti-terminator activity as 
their dissociation from the CP machinery upon PAS recognition facilitate termination (204).  
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Another anti-terminator that prevents premature Pol II termination is Npl3 that competes 
for RNA binding with CF I components Rna15 and Hrp1 (233, 234). Npl3 interacts with 
Ser2-P CTD, which increases Pol II elongation rate (235). This interaction is inhibited by 
Npl3 phosphorylation by Casein Kinase 2 (CK2), affecting Npl3 ability to compete against 
Rna15 for RNA binding. In turn, Npl3 methylation by an arginine methyltransferase Hmt1 
stimulates its export from the nucleus and weakens interaction with Tho2, a subunit of the 
THO and TREX complexes (236, 237). Hmt1 was shown to promote elongation and to 
suppress termination at cryptic terminators and may facilitate recycling of Npl3 and Tho2 
(238). The important function of Npl3 is to ensure the fidelity of pre-mRNA processing and 
mRNP formation prior to termination. Similarly, CBC that interacts with Npl3, was shown to 
independently act as an anti-terminator that prevents early termination at weak PASes (86). 
However, it does not influence Pol II elongation rate, but interferes with binding of Rna15 
and Pcf11. Both proteins are also engaged in inhibiting premature termination at naturally 
occurring weak PASes within the RNA14 gene, serving as an additional regulation system, as 
Rna14 stabilizes Rna15 and Hrp1 interaction with pre-mRNA and its overexpression 
increases recognition of weak PASes (234, 239). The mechanism of CBC suppression of 
cryptic PASes was not fully described and it is unclear whether it acts on its own or through 
interaction with other factors such as U1 snRNP. It was shown in mammals that U1 has a very 
strong anti-terminator activity and is implicated in regulating promoter directionality (240–
243). Recognition of proximal PASes located in the sense orientation is inhibited by U1 
snRNP binding, whereas U1 binding sites are depleted in the antisense orientation, where a 
high density of PASes promotes early termination, thus defining promoter directionality. 
Other factors that play important roles in transcription termination of protein coding genes 
are Pol II subunits Rbp3 and Rpb11. They were proposed to “read” or “transfer” the 
termination signal, as their mutations cause readthrough at both mRNA and snoRNA 
terminators (244). Although these mutations are distant from Pol II RNA exit channel, it is 
possible that Rpb3/Rpb11 surface interacts with some termination factor such as APT 
subunits or Sen1 helicase. Pol II subunit Rpb4 is also involved in recruiting termination 
factors, including Rna14, to the EC (245). Moreover, loss of Rpb4 results in altered PAS 
usage at the RNA14 gene as a part of a feedback upregulating Rna14 levels in response to a 
low CF IA recruitment. Rpb4, located near CTD of Rpb1 and the RNA exit channel, probably 
stabilizes interactions of 3’ end processing factors with CTD and PAS on the nascent 
transcript. 
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Sen1 (senataxin in human cells), the putative RNA/DNA helicase, was proposed to 
cooperate with Rat1, exposing the downstream cleavage product and facilitating its 
degradation (246). However, loss of Sen1/senataxin function does not affect termination at all 
poly(A)-dependent genes and its depletion does not result in readthrough at most protein 
coding genes (220, 247). 
1.3.2 Noncoding genes: NNS-dependent transcription termination 
Transcription termination of S. cerevisiae ncRNAs, such as sn/snoRNAs or cryptic 
unstable RNAs (CUTs), depends on a distinct mechanism employing the NNS complex as a 
key player (204, 206, 207, 248). The NNS complex comprises RNA-binding proteins Nrd1 
and Nab3 and the putative RNA/DNA helicase Sen1. All three proteins and their roles are 
described in details in subsequent chapters (see 1.3.2.1-3). In addition, several mRNA 3’ end 
processing factors have been shown to be involved in the transcription termination of Pol II 
transcribed ncRNAs (see 1.3.2.4). Their interaction with the elongation complex could 
facilitate some conformational changes, stimulating its dissociation from the DNA template. 
However, the major activity that dismantles Pol II complex is attributed to Sen1 (see 1.3.2.3) 
(Fig. 6C). 
snoRNA terminators appear to be bipartite (Fig. 6A), with a major NNS-dependent 
terminator (terminator I) containing clusters of Nrd1 and Nab3 binding sites (see 1.3.2.1) and 
downstream mRNA-like signal (terminator II) (217, 244, 249–251). Both signals are required 
for efficient Pol II termination that generates two classes of polyadenylated pre-snoRNAs 
(251). The recognition of ncRNA terminator either by the NNS or CPF complexes was 
proposed to depend on the distance from the transcriptional start site (252), but recent studies 
show that both complexes probably cooperate in efficient termination of sn/snoRNA 
transcription (41). Notably, ncRNA termination in yeast growing at 25°C overlapped with 
Nrd1/Nab3 binding sites (terminator I), whereas at 37°C it was shifted downstream to distal 
regions (terminator II), where Pcf11 level reached its maximum. It was proposed that 
increased Pol II elongation kinetics at elevated temperature affects Sen1 termination activity 
(253). Higher concentration of Pcf11 on chromatin is therefore necessary to stimulate Sen1 
(41). Another constituent of the non-poly(A) terminator is a region containing a series of U 
residue runs located downstream of I and II sequences (220). When Pol II fails to recognize 
these terminators it continues transcription until the next PAS (206). 
sn/snoRNA transcription termination at both sites is followed by polyadenylation 
performed by poly(A) polymerases, TRAMP components Trf4/5 and the major mRNA 
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enzyme Pap1 (Fig. 6C) (see 1.3.3.3). Similarly to protein coding genes, coupling of 
sn/snoRNA termination and 3’ end processing also involves polyadenylation, though the role 
of snoRNA poly(A) tail, unlike that of mRNA, is to facilitate their 3’ end processing or 
degradation by the nuclear exosome/Rrp6 (251, 254, 255).  
 
Figure 6. Polymerase II transcription termination at noncoding genes. (A) NNS-dependent terminators: Nrd1 
(red) and Nab3 (green) binding sites (BS), AU-rich elements resembling mRNA terminator signals and 
downstream U stretch (grey), according to (206, 220, 252). Pre-snR13 3’ end sequence is shown below to 
exemplify the spacing and composition of these motifs in the RNA sequence. (B) Suggested organisation of the 
NNS-CFI-APT complex on noncoding RNAs, according to (206). Sub-complexes are colour-coded as in Figure 
5. The NRD-CFI-APT complex has not been biochemically purified, but inferred from genetic studies. (C) 
Current model of NNS-dependent Pol II transcription termination, based on (41, 207). Lines with arrowheads 
indicate either activation, catalysed reaction or interaction (arrow heads at both ends), while lines with 
barheads indicate inhibition. Circles on Pol II CTD tail indicate phosphorylated residues and are colour-coded 
as on Figure 1. Purple circle on Sen1 represents phosphorylated residue dephosphorylated by Glc7. RNA is 
drawn as a black ribbon, terminator elements and termination factors are coloured as on schemes presented 
above. DNA template is drawn as a black line. Red bars indicate interaction between RNA and DNA. 
Description in the text. 
Initially, NNS-dependent termination was demonstrated mainly for sn/snoRNAs but more 
recent genome-wide and high-resolution studies have expanded the list of NNS targets that 
include both stable and unstable ncRNAs and some mRNAs. NNS role is therefore not only 
restricted to Pol II ncRNA termination but seems to be extended to widespread regulation of 
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gene expression either directly or by degradation of intergenic and antisense ncRNAs (248). It 
appears that 80% of yeast sn/snoRNAs biogenesis relies upon the NNS complex, as revealed 
by RNA-seq studies upon Nrd1 conditional depletion from the nucleus (256). In addition, 
noncoding Nrd1-unterminated transcripts, called NUTs, from nucleosome-depleted regions 
were shown to be common at promoters for divergent species or at most 3’ regions of genes 
for antisense NUTs. 
According to genome-wide studies of Pol II occupancy in sen1 mutant or upon Nrd1 
depletion, transcription termination of only a small subset of mRNAs is affected by NNS 
dysfunction and this concerns not only not only expression of short genes (∼200–550 bp), but 
also these of the average length (∼1.2 kb) (247, 256). Remarkably, binding of Nrd1 and Nab3 
proteins was shown for more than 1,000 mRNA targets by cross-linking approaches (257, 
258). In several cases NNS-dependent terminators are localized in 5’ regions of many protein 
coding genes and the association of Nrd1/Nab3 as well as APT subcomplex with this regions 
probably promotes early termination coupled to degradation of non-functional transcripts, 
acting as a attenuation type of gene expression regulation. Based on genome-wide transcript 
profiling in sen1 and nrd1 mutants and recent high-throughput studies it is considered that this 
mechanism may concern even hundreds of mRNA genes (256, 258), including NRD1 and 
other termination or RNA surveillance factors such as PCF11, HRP1, MUD1 (U1 snRNA 
binding protein) and TRF4. Accordingly, expression of these proteins is upregulated when 
components of the NNS-dependent termination pathway are mutated (206, 207, 248). The 
best characterized example is expression of NRD1, controlled via a negative feedback loop 
involving NNS-dependent termination with a suboptimal efficiency that depends on cellular 
levels of Nrd1 protein (259). Similar mechanism is employed by the ribosomal protein Rpl9 
that autoregulates its own synthesis, probably by masking CPF–CF termination signals and 
enabling NNS-dependent termination and nuclear degradation of abortive transcripts (260). 
NNS-dependent termination can also operate as the fail-safe mechanism in situations when 
Pol II reads through the normal terminator, especially for highly expressed genes. Often this 
termination is coupled to degradation of the nascent transcript by the exosome, unless it is 
prevented by mRNP assembly factors or readenylation by Pap1 (206). Nrd1/Nab3 binding 
sites downstream of the PAS, unlike these located within gene body, are recognized as 
terminators due to changes in Pol II CTD phosphorylation status and other rearrangements of 
the elongation complex (142). 
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Transcription termination of CUTs is also dependent on the NNS-complex, although it is 
connected with transcript degradation instead of its further processing (206, 207, 248). This is 
probably caused by the lack of protection provided by specific RNP proteins that might 
otherwise stabilize these transcripts. Following transcription termination, CUTs are 
oligoadenylated by the TRAMP complex and then degraded by the exosome associated with 
Nrd1 and TRAMP. Exosomal degradation of these RNAs is so rapid that they are only 
detected when the exosome is not fully functional (261, 262). NNS involvement in CUTs 
transcription termination and degradation has been shown in many genome-wide studies as 
well as by directed experiments for some well-characterized genes such as PHO84 (248). 
RNA-seq analyses of Nrd1 depletion effects revealed widespread function of Nrd1 in 
terminating intergenic and antisense transcripts and controlling their level and length (256, 
263). The regulation of CUTs termination is important for proper transcription of functional 
transcription units, as they are widespread, often originate from bidirectional promoters 
associated with coding genes and sometimes overlap with mRNA genes in sense or antisense 
orientation. This bidirectionality, implicated in regulation of gene expression, arises from two 
adjacent PICs that usually give rise to a functional and antisense transcript (248).  
A similar regulation strategy has been observed in humans, where PROMPTs (promoter-
proximal transcripts) are the equivalent of CUTs (207). Although transcription termination of 
these short RNAs involves the PAS and CP machinery, it also depends on factors analogous 
to these directing termination of snRNA and histone genes. The important players that 
stimulate this process are CBC and ARS2 (see 1.2.2), that probably recruit the CFII 
component CLP1 specifically to promoter proximal PASes (95, 96). Similarly to the yeast 
NNS complex, CBC–ARS2 associates with the NEXT complex, which promotes PROMPT 
degradation, important for the suppression of promoter bidirectionality in humans. It is not 
entirely clear however, whether this pathway interferes with the recently described Xrn2- and 
Dcp1/Dcp2-dependent “torpedo” termination at promoter proximal regions of human genes 
(192). 
In contrast to yeast, most of mammalian snoRNAs are encoded within introns and their 
biogenesis in not coupled to transcription termination (109). However, mammalian snRNAs 
(U1, U2, U4, and U5) are encoded by independent transcription units and their 3’ end 
maturation depends on specific snRNA promoters, distinct from those of protein coding 
genes, and requires a 3’ box element located 9–19 nt downstream of their mature 3’ end (204, 
264). A large Integrator complex is responsible for termination and 3’ end processing of for 
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mammalian snRNAs. It is recruited to the EC through Pol II CTD phosphorylated on Ser7 and 
Ser2 and one of its components (see 1.1.1), IntS11, belonging to the β-CASP family, is 
believed to perform endonucleolytic cleavage of the nascent transcript (22, 264, 265). In turn, 
APT and CF subunits function as transcription terminators for human snRNA genes with 
little, if any, role in their 3’ end processing (266). Pol II release has been linked to the 
particular chromatin structure at snRNA genes and to the action of the negative elongation 
factor NELF, which is involved in promoter-proximal pausing at protein coding genes (266, 
267). Another complex shown to be engaged in human snRNA transcription termination and 
the recognition of early 3’ processing signals is CBCA (95, 96). Moreover, ARS2 stimulates 
PHAX association with CBC on snRNPs that couple transcription termination to nuclear 
export (96). The CBCA complex was proposed to be the functional analogue of the yeast 
NNS complex. 
1.3.2.1 Nrd1 
Nrd1 (nuclear pre-mRNA down-regulation) is an essential RNA-binding protein that 
governs termination of ncRNAs and some mRNAs, in association with another RNA binding 
protein Nab3 and helicase Sen1 (36, 103, 268, 269). Nrd1 consists of a central RNA 
recognition motif (RRM), N-terminal CTD interacting domain (CID), C-terminal 
glutamine/proline rich (Q/P-rich) domain and Nab3-interacting region. Importantly, Nrd1 
CID, which is dispensable for yeast viability, preferentially binds Ser5-P CTD (268, 270–
273).  
Nrd1/Nab3 heterodimers cooperatively bind RNA in a sequence specific manner, it has 
been shown that Nrd1 affinity to its target is enhanced within the heterodimer (274). Nrd1 and 
Nab3 binding motifs in snoRNA terminators, GUAA/G and UCUU, respectively, are located 
downstream from the mature sn/snoRNA 3’ end and their number vary from one to more than 
ten (Fig. 6A) (244, 259, 274–277). Direct Nrd1 and Nab3 interaction with RNA was 
confirmed and their binding sites within ncRNA terminators precisely mapped using genome-
wide cross-linking methods such as PAR-CLIP (photoactivatable ribonucleoside-enhanced 
cross-linking and immunoprecipitation) and CRAC (cross-linking and analysis of 
complementary DNAs) (256–258, 278, 279). Consensus Nrd1 and Nab3 binding motifs from 
these studies closely match those obtained using the in vivo SELEX (systematic evolution of 
ligands by exponential enrichment) approach and mutagenesis of specific snoRNA 
terminators, but they were placed within longer supermotifs overrepresented in ncRNA 
terminators: U/AGUAA/G for Nrd1 and UCUUG for Nab3 (217, 244, 252, 275). Nrd1 and 
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Nab3 binding motifs are depleted from coding regions, but are mainly present within AT-rich 
intragenic regions of either short or long genes, some promoter proximal regions, ORF 
antisense orientations and tRNA elements (252, 256–258). The NNS complex seems to be 
involved in the regulation of expression of wide range of transcripts, though only Nrd1 
cooperative binding to Ser5-P CTD and RNA motifs containing also downstream AU-rich 
elements results in transcription termination (252, 271). Nrd1/Nab3 binding sites are also not 
recognized when located within gene bodies more than 1000 bases downstream of promoters 
(259, 271).  
The exact role of Nrd1 in ncRNA transcription termination, where Sen1 seems to be 
responsible for Pol II release, is not fully understood. Together with Nab3 it acts as a specific 
sensor of ncRNA terminators, recognizing sequence motifs described above. Multiple Nrd1-
Nab3 heterodimers bound to RNA create a ribonucleoprotein platform that recruits Sen1, 
which is underrepresented in the cell (248). Nrd1 seems to be important for Pol II pausing 
prior to termination, as its depletion eliminates pausing and enables Pol II to transcribe 
through the termination site (220). Simultaneous binding of the NNS complex to Pol II CTD 
and the nascent transcript contributes to efficient transcription termination and was proposed 
to stimulate the formation of the RNA:DNA hybrids by bridging the nascent transcript and the 
DNA template (41, 273). Furthermore, Nrd1 stimulates Pcf11 recruitment, which in turn 
promotes Nrd1 release from the CTD, making it accessible for interactions with different 
termination and 3’ end processing factors (41). This exchange of NNS interacting partners is 
proposed to coordinate transcription termination and nascent RNA degradation. Mechanism 
responsible for coupling ncRNA termination with 3’ end processing or degradation depends 
on Nrd1 interaction with a CTD mimic, so called Nrd1-interacting motif (NIM) of Trf4 
(poly(A) polymerase from the TRAMP complex) (280). Interaction with Pol II CTD and Trf4 
are mutually exclusive and Nrd1-Trf4 interaction is required for optimal exosome and 
TRAMP activity (280). Nrd1 also associates with the nuclear exosome complex through 
direct binding with Rrp6 (103, 280). This interaction is not mediated by CID, although 
replacing Nrd1 CID with that of Rtt103 reduces NNS binding to both Rrp6 and Trf4, while 
CID deletion completely abolishes association with the exosome (273, 280). Moreover, Nrd1 
interacts with CBC, although the role of this interaction and its importance for ncRNA 
transcription termination and 3’ end processing is not clear. The current model of NNS-
dependent transcription termination is presented in Fig. 6C. 
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The NNS complex activity is modulated in response to external factors. Although it is not 
fully understood how it is achieved, one possibility could include Nrd1 post-translational 
modifications that are influenced by the level of Nab3 (206). It turns out that Nrd1, as well as 
other two components of the NNS complex, is phosphorylated, but no particular kinase has 
been attributed to carry out these modifications (270, 281, 282). There is evidence that the 
Ras signalling pathway negatively affects NNS-dependent termination, however, it is not 
connected to Nrd1 phosphorylation, but may be associated with the transcriptional regulatory 
mechanism involving interaction of Nrd1/Nab3, Pol II transcription factors Spt4/5 and Ras 
with the CTD within the early EC (283). In turn, NNS-dependent termination plays an 
important role in the regulation of the cellular response to nutrient availability. It causes rapid 
suppression of some genes upon glucose depletion that is associated with Nrd1 
dephosphorylation and sequestration of Nrd1/Nab3 in novel nuclear speckles (283). Nrd1 was 
also implicated in controlling cell size and mitochondrial abundance and monitoring the 
expression of the cell cycle regulator CLN3.  
The N-terminal 163 amino acids of Nrd1 are essential for viability and deletions of Nrd1 
RRM, P1Q and RE/RS domains or mutations in RRM or CID domains confer temperature 
sensitivity (268, 270). Nrd1 mutations or its nuclear depletion cause defective termination of 
many NNS-dependent transcripts resulting in accumulation of over 1,500 extended ncRNAs 
referred to as NUTs (228, 256). Generation of NUTs leads to severe changes in gene 
expression, predominately through transcription interference. 
1.3.2.2 Nab3 
Nab3 (nuclear polyadenylated RNA-binding) was identified as a nuclear RNA-binding 
protein related to vertebrate hnRNP-C through its RRM (284). Besides the conserved RRM 
that is essential for yeast viability it is composed of low complexity domains: non-essential N-
terminal, aspartic/glutamic acid rich region of unknown function and essential C-terminal 
glutamine/proline rich region (274, 285, 286). The latter is similar to prions and can 
polymerize into an amyloid-like structure and form hydrogel in vitro (285, 286).  
Nab3 interacts with Nrd1 forming a stable heterodimer through Nrd1 interacting domain 
(270, 274). It can also self-associate into a tetrameric form through a region of structural 
homology shared with hnRNP-C (287, 288). This tetramerization is independent of 
interactions with RNA and Pol II, but it is important for transcription termination, providing 
an additional tether between Nrd1/Nab3 heterodimers bound to multiple sequence motifs on 
the nascent RNA.  
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Nab3 recognizes UCUU motifs within ncRNAs terminators (244, 274, 275, 289). The 
extended, UCUUG supermotif is highly enriched in CUT terminators, where Nrd1 binding 
motif is often absent, so in contrast to snoRNAs, CUT terminators seem to be predominately 
recognized by Nab3 (219).  
1.3.2.3 Sen1 
Sen1 belongs to a conserved RNA/DNA helicase superfamily I and its helicase activity has 
been confirmed for the S. pombe orthologue (268, 290, 291). S. cerevisiae Sen1 consists of a 
leucine zipper motif, consensus elements for nucleoside triphosphate binding, and the nuclear 
localization signal (290). Its large surface is responsible for interactions with many factors, 
proposed to play an important role in coordinating NNS-dependent processing and 
termination (292). In contrast to abundant Nrd1 and Nab3 proteins (5,800 and 19,600 
molecules per cell, respectively), only about 125 molecules of Sen1 are present in a cell (293). 
Sen1 binds Pol II CTD preferentially in the Ser2-P state and this interaction is important for 
ncRNA termination in vivo as it promotes Sen1 function, although it is dispensable for Sen1 
termination activity in vitro (37, 292, 294–297).  
Sen1 interacts with the protein phophatase-1 catalytic subunit Glc7 that, as a CPF 
component, dephosphorylates Tyr1-P CTD and is required for efficient termination at both 
sn/snoRNA and protein coding genes (46, 298, 299). The interaction between Sen1 and Glc7 
can facilitate recruitment of Sen1 to the APT complex and of Glc7 to the Nrd1/Nab3 complex 
(Fig. 6C). Considering that Glc7 was shown to dephosphorylate Sen1 in vitro, these 
associations may enable Glc7 to dephosphorylate Sen1 and possibly also Nrd1.  
The large network of Sen1-binding partners include all snoRNP core proteins, 
endonuclease Rnt1 and deoxyribonuclease Rad2 (36, 292, 298). Sen1 interaction with Rnt1 
seems to play a role in exonucleolytic processing of Rnt1 cleavage products (292). In turn, 
association with Rad2 suggests Sen1 involvement in DNA repair, that was demonstrated for 
its mammalian homologue, Senataxin (300–302). 
As the only catalytic subunit of the NNS complex Sen1 is proposed to be responsible for 
Pol II release from the DNA template. Although the exact mechanism is not completely 
understood, it probably involves ATP hydrolysis by Sen1 triggering EC dissociation in a 
similar manner to the bacterial termination factor Rho (297). In vitro Sen1 is sufficient to 
elicit termination independently of Nrd1 and Nab3 and probably in a sequence independent 
manner. This mechanism involves both ATPase and helicase activities of Sen1, as well as its 
interaction with the nascent transcript (minimum 15 nt long). In turn, NNS-dependent 
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transcription termination in vivo is enabled by a temporal and spatial window, established by 
the kinetic competition between elongating Pol II and Sen1 helicase action (303). Together, 
these data support a termination model wherein Sen1 translocates along the nascent RNA to 
catch up with Pol II and trigger its dissociation from the template, similarly to the bacterial 
termination factor Rho, while Nrd1 and Nab3 act mainly upstream, ensuring efficient and 
specific recruitment of Sen1 (207, 297).  
On the other hand, Sen1 was proposed to function in dismantling of RNA-DNA hybrids 
(R-loops) that form between the nascent transcript and the unwound template (304). Such role 
of Sen1 is supported by genome-wide cross-linking studies that showed its association with 
many transcribed genes, also independently of the Nrd1/Nab3 heterodimer (37, 278, 279, 
305). R-loops may play a role in termination by slowing down Pol II and providing time for 
association of termination factors such as Pcf11. However, this alternative appears 
incompatible with the in vitro data claiming that R-loops cannot be removed by Sen1 during 
transcription and they actually inhibit termination in vitro (297). It has been proposed that 
Sen1 instead of actively removing RNA-DNA hybrids may suppress their formation by 
association with the nascent RNA. Moreover, Sen1 has been shown to prevent transcription-
associated recombination, genome instability and replication fork defects, possibly via its 
ability to control accumulation of R-loops (305, 306). In accordance, human Senataxin 
(SETX) has been proposed to facilitate Pol II termination by resolving RNA-DNA hybrids to 
allow access of Xrn2 (307). Senataxin mutations cause pleiotropic transcription processing 
and termination defects that are manifested in cerebellum and result in neurodegenerative 
disorders such as AOAII (ataxia ocular apraxia type II) and ALS4 (amyelotropic lateral 
sclerosis 4) (307–309). Although Senataxin does not rescue SEN1 mutations in yeast, some of 
the disease-related SETX mutations cause termination defects when introduced into yeast 
SEN1 (296). 
Yeast Sen1 is essential for viability, however only the C-terminal 1,214 amino acids are 
indispensable, whereas the N-terminal 898 amino acids are nonessential (290). SEN1 
mutations or lack of Sen1 helicase activity cause most severe termination defects not only for 
Pol II genes, including most snoRNAs, but also for rDNA transcribed by Pol I (206, 228, 
247). Defective termination in sen1 mutants is modulated by mutations in RPB1, respectively 
enhanced by faster polymerase and suppressed by its lower processivity (303). Hence, kinetic 
competition between elongation and Sen1 activity was proposed to create a spatial and 
temporal window, mainly important for termination of short Pol II transcripts. 
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In addition to direct termination phenotype, sen1 temperature sensitive mutants or Sen1 
depletion exhibit pleiotropic effects, including defects in pre-tRNA splicing and rRNA and 
snRNA processing, as well as complications in nuclear fusion and chromosomal stability (36, 
310–312). It is possible that these dysfunctions are indirectly caused by transcriptional 
readthrough into relevant genes, as is the case for tRNA splicing ribonuclease SEN2 (269).  
1.3.2.4 The CP machinery and additional factors 
Several studies have shown that many components of the CP machinery contribute to 
ncRNA transcription termination, but their exact role is often not clear (Fig. 6B). In particular, 
mutations of the CF IA subunits, Rna15, Rna15, Clp1 and Pcf11, cause transcriptional 
readthrough at several sn/snoRNA genes, while inactivation of Rna14 and Rna15 leads to 
delocalisation of polyadenylated snoRNPs from the nucleolus to discrete nucleoplasmic foci 
(228, 250, 313). Remarkably, cleavage is not required for yeast sn/snoRNA termination and 
depletion of Ysh1 (CPF) or PCF11 mutation that blocks cleavage does not affect this process 
(228). Although a cold-sensitive ysh1 mutant showed defective termination at some snoRNA 
genes, no genome-wide snoRNA termination defect was observed upon Ysh1 depletion from 
the nucleus (212, 220). In contrast, PCF11 mutations disabling its binding to CTD impair Pol 
II release and snoRNA termination, probably due to ineffective competition with Ser5-P 
bound Nrd1 (51, 228) or by preventing Pcf11-Nrd1 CP-independent cooperation in ncRNA 
termination (41). Pcf11 is recruited downstream of Nrd1-binding, over distal NRD terminator 
regions, and facilitates Nrd1 release from CTD. On the other hand, Pcf11 binding to CTD 
enhances Ser2 phosphorylation that in turn promotes Sen1-CTD interaction that is crucial for 
its termination activity in vivo (Fig. 6C) (37, 292). 
Core CPF subunits are not necessary for sn/snoRNA transcription termination, whereas all 
APT components, namely Glc7, Swd2, Pti1, Pta1, Ref2, Ssu72, were shown to be required 
(Fig. 6B) (16, 211, 217, 228, 298, 314, 315). Pti1 was proposed to uncouple cleavage from 
polyadenylation, as its overexpression inhibits polyadenylation (314). This control of 
snoRNA poly(A) tail length may serve to ensure their nuclear localisation, as pre-mRNA 
polyadenylation is directly coupled to export (206). Both Pti1 and Ref2 are important for 
snoRNA termination and act as multicopy suppressors of pcf11 mutations, but are not 
essential for pre-mRNA processing in vitro. In addition, Ref2 interacts with the snoRNP 
specific protein Nop1 (316). Similarly, the N-terminal region of Pta1 is necessary for 
snoRNA termination being dispensable for pre-mRNA 3’ end processing (16), whereas its 
conserved C terminus, that connects it with the core CPF, is essential for mRNA cleavage and 
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polyadenylation (16, 211). In turn, deletion of the N-terminal region of Pta1, a CPF scaffold 
protein interacting with Ssu72, Pti1 (APT), and Ysh1 (core CPF), weakens its association 
with the CTD phosphatase Ssu72, affecting its stability, CTD Ser5-P dephosphorylation, 
snoRNA transcription termination and gene looping (16). Ssu72 CTD phosphatase that 
removes Ser5-P and Ser7-P marks at terminators, plays an important role in both CP- and 
NNS-dependent transcription termination (14, 217, 315, 317). Ssu72 inactivation causes 
transcriptional readthrough and impairs reinitiation, as it is crucial for CTD 
dephosphorylation prior to Pol II engagement into new PIC (14). Another APT subunit, 
Swd2, is also a component of the Set1-COMPASS complex, which modifies lysine 4 of 
histone H3 (H3K4) (318, 319). These two roles of Swd2 are probably separable. Depletion of 
Swd2 results in loss of APT recruitment, leading to snoRNA termination defect. This 
phenotype can be overcome by SET1 deletion, or overexpression of Ref2 or non-functional C-
terminal fragment of Sen1 (298, 318). Recent data suggests that histone modification by the 
Set1 complex can be antagonistic to NNS-dependent termination (320). It is possible that 
Swd2 recognizes the early EC, perhaps via sensing CTD-Ser5-P, and coordinates the 
simultaneous or sequential recruitment of both complexes. Consistently, SET1 deletion 
increases CTD-Ser5-P level and affects binding of NNS and APT complexes to snoRNA 
terminators (320). Similar termination defects at snoRNA genes is caused by Glc7 
downregulation or its dissociation from CPF in the absence of Ref2 or Swd2 (298). Glc7 is a 
protein phosphatase that directly interacts with Sen1 and dephosphorylates this protein in 
vitro. Loss of Glc7 from CPF can be compensated by its direct recruitment to snoRNA 
terminators via interaction with Sen1. 
Similarly to protein coding genes, Rpb3/11 heterodimer as well as the antiterminator Paf1 
complex are involved in snoRNA transcription termination. The latter interacts with Pol II 
and mediates histone modifications during elongation and was proposed to facilitate Nrd1 
recruitment to EC (68). Also co-transcriptional association of specific pre-sn/snoRNP proteins 
that stabilize RNA three-dimensional structure ensuring its stability is important for proper 
transcription termination and 3’ end processing (316, 321). 
Recent findings suggest that exonuclease Rrp6 associated with the nuclear exosome is not 
only involved in processing/degradation of transcripts terminated via the NNS-dependent 
pathway but is also engaged in the termination process itself (Fig. 6C) (322). Genome-wide 
studies revealed that Rrp6 deletion leads to decreased expression of the majority of 
sn/snoRNAs and causes changes in Pol II occupancy at some but not all NNS-dependent 
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transcripts. For instance, transcription termination of snR71, snR4, snR34, CUT281, CUT882 
as well as NRD1, HRP1 and YPL222C-A was shown to be Rrp6 dependent, while snR13 does 
not require Rrp6 for proper termination (322–324). Rrp6 directly interacts with Nrd1 and this 
interaction has been postulated to play an important role in termination of a subset of specific 
NNS-dependent RNAs (103, 273, 280). Thus, Rrp6 can regulate both degradation and the 
efficiency of NNS-dependent termination of sn/snoRNAs, CUTs, NUTs as well as some 
SUTs and mRNAs and is therefore implicated in gene expression regulation through 
transcription interference. There are also some indications of the involvement of the core 
exosome nuclease Dis3 in NNS-dependent termination of snR4 and snR34 (323). In turn, S. 
pombe exosome was recently suggested to be directly engaged in transcription termination 
according to a novel, provocative, double-torpedo model, based on observations that depletion 
of Dis3 or Rrp41 (but not Rrp6) induces a termination defect in approximately 30% of Pol II 
transcripts (325). This model proposes that the exosome can promote Pol II release by 
degrading the 3’ extension in backtracked Pol II, possibly complementing the concurrent 5’-3’ 
torpedo degradation by Rat1 (325). However, it is still debatable whether the 3’ RNA 
extension presented by the backtracked Pol II is a substrate sufficiently long for the exosome.  
1.3.3 Endo- and exonucleolytic 3’ end processing 
Transcription termination at sn/snoRNA genes generates 3’ end extended precursors (264). 
Thus, in contrast to the CP pathway, NNS-dependent termination is directly coupled to 
TRAMP/exosome-dependent processing of nascent transcripts. In the case of CUTs and many 
other unstable ncRNAs TRAMP/exosome action leads to total transcript degradation. It was 
proposed that Nrd1 is important for determining the fate of NNS-dependent transcripts 
between their processing or degradation (103). In addition, this decision is most likely 
dictated by sn/snoRNA-associated proteins that serve as a barrier against further 
exonucleolytic trimming and in this way define mature RNA ends. Some yeast pre-snoRNA 
and all pre-snRNAs contain a stem-loop structure located downstream of their mature 3’ ends, 
which is recognized and cleaved by Rnt1, generating the entry site for further 
TRAMP/exosome action (143, 326–329).  
1.3.3.1 Rnt1 
Rnt1 endonuclease and its role in S. cerevisiae RNA metabolism are described in chapter 
1.2.4.1. The 3’ end extensions of pre-snRNAs and some pre-snoRNAs (e.g. U3) are cleaved 
by Rnt1 prior to exonucleolytic trimming. One of the best-characterized example is 
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maturation of U5 snRNA that exists in two forms, U5L and U5S, with different 3’ ends 
generated by Rnt1cleavage at two sites (328). The cleavage choice is dictated by interaction 
of Rnt1 with Sen1, important for efficient maturation of U5L (36). The role of Rnt1 in 3’ end 
processing of other sn/snoRNAs is described in chapter 1.5. 
Rnt1 is also involved in the alternative fail-safe mechanism of transcription termination 
when PAS is not recognized by a standard termination machinery (141, 142). In this case, 
Rnt1 cleavage of a steam-loop structure generates an entry site for the Rat1 exonuclease 
promoting torpedo termination that is usually not coupled to polyadenylation. The resulting 
transcripts that are not stabilized by the poly(A) tail undergo rapid degradation by the 
TRAMP/exosome complex (142). However, if Rnt1 cleavage occurs close to the weak pA 
site, 3’ end processing machinery is recruited and the transcript is polyadenylated by Pap1 
(141). Association of Rnt1 with the termination site probably occurs via the interaction with 
the Pol II CTD. Rnt1 was shown to interact with the CTD mutated in Ser2 or Ser5 positions, 
required for termination by the two major mechanisms (141). Rnt1 cleavage provides 
additional possibility to terminate transcription and remove aberrant transcripts to avoid 
transcription interference. 
Out of several cases of Rnt1-dependent Pol II transcription termination, the best-
characterized example is NPL3, with an inefficient PAS-dependent mechanism (141, 330). 
Binding of Npl3 to its own PAS autoregulates its usage by causing transcriptional 
readthrough. This effect is further enhanced by Sen1, possibly by influencing the structure of 
the NPL3 transcript (247). These readthrough transcripts become cleaved by Rnt1 and are 
degraded by TRAMP/exosome complex (141, 142).  
1.3.3.2 Nuclear exosome 
The exosome complex is the main eukaryotic 3’-5’ exonuclease that is a key player in 
numerous RNA decay and processing pathways (331, 332). Two complexes of slightly 
different composition are present in the cytoplasm and the nucleus where they participate 
mainly in mRNA turnover and maturation of stable RNA species, respectively. Furthermore, 
both exosome complexes take part in RNA surveillance pathways that eliminate aberrant 
RNAs, while the nuclear exosome is engaged in degradation of RNA processing byproducts 
and ncRNAs such as asRNAs or CUTs.  
The eukaryotic exosome consists of nine subunits that form a ring-like structure (referred 
to as Exo-9) (331–333). A central channel is composed of bacterial RNase PH homologues, 
Rrp41- Rrp46 and Mtr3. Three remaining subunits, Rrp4, Rrp40 and Csl4, that contain S1 
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and/or KH-type RNA binding domains, form a cap on the top of the channel. Despite of the 
structural similarity to the archaeal exosome-like complex and the bacterial 
polyribonucleotide phosphorylase (PNPase), eukaryotic Exo-9 complex, possibly with the 
exception of RRP41 subunit in some plant species, does not display catalytic activity (334–
336). Instead, it serves as a scaffold for interactions with outer catalytic subunits and 
additional factors (335, 337). Its additional important role is to bind the RNA substrate and 
‘present’ it for catalytic subunits. 
The major catalytic exosome subunit is Dis3 (also referred to as Rrp44), which in yeast is 
associated with the Exo-9 ring of both the nuclear and cytoplasmic complexes, forming the 
Exo-10 complex (335, 338). In human cells, two Dis3 homologues, predominantly nuclear 
DIS3 and strictly cytoplasmic DIS3L, form the respective Exo-10 complexes (339). The 110 
kDa Dis3 is composed of five domains: an N-terminal Pilus-forming N-terminus (PIN) 
domain, two cold-shock domains (CSD1 and CSD2), a central ribonuclease domain (RNB), 
homologous to bacterial RNase II/R, and a C-terminal S1 domain (332). It displays 3’-5’ 
processive hydrolytic exoribonuclease activity, conferred by the RNB domain, and 
endonuclease activity located in the PIN domain (340–342). Surprisingly, of two human 
variants only nuclear DIS3 has endonucleolytic activity (339). Additionally, PIN and CSD1 
domains interact with Rrp41/Rrp45 and Rrp43 subunits of the core Exo-9 ring, respectively. 
According to recent biochemical and structural data, Dis3 is located at the bottom, on the 
opposite side of the trimetric cap (337, 342–345).  
Additional catalytic cofactor, Rrp6, homologue of bacterial RNase D, interacts with yeast 
nuclear exosome, forming the Exo-11 complex (334, 338). Human RRP6 is present in the 
nucleus and probably also nucleolus, where it associates with the Exo-10 or Exo-9 (lacking 
DIS3), respectively (339). Rrp6 is composed of five domains: an N-terminal PMC2NT 
domain, an EXO domain with a distributive 3′-5′ exoribonuclease activity, a HRDC domain 
(helicase and RNase D C-terminal domain), a predicted HRDC2 domain, and a C-terminal 
domain (CTD) (332). Rrp6 is located on the other side of the channel, in the vicinity of the 
trimeric cap, making contacts with Csl4, Mtr4 and Rrp43 (333, 345, 346). The C-terminal 
region of Rrp6 is predicted to stabilize RNA binding by the core exosome, extending it 
through the channel (345).  
Before reaching Dis3 RNB domain, RNA substrate is threaded through the channel to 
obtain at least 31-33 nt long single-stranded 3’ end (334, 335, 337, 347). RNA unwinding, 
probably assisted by cap proteins, occurs by its passage through the Exo-9 barrel in a single-
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stranded conformation, while interacting with channel subunits in a sequence-unspecific 
manner (345). Threading appears to protect the substrate from Dis3 endonuclease active site, 
which faces the solvent (337, 345). Both catalytic activities of Dis3 probably cooperate on 
most substrates, particularly those containing strong secondary structure when 
endonucleolytic cleavages facilitate exonucleolytic degradation (333, 340, 348). In turn, the 
upper portion of the channel, comprising the S1/KH ring, is important for Rrp6 activity (349). 
Therefore, shown in vitro and in vivo, threading through the core exosome channel appears to 
influence all three exosome RNase activities (337, 349, 350). Furthermore, Dis3 and Rrp6 
seem to cooperate, as Rrp6, independently of its catalytic activity, stimulates both endo- and 
exoribonucleolytic action of Dis3, while Dis3 lacking exonuclease activity severely inhibits 
Rrp6 activity (349). Notably, highly structured Dis3-dependent substrates are often associated 
with both catalytic subunits, but not the core exosome. The alternative recruitment pathway to 
the Dis3 catalytic site was proposed to be aided by docking to Rrp6 and other exosome 
cofactors (348). It probably allows the direct access of shorter single-stranded RNA regions to 
Dis3 or Rrp6.  
The choice of degradation pathways of particular substrates can be additionally regulated 
by cofactors competing for interactions with the exosome core or by influencing activities of 
Rrp6 and/or Dis3 (332, 333). In S. cerevisiae two related DExH-box RNA helicases, Mtr4 and 
Ski2, activate the exosome in the nucleus and cytoplasm, respectively. Although Mtr4 can 
function alone in assisting RNA unwinding, it also acts in the context of the TRAMP complex 
(Trf4/5–Air1/2–Mtr4 polyadenylation complex) which, in co-operation with the NNS 
complex interacting with Rrp6, recruits the exosome to degrade or process certain Pol II 
ncRNAs (see 1.3.3.3) (103, 142, 351). Similarly, in humans, the equivalent NEXT complex, 
comprising hMTR4, the Zn-knuckle protein ZCCHC8, and the putative RNA binding protein 
RBM7, binds the exosome to promote degradation of PROMPTs (352). The nuclear exosome 
interacts also with Rrp47/C1D via Rrp6 and Mpp6/MPP6 to process structured RNAs such as 
precursors of 5.8S rRNA and sn/snoRNAs (332, 353). The latter is mediated through the 
interaction between Rrp47 C-terminal region and box C/D small nucleolar ribonucleoproteins 
Nop56 and Nop58. Rrp47 is important for the recognition of Rrp6 substrates prior to their 
degradation, and was proposed to promote NNS-dependent transcription termination in 
concert with Rrp6 and Trf4 (251, 255, 259, 324). However, Rrp47 and Rrp6 also have 
separate functions in Rrp6-mediated RNA surveillance and processing. For example, Rrp6 
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can be at least partially replaced by another exoribonuclease, Rex1, in snoRNA maturation 
(255).  
Exosome is responsible for degradation and/or processing of bulk transcripts, which 
reflects tight interconnection between 3’ end processing and RNA surveillance pathways 
(332, 333). In yeast it is engaged in maturation of 3’ ends of many RNA species, including 
5.8S rRNA, sn/snoRNAs and even some mRNAs (333). In the case of NAB2 and CTH2 
mRNAs, their processing from 3’-extended precursors mediated by the NNS and nuclear 
exosome/TRAMP complexes may ensure additional regulation of their expression (258, 333, 
354, 355). Notably, the levels of NAB2 are controlled by a competition between Rrp6-
dependent surveillance and polyadenylation. Specifically, Nab2 binding to its own mRNA 
promotes its degradation by Rrp6, whereas displacement of Nab2 by Rrp6 may contribute to 
polyadenylation efficiency and association with poly(A) binding proteins (355).  
Another important role of the nuclear exosome is to eliminate many aberrant or 
superfluous transcripts and processing intermediates, both coding and noncoding. These 
substrates include excised pre-rRNA spacers, most misassembled RNPs and misprocessed 
precursors, for example unspliced or 3’-unprocessed pre-mRNAs and mRNAs trapped in the 
nucleus that would otherwise accumulate in various RNA processing and export mutants 
(100, 356–359). Multiple high-throughput RNA-seq, CRAC and PAR-CLIP analyses 
identified additional classes of Dis3/DIS3 and Rrp6/RRP6 targets, including CUTs and SUTs, 
PROMPTs (in humans), snoRNAs, and, most prominently, pre-tRNAs and other Pol III 
transcripts (257, 348, 360). In addition, these approaches revealed that Dis3 and Rrp6 have 
both overlapping and specific functions. Although Rrp6 normally acts within the context of 
EXO-11, it can also degrade some targets independently of the exosome, as subset of its 
functions are not affected by loss of Dis3 or any other Exo-9 components (333, 361). The 
nuclear exosome has been also proposed to be engaged in transcription termination, which is 
described in chapter 1.3.2.4 (322–325).  
The core exosome subunits and Dis3 are all strictly essential for yeast viability, whereas 
Rrp6 is not essential, but its deletion causes a temperature-sensitive growth phenotype. 
Exosome function has been recently connected to several other cellular pathways, including 
an role in generating antibody diversity (362). It was also linked to human diseases such as 
polymyositis-scleroderma overlap syndrome and multiple myeloma (363, 364). 
54 
 
1.3.3.3 TRAMP 
The role of the TRAMP (Trf4/5–Air1/2–Mtr4 polyadenylation complex) complex in the 3’ 
end processing or degradation is to activate and modulate catalytic activity of the nuclear 
exosome (365). TRAMP oligoadenylates transcripts that are further digested by Rrp6 and 
Dis3, assisting in transcript recognition and enhancing exonuclease activity. There are two 
TRAMP complexes present in the S. cerevisiae nucleus, namely TRAMP4 and TRAMP5 that 
contain Trf4 or Trf5, respectively. Trf4 and Trf5 are non-canonical poly(A) polymerases that 
lack RNA binding domain and therefore require one of two RNA binding proteins, Air1 or 
Air2, for substrate recruitment (366, 367). Although Trf4 is able to add quite long poly(A) 
tails to its substrates in vitro, recent in vivo studies showed that its catalytic activity is 
modulated by Mtr4 suppressing polymerization after addition of 3–5 adenosine residues and 
that distribution of oligo(A) tails added by TRAMP peaks around 4–5 adenosines (257, 368). 
Such a short poly(A) tail is not recognized by poly(A) binding proteins, Pab1 and Nab2, that 
require 12 or 20 nucleotide overhangs, respectively, which prevents transcripts 
polyadenylated by TRAMP from being exported to the cytoplasm (368, 369). 
Air1/2 proteins, having 5 zinc knuckle RNA binding motifs, contribute to substrate 
specificity of both TRAMP complexes (365, 367, 370, 371). TRAMP4 usually contains Air2, 
while TRAMP5 only contains Air1 (261, 366, 372, 373). Air1 and Air2 have non-redundant 
functions in polyadenylation of different mRNA sets, while Air2 additionally has a strong 
preference for snoRNAs (374). Consistently, favoured TRAMP4 and TRAMP5 substrates 
complexes also differ. Trf4 is required for 3’ end formation of CTH2 and polyadenylation of 
rRNAs and pre-sn/snoRNAs, while Trf5 enhances degradation of aberrant rRNAs, NAB2 and 
noncoding transcripts from intergenic spacer region (354, 355, 373, 375, 376). 
The mechanism of substrate recognition by Air proteins is not fully understood. It was 
proposed that zinc knuckles bind to specific and distinct (but not yet identified) sequence 
motifs in target RNAs or may recognize particular structures, e.g. irregular folds common 
within aberrant transcripts, and in this way recruit or exclude some specific RNA binding 
proteins (RBPs) (365). Such structures may either directly interact with Air proteins (or their 
associated factors) or prompt other factors dissociation from RNA 3’ end, making it available 
for Air1 or Air2 binding. Other proteins associated with Air1/2 may also contribute to their 
substrate specificity. For instance, the Air2-containing TRAMP complex interacts with the 
NNS complex, but this interaction is mediated by binding of Nrd1 CID with the NIM motif of 
Trf4 (103, 280, 377). In turn, overexpressed Air1 copurifies with Hrb1, a poly(A) binding 
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protein involved in mRNA export, methylated by Hmt1 (365). Also differential localization 
may influence substrate specificity of TRAMP4/5 complexes, which are both localized to the 
nucleus, but Trf5 and Air1 seem to be slightly enriched in the nucleolus, in agreement with 
their preferential function in polyadenylation of rRNA precursors (371, 373, 378). However, 
Trf4 is able to shift from nucleolus to nucleoplasm upon nucleolar accumulation of rRNAs, 
suggesting that differential localization of TRAMP complexes is more likely a result rather 
than a cause of substrate specificity (379). 
Both TRAMP complexes also comprise the nuclear 3’-5’ RNA helicase Mtr4, that is 
composed of a central ATPase core, typical of DExH helicases, and a unique arch domain, 
similar to the KOW domain of ribosomal proteins and required for 5.8S rRNA processing and 
tRNAi
Met binding (380, 381). Mtr4 interaction with Trf4 and Trf5 is most likely direct and 
independent of Air proteins (372). Mtr4 binds poly(A) RNA and probably functions 
downstream of TRAMP-mediated oligoadenylation that facilitates RNA unwinding (365). 
Since Trf4 and Mtr4 are present in excess over Air1, Air2 and Trf5, it was proposed that they 
may also perform some TRAMP-independent functions (327, 372, 382, 383). For example, 
Mtr4 can act outside the TRAMP complex as an exosome cofactor in the processing of 
structured RNAs such as 5.8S rRNA, and a group of substrates may require TRAMP, but not 
Mtr4, to stimulate degradation by the exosome (351, 366, 372). It has been proposed that 
Mtr4 in the TRAMP complex is located in the vicinity of Rrp6 and the RNA entry site, on top 
of the exosome (345, 380, 381). Both complexes are bridged by the arch/KOW domain of 
Mtr4 that hands off the substrate to the exosome or Rrp6. Structural data suggest that it may 
form a pore through which target RNA is likely to pass before reaching the exosome core 
channel (380, 381). The precise mechanism remains unclear, but it was suggested that RNA-
bound Mtr4 has to dissociate from Air-Trf to associate with the exosome. 
The exact mode of exosome activation by the TRAMP complex is not fully understood. A 
single-stranded poly(A) tail seems to make the highly structured RNAs more favourable 
substrates for the sterically restricted exosome. Although Trf4 catalytic activity is required to 
stimulate degradation of unmodified pre-tRNAi
Met, multiple studies have shown it is not 
necessary for activation and/or recruitment of the exosome (261, 351, 366, 372, 375, 383, 
384). On the other hand, the 3’-5’ helicase activity of Mtr4 is required for degradation of 
some tRNAs, likely producing a single stranded fragment that can be degraded by the 
exosome (366, 385). Mtr4 preferentially binds to tracts of adenosines and unwinds substrates 
containing overhangs of 5–6 nucleotides (365). Its activity seems to be stimulated by 
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Trf4/Air2 by increasing its ATP affinity and rate of strand separation (386). However, 
transcripts that naturally contain 3’ oligo(A) tail long enough to recruit Mtr4 and/or the 
exosome are not necessarily polyadenylated by Trf4. Another factor influencing RNA fate is 
the kinetics of its maturation (365). Defects within transcripts that stall the processing 
machinery may lead to its dissociation, thus making unprotected RNA 3’ end accessible for 
binding of the processive TRAMP complex that prevents 3’ end processing to resume and 
allows the exosome to capture the exposed terminus (368, 372). Trf4 may also act on RNAs 
already polyadenylated by Pap1 (387). Therefore, TRAMP serves also as a scaffold 
presenting transcripts to the degradation machinery. Interestingly, TRAMP may have an 
additional role in retaining aberrant transcripts in the nucleus. Air proteins inhibit Hmt1 
methyltransferase that modifies mRNA export factors Nab2 and Npl3 (237, 388), and 
therefore may promote retention of some aberrant transcripts in the nucleus to ensure their 
degradation by the nuclear surveillance (365). Consistently, polyadenylated RNAs accumulate 
in the nucleus of cells lacking both Air1 and Air2 (388). 
TRAMP in concert with the exosome is also engaged in silencing of some heterochromatic 
regions in yeast (262, 375, 389). In S. cerevisiae, this involves ncRNA transcription and 
NNS-dependent transcription termination (375, 389). Mechanisms of gene silencing in other 
organisms, particularly S. pombe, also implicate TRAMP-mediated ncRNA degradation, 
including transcriptional interference, leading to changes in chromatin structure and histone 
modification (374). 
In humans, two MTR4-associated complexes were described, TRAMP and NEXT, that 
differ is composition, localization and function. The first complex is excluded from nucleoli, 
and is specifically required for the exosome-mediated degradation of PROMPTs, whereas the 
second one contains putative homologs of Trf4 (hTRF4-2, also referred to as PAPD5) and 
Air2 (ZCCHC7) and is restricted to nucleoli, with a postulated function in 3’ end adenylation 
of Pol I transcripts targeted by the exosome (352, 390, 391). An interesting case of a 
competition between TRAMP and NEXT was recently reported for a biogenesis pathway of 
human telomerase RNA (hTR) two precursor forms. While the longer variants are 
preferentially targeted to exosomal degradation by the CBCN complex, the shorter RNA 
serves as an actual hTR precursor that is oligo-adenylated by TRF4-2 acting in the TRAMP 
complex, and either processed by PARN (poly(A)-specific ribonuclease) deadenylase or 
degraded by the exosome (102, 392). 
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1.4 sn/snoRNP structure and functions 
snRNAs comprise a small group of highly abundant ncRNAs that function in pre-mRNA 
splicing in the nucleoplasm (109). In turn, snoRNAs are mainly localized to the nucleolus and 
belong to a structurally and functionally diverse families with two major classes being box 
C/D and box H/ACA (reviewed in (109, 393). Both groups are involved in rRNA processing 
and modification. 
 
Figure 7. Small nuclear (snRNP) structure and function. The schematic structure of Sm (A) and Lsm class (B) 
snRNPs: (A) Structure of yeast U5 snRNA and general location of associated proteins according to (394, 395) 
(B) Structure of yeast U6 snRNA and general location of associated proteins according to (396). Conserved 
sequences are shown in red, dashes represent Watson-Crick base pairing, open and closed circles denote non-
Watson-Crick pairing. 
Based on their biogenesis and structure, snRNAs also can be divided into two classes 
(109). The so called Sm-class, transcribed by Pol II, contains a characteristic 3’stem–loop and 
is associated with seven Sm proteins, namely B/B’, D1, D2, D3, E, F and G (Fig. 7A), which 
form a heteroheptameric ring structure that binds to the conserved Sm-site-containing PuAU4-
6GPu motif (397). This class includes U1, U2, U4 and U5 snRNAs present in all eukaryotes, 
with additional U7 and minor spliceosome U4atac, U11 and U12 snRNAs in higher 
eukaryotes (109). In turn, U6 and U6atac (in metazoans), synthesized by Pol III, belong to the 
Lsm-class, which also contains a 3’ stem-loop, but is terminated in a stretch of uridines that 
bind a distinct heteroheptameric ring of Lsm2-8 (Sm-like) proteins (Fig. 7B) (109). Both 
groups differ also at their 5’ end, as the Sm-class carries a trimethylguanosine (TMG) cap, 
whereas U6 snRNA has a monomethylphosphate cap (109). Since individual snRNAs 
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perform different functions in pre-mRNA splicing, they are associated with specific sets of 
additional proteins (398). 
With the exception of mammalian U7 snRNP that functions in histone pre-mRNA 3’ 
processing, U snRNPs are engaged in pre-mRNA splicing forming the core of the 
spliceosome (109). U1, U2, U4, U5, and U6 snRNAs together with over 150 protein factors 
make up the major spliceosome. U1 and U2 bind at the 5’ splice site and the branch point 
adenosine, respectively, establishing crucial contacts with pre-mRNA, whereas U5 binds the 
3’ splice site. Multiple, dynamic RNA- and protein-based interactions contribute to 
communication between individual snRNPs and pre-mRNA, but intron removal is guided by 
base-pairing interactions between spliceosomal snRNAs and intron–exon junctions. Recent 
studies in yeast showed that it is U6 snRNA that catalyses both transesterification reactions by 
positioning divalent metal ions, which stabilize the leaving groups (399).  
SnoRNAs are found throughout both eukaryotes and archaea (snoRNP-like complexes; 
sRNPs) (393). The eukaryotic H/ACA snoRNAs usually comprise two stems containing H 
and ACA motifs (Fig. 8A) that are both required for RNP formation. A model based on 
archaeal sRNPs data predicts that box H/ACA RNP contains two copies of each of the core 
proteins, i.e. catalytic subunit Cbf5, Nop10, Nhp2 and Gar1 (393). Two Cbf5 proteins 
probably interact with each other and bind the conserved ACA motifs and the lower stems in 
snoRNA through their PUA domains (Fig. 8A). Interestingly, mutations that affect a cluster of 
amino acids in the PUA domain of human Cbf5 (dyskerin) result in dyskeratosis congenital 
(400). Box H/ACA RNP proteins organize the snoRNA structure and position the target 
nucleotide in the catalytic centre of Cbf5. Nop10 coordinates snoRNP function, probably 
interacting with Nhp2, H/ACA RNA and Cbf5, whereas Gar1 seems to be responsible for 
binding and/or release of the target rRNA (400, 401). 
Box C/D snoRNAs contain a C/D motif at the RNA termini and an internal C’/D’ motif 
with the same consensus, though C/D motif seems more conserved (402, 403) (Fig. 8B ). The 
C/D motif is a part of a stem-internal loop-stem structure, known as a K-turn, while the C’/D’ 
often forms a stem-loop structure, named the K-loop (402, 404). The regions between the C 
and D’ or C’ and D boxes (guide regions) base-pair with target sites in rRNA. When longer, 
the extra sequence often folds into a stem structure. Both boxes are associated with one copy 
of each core proteins, namely RNA-binding protein Snu13, Nop56, Nop58, and the catalytic 
subunit Nop1 (402). Two parts of the complex are linked by the interaction between Nop56 
and Nop58 via their coiled-coil domains (405) (Fig. 8B). Nop56 and Nop58, which 
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preferentially associate with C/D and C’/D’ motifs, respectively, play a direct role in substrate 
recognition, as they contact guide regions of snoRNAs and rRNA (403, 406).  
 
Figure 8. Small nucleolar RNP (snoRNP) structure and function. Schematic structure of yeast box H/ACA (A) 
and box C/D (B) snoRNPs with associated proteins based on archaeal snoRNP-like complexes according to 
(393). The mode of interaction with complementary sequences in rRNA is shown. Conserved sequences are in 
red, dashes represent Watson-Crick base pairing, and black circles denote non-Watson-Crick pairing. The 
pseudouridylated or methylated residue is indicated by Ψ (A) or a blue circle (B), respectively. 
Several additional proteins associate with some snoRNAs in a snoRNP-specific manner 
(393). The best characterized example is the U3 snoRNP-specific protein Rrp9 (403, 407).  It 
binds the B/C motif in U3 and is essential for U3 recruitment to the processome, a large 
complex involved in 18S rRNA processing (404, 408–411). Human homologue, hU3-55K, is 
essential for snoRNP formation and its level regulates the amount of U3 snoRNP during 
epithelial cell differentiation (412). Several poorly characterized snoRNP-specific proteins 
associate with yeast snR30 and the Lsm2-7 complex associate with snR5 (393). 
Box C/D and H/ACA RNPs catalyse site-specific rRNA modifications, pseudouridylation 
and methylation, respectively, that take place in the nucleolus (393). Pseudouridines (Ψ) and 
2’-O-methyl groups are clustered in functionally important regions of the rRNA, where they 
stabilize specific RNA structures and are important for ribosome function, which is essential 
for cell growth (109, 393). snoRNAs are responsible for substrate binding and the choice of 
the modification site in rRNA. Moreover, they serve as scaffolds that coordinate snoRNP 
organization. Selection of the target site is achieved through base-pairing between both 
RNAs. In the case of H/ACA snoRNAs, a pseudouridylation loop in a hairpin structure 
adjacent to the H or ACA box recognizes the substrate and the unpaired uridine residue is 
then converted to Ψ by Cbf5 (dyskerin in humans) (413, 414). In turn, the target region in 
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rRNA interacts with box C/D snoRNA in the vicinity of the D or D’ motifs, and the 
nucleotide located five base pairs away is methylated by Nop1 (fibrillarin in humans) (415–
417). 
A subset of eukaryotic snoRNPs does not catalyse modification, but is directly engaged in 
pre-rRNA folding and processing. These include the box C/D snoRNPs U3, that is a part of 
the rRNA processing complex called the processome, U14, U8, and U22, and the H/ACA 
snoRNPs snR30/U17 and snR10 (418). Both modifying and processing snoRNPs associate 
with the target pre-rRNA and have to be subsequently released to enable ribosome biogenesis 
to proceed and to permit access to other snoRNPs. It has been proposed that ATP-dependent 
RNA helicases, such as Prp43, are responsible for removing snoRNPs from pre-ribosomes 
(418). 
snoRNPs in higher eukaryotes, in addition to their functions in rRNA biogenesis, modify 
U6 snRNA (419). Recent studies suggest even broader roles for snoRNPs, including 
regulation of metabolic stress, alternative splicing, RNA editing and gene expression (109, 
393). In humans, telomerase RNA, required for telomere synthesis, belongs to the box 
H/ACA snoRNA class (420). Some snoRNAs target other RNAs, for example pre-mRNAs, 
such as brain-specific pre-mRNA encoding serotonin 2C receptor, recognized by snoRNA 
MBII-52, related to Prader-Willi syndrome (393). MBII-52 is processed to micro (mi)RNA-
like fragments that influence alternative splicing and editing of target pre-mRNAs. Many 
examples of snoRNA-derived miRNAs (sno-miRNAs) were recently discovered in 
mammalian cells (393). There are also several so-called orphan snoRNAs, which do not 
appear to target known substrates and could therefore function as miRNA precursors 
regulating mRNA level. Finally, yeast MRP (mitochondrial RNA processing) ncRNA, 
component of RNase MRP endonuclease, is also classified as a snoRNA. In yeast, it cleaves 
rRNA precursor in the nucleus and is also implicated in processing of mitochondrial RNAs to 
generate primers for mitochondrial DNA replication (421).  
1.5 Sn/snoRNA biogenesis: transcription termination, processing and 
assembly 
Eukaryotic sn/snoRNP biogenesis is a highly complex and coordinated process that 
slightly differs depending on the sn/snoRNA class and gene organization. Whereas most 
spliceosomal snRNA are encoded by separate genes, gene organization of snoRNAs varies 
between different organisms: they may arise from independent or polycistronic transcription 
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units or are excised from pre-mRNA introns (Fig. 9) (422). S. cerevisiae snoRNAs are 
predominately transcribed from independent genes, but some intronic and polycistronic 
molecules also exist. In turn, more than 90% of human snoRNA genes reside within introns 
and only few essential snoRNAs involved in pre-rRNA processing are autonomously 
transcribed (422, 423). Among eukaryotes, both intergenic and intronic snoRNA genes are 
either standalone or are part of a cluster, although all of eight S. cerevisiae intronic snoRNAs 
are encoded by individual units. Interestingly, most intronic snoRNAs in different known 
genomes are associated with genes encoding proteins involved in nucleolar function, 
ribosome structure or protein synthesis. It strongly suggests that biogenesis of partners acting 
in the same biological process is coordinated (422). There is an evolutionary tendency toward 
a reduction of the number of independent promoters in snoRNA organization by either 
clustering of snoRNA coding units (polycistronic transcripts) or colonization of introns (422). 
 
Figure 9. Schematic representation of independently transcribed sn/snoRNA precursor types derived from 
mono- (A, B, C and E) or polycistronic (D) transcription units according to (249). Boxes represent mature 
sn/snoRNA coding regions, scissors indicate Rnt1 cleavage sites and black circle represents the cap structure. 
Most of monocistronic box C/D and only a few box H/ACA pre-snoRNAs (e.g. snR36) are cleaved by Rnt1, 
whereas the majority of box H/ACA and a few box C/D snoRNAs (e.g. snR4 and snR13) retain cap structure at 
their 5’ terminus. Yeast pre-snRNA, except U6, are cleaved by Rnt1 during their 3’ end maturation. 
The vast majority of sn/snoRNAs is transcribed by Pol II, except yeast snR52 and U6 
snRNA that are Pol III transcripts (158, 422). Single gene encoded sn/snoRNAs are generally 
transcribed from upstream, poorly characterized promoters containing TATA boxes (424). 
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Furthermore, promoter regions of sn/snoRNAs in yeast usually comprise A/T-rich elements 
and binding sites for general transcription factors (Rap1 and Abf1) and, in the case of 
snoRNAs, also more specific transcription factors (Tbf1) (149, 425). In turn, promoters of U 
snRNA genes in higher eukaryotes are characterized by a distal sequence element (DSE) that 
recruits the Oct1 and Sp1 transcription factors and a proximal sequence element (PSE) bound 
by the specific snRNA activating protein complex (SNAPc) (264). 
In the case of snoRNA clusters, individual snoRNAs are released from the polycistronic 
transcript by Rnt1-mediated endonucleolytic cleavage in the spacer separating each snoRNA 
(Fig. 9) (131, 149). In turn, processing of intron-encoded snoRNAs is largely splicing-
dependent in yeast and mammals (422). However, biogenesis of some snoRNAs in yeast, 
such as U18, snR39 and snR59, can proceed via two different pathways: major based on 
conversion of the debranched intron by the lariat-debranching enzyme Dbr1 and minor 
depending on the endonucleolytic cleavage of pre-mRNA by Rnt1 (131, 150, 158). Most of 
yeast intronic snoRNAs are flanked by the stem loop recognized by Rnt1, however some of 
this tetraloops are not canonical (134). The assembly of snoRNPs specific proteins is 
important for proper release of these snoRNAs from pre-mRNA introns and probably Nop1 
acts as one of the chaperones, as its interaction with Rnt1 is necessary for proper cleavage of 
intron-encoded U18, snR38 and possibly also other box C/D snoRNAs (134).  
Transcription termination (see 1.3.2), Rnt1 cleavage of polycistronic or monocistronic pre-
snoRNAs or excision from introns generate sn/snoRNA precursors with extended 3’ ends that 
are further processed by exonucleolytic digestion performed by the exosome/TRAMP 
complexes (Fig. 10B) (158). Both complexes are co-transcriptionally recruited to pre-
sn/snoRNA via their interaction with the NNS complex, at least in the case of independently 
encoded sn/snoRNAs (see 1.3.2 and 1.3.3). NNS-dependent transcription termination is 
followed by polyadenylation of released precursor by the canonical poly(A) polymerase Pap1 
and the TRAMP component Trf4 (251). The contribution of exosome nuclease activities in 
pre-sn/snoRNA maturation is not fully established (see 1.3.3.2), but both Dis3 and Rrp6 are 
engaged in this process (251, 323). Shorter 3’ end extensions are rapidly degraded by Rrp6, 
whereas the 3’ end of pre-sn/snoRNAs terminated at distant termination elements seems to be 
processed mainly by the core exosome with the assistance of Rrp6 (251). Rrp6 is more likely 
responsible for the digestion of final nucleotides, as the progress of the exosome is slowed 
down by the association of specific protein factors and formation of sn/snoRNPs, that protect 
the mature 3’ end (see below) (251, 316, 321, 426, 427). 
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Additional, multiprotein THO complex has been implicated in snoRNA processing in 
collaboration with the TRAMP and the exosome in fission yeast (428). THO is responsible 
for coupling between transcription and mRNA processing and negatively regulates the 
expression of snoRNAs. Both TRAMP and THO complexes are recruited to snoRNA genes, 
and the latter is required to maintain TRAMP occupancy at snoRNA transcription sites. 
snRNAs (except U6 snRNA) and U3 box C/D snoRNA constitute a more specific group in 
that they are cleaved by Rnt1 at their 3’ end prior to exonucleolytic trimming (Fig. 9) and 
their 3’-extended precursors and cleavage intermediates are stabilized against degradation by 
binding of Lhp1 (429, 430). However, Rnt1 cleavage is not necessary for accumulation of 
mature species, as these are also processed from precursors derived from the NNS-dependent 
terminator (U1, U4 and U5) or PAS (U2) (264). Regardless of the pathway, U1, U2, U4 and 
U3 are subsequently trimmed by the exosome or alternatively by Rex exonucleases (429, 
431). The 3’ end processing of two mature forms of U5, U5L and U5S that differ at their 3’ 
ends, is more complex (328). Both functional isoforms can be generated from two distinct 
Rnt1 intermediate cleavage products, further trimmed by the exosome or Rex2 to U5S and 
U5S, respectively, but only U5S can be produced in the absence of Rnt1, possibly via the 
NNS-mediated termination (264). The ratio of both U5 variants is regulated by Rnt1 together 
with Sen1. 
3’ end processing of metazoan Pol II transcribed snRNAs proceeds differently and takes 
place in the nucleus and the cytoplasm (264). The first step involves endonucleolytic cleavage 
of the nascent transcript that leaves 2–10 nucleotide extension beyond the mature 3’ end. This 
requires the presence of a U snRNA-specific promoter, conserved 3’ box, the Integrator 
complex and Pol II CTD phosphorylated at Ser2 and Ser7 residues (see 1.1.1 and 1.3.2). 
snRNA precursors are then exported to the cytoplasm using RNA adaptor PHAX that 
interacts with CBC, and the CRM1/RanGTP complex (see 1.2.2 and 1.2.3). In the cytoplasm, 
the 3’ end is trimmed by unidentified exonuclease (264). In contrast, Pol III-dependent U6 
and U6atac snRNAs are processed as typical Pol III transcripts and their termination is driven 
by the stretch of thymidines at the 3’ end (264). Subsequently, the U6-specific uridyl terminal 
transferase, TUT1 or U6-TUTase, adds a poly(U) tail to the 3’ end. This tail is then trimmed 
to an average of 5 Us by exonuclease Mpn1 that also generates the final 2’-3’ cyclic 
phosphate of the mature U6 snRNA (264). 
Processing of 5’ termini is more diverse depending on snoRNA (Fig. 10A). In the case of 
independently transcribed snoRNAs, the 5’ end either undergoes endonucleolytic cleavage by 
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Rnt1 and further exonucleolytic trimming by Rat1 or remains unchanged. In the latter case, 
their m7G cap structure is hypermethylated to the TMG cap by methyltransferase Tgs1 (108). 
In yeast, most box C/D snoRNAs, with the exception of snR4, snR13 and snR45, are cleaved 
by Rnt1 at their 5’ end, whereas this occurs for only three box H/ACA snoRNAs, namely 
snR36, snR43 and snR46 (Fig. 9). In turn, all Pol II transcribed snRNAs retain their cap 
structure that becomes hypermethylated. Metazoan snRNA cap trimethylation as well as 3’ 
end processing and snRNP assembly takes place in the cytoplasm, whereas yeast sn/snoRNA 
and metazoan snoRNA maturation takes place in the nucleus (see 1.2.3). In higher 
Eukaryotes, snoRNAs transcribed from a separate promoter are transported to the Cajal 
Bodies thanks to CBC-PHAX/CRM1 interaction (432). After snoRNP assembly, 3’ end 
trimming and cap hypermethylation CRM1 is displaced from the complex by Tgs1 and 
mature snoRNPs is transport to the nucleolus. 
5’ end processing of extended pre-snoRNAs requires cap removal as it cannot be 
hydrolysed by 5’-3’ exonucleases. Although all known 5’ end extended pre-snoRNA are Rnt1 
substrates, RNT1 deletion does not completely blocks their maturation. The importance of 
Rnt1 cleavage for this process ranges from being essential (e.g., snR50) to almost dispensable 
(e.g. Pol III-dependent, uncapped snR52) (120). Therefore, another mechanism enabling 
exonucleolytic trimming of the 5’ end must be employed. It is likely that some decapping 
enzymes, such as the Dcp1/Dcp2 complex or Nudt proteins, are involved in this pathway that 
can operate as an alternative or in parallel with Rnt1 cleavage. 
5’ end of polycistronic snoRNAs that are not first in the cluster is generated by Rnt1 
cleavage. In principle, as Rnt1 is implicated in the backup transcription termination 
mechanism, co-transcriptional Rnt1 cleavage could be followed by degradation of the second 
and next snoRNAs within the polycistronic unit by Rat1, which could interfere with their 
processing (141). This may be prevented by the presence of some RNA-binding proteins or 
transcription factors that protect snoRNA 5’ end. 
The assembly of snoRNPs is a highly complex and dynamic process that begins co-
transcriptionally. Some snoRNP proteins were shown to be recruited to snoRNA genes, 
influencing their transcription, transcription termination and processing of nascent transcripts. 
In the case of box C/D snoRNAs, Nop1 associates with snoRNA genes co-transcriptionally 
and by physical interaction with the APT component Ref2 facilitates its recruitment (316). 
Similarly, early recruitment of assembly factor Naf1 and core components Cbf5 and Nhp2 to 
snoRNA genes during transcription is required for efficient assembly of box H/ACA snoRNA 
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(321, 433). This co-transcriptional association of Naf1 and Cbf5 is facilitated by Pol II CTD 
Ser2 phosphorylation, as Cbf5 interacts with elongation factor Spt5 and Naf1 directly binds to 
Pol II CTD (434, 435).  
 
Figure 10. Processing of 5' (A) and 3' (B) ends of sn/snoRNA. Thin lines with arrowheads indicate catalysed 
reaction or interaction (arrowheads at both ends), while lines with bar heads indicate inhibition. RNA is drawn 
as a black line. A stem-loop recognized by Rnt1, present only in some sn/snoRNA precursors, is indicated by 
dashed lines. Only 5’ part (A) or 3’ part (B) of sn/snoRNA precursors is shown. The involvement of Dcp1/Dcp2 
decapping complex in the 5’ end maturation, proposed by (120) as an alternative pathway to Rnt1 cleavage, is 
indicated by the dashed arrow. Description in the text. 
snoRNP assembly proceeds in several steps with rearrangements that require multiple 
trans-acting auxiliary factors such as Hsp90, R2TP complex and Rsa1 (NUFIP in Metazoa) 
(436). These chaperones interact with each other and are involved in the assembly of core 
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proteins of both box C/D and box H/ACA snoRNP. Hsp90 stabilizes Nop17 (also called 
Pih1), a component of the R2TP complex that also consists of Hsp90 co-chaperone Tah1 and 
two AAA + helicases Rvb1/Rvb2 (also termed Tip49/Tip48) (436, 437). Rsa1 acts as a 
scaffold that interacts with the R2TP complex, box C/D specific assembly factor Hit1 and 
snoRNP core proteins, such as Snu13 and Nop58, which associate as first components with 
box C/D snoRNAs (438). Binding of Nop56 and Nop58 is assisted by Nop17 that stabilizes 
Nop56 and increases its affinity to snoRNA, and this allows Nop1 binding to boxes D and D’ 
(439). In turn, Naf1 and Shq1 are involved in box H/ACA snoRNPs assembly. Naf1 
facilitates co-transcriptional recruitment of the preformed Naf1-Cpf5-Nop10-Nhp2 complex 
to the nascent pre-snoRNAs and Shq1 is an RNA mimic that prevents unspecific RNA 
binding (437). Stability and subcellular localization of Cpf5 (human Dyskerin) is ensured by 
binding Nhp2 and Shq1. Finally, in the post-transcriptional step, Naf1 is replaced by Gar1 to 
form the functional box H/ACA snoRNP (437). R2TP complex is required for removal of 
H/ACA snoRNPs assembly inhibitors from pre-snoRNPs at early stages of the H/ACA 
snoRNP maturation (440). The assembly of intronic snoRNAs is coupled to pre-mRNA 
splicing and the position of snoRNA in the intron is critical for this process (441, 442).  
The formation of mature spliceosomal snRNPs was extensively studied in higher 
eukaryotes, where it takes place in the cytoplasm. Sm proteins can spontaneously associate 
with U snRNA in vitro, forming heterooligomeric complexes (D1–D2, B/B0– D3, and E–F–
G) that bind to RNA (398). However, in vivo U snRNP formation is governed by two 
complexes, namely the survival motor neuron (SMN) complex and protein arginine 
methyltransferase 5 (PRMT5) complex (109, 398). SMN, whose reduced expression causes 
neuromuscular disease called spinal muscular atrophy (SMA), comprises at least eight key 
subunits (Gemins2–8 and unrip) (443, 444). Sm proteins are sequestered by the PRMT5-
complex with important contribution of chloride conductance regulatory protein (pICLn) that 
directly binds to Sm proteins and PRMT5 (398). Sm proteins B/B0, D1 and D3 are then 
symmetrically dimethylated, which activates them increasing their affinity to the SMN 
complex (398). Both complexes form the SMN-/PRMT5 complex and the set of Sm proteins 
is transferred onto the SMN to be next passed onto snRNA (398). The assembled snRNP is 
transferred to the nucleus along with the SMN complex and is directed to Cajal Bodies to 
undergo final maturation, including association of snRNP-specific proteins and snRNA 
modification (432). SMN, that is a multifunctional complex, may be also involved in box 
H/ACA snoRNP assembly as it has been shown to interact with Gar1 (437).  
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Recent studies showed that biogenesis of U4 snRNA also requires Rsa1/NUFIP and the 
R2TP complex (445). U4 snRNP shares some structural similarity to box C/D snoRNAs and 
contains Snu13 (15.5K in Metazoa) and Prp31, which similarly to Nop56/58 has a NOP 
domain. In higher eukaryotes NUFIP directly interacts with the SMN complex, connecting the 
assembly of Sm and U4 snRNP specific proteins (445).  
It is well established that pre-mRNA maturation, including capping, splicing and 3’ end 
formation, occurs co-transcriptionally. The timing of sn/snoRNA processing and its 
connection with transcription is less obvious, though as described above, efficient and correct 
3’ end formation of snoRNAs requires co-transcriptional association of snoRNP core factors 
(316, 321, 426). Components of nascent RNPs may then influence their transcription and 
processing, but coordination between these aspects for sn/snoRNAs has not been extensively 
studied. Although the 3’ end trimming must occur post-transcriptionally, 5’ end cap 
hypermethylation or Rnt1 cleavage may take place concurrently with RNA synthesis. On the 
other hand, the interaction between CBC and the NNS complex suggests that CBC remains 
bound to the nascent sn/snoRNA until the late stages of transcription. 
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2. RESEARCH OBJECTIVES 
The aim of this project was the analysis of the relationship between the processing of 5’ 
and 3’ end of sn/snoRNA in yeast S. cerevisiae. In particular I wanted to investigate the 
following aspects: 
1. Characteristics of the interaction between CBC and NNS complexes and its 
contribution to S. cerevisiae sn/snoRNA biogenesis; 
 
2. The role of Rnt1 in coupling and synchronizing pre-snoRNA 3’ and 5’ end processing; 
 
3. The role of the cap methyl transferase Tgs1 and the decapping complex Dcp1/Dcp2 in 
S. cerevisiae sn/snoRNA biogenesis. 
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3. RESULS 
7-methylguanosine 5’ cap is a unique mark of RNA Polymerase II (Pol II) transcripts and 
its recognition by specific proteins, such as nuclear cap-binding complex (CBC), is essential 
for regulation of gene expression and RNA stability. CBC is recruited to all Pol II RNAs at 
the early stages of transcription and is involved in co-transcriptional processing of pre-
mRNAs, including transcription termination and 3’ end formation. In contrast, the role of cap 
structure of ncRNAs is not fully understood.  
Yeast sn/snoRNAs never leave the nucleus and the importance of cap and CBC for their 
biogenesis has not been conclusively demonstrated, despite strong indications that CBC 
interacts with the ncRNA-specific termination NNS complex (103). Preliminary data revealed 
that when 5’ processing is inefficient snoRNA precursors do not possess mature 3’ ends 
(Grzechnik, unpublished results). This 3’ processing defect is further increased when CBC is 
missing suggesting its involvement in a quality control mechanism that coordinates 5’ and 3’ 
end processing. The aim of this project was to thoroughly analyse the role of CBC and 
endonuclease Rnt1 in coordinated processing of sn/snoRNA 5’ and 3’ termini. Since 
maturation of sn/snoRNAs shares several common features I concentrated mainly on selected 
single gene-encoded box C/D snoRNAs.  
3.1 Specificity and efficiency of new cap analogue modified affinity resins 
Affinity chromatography is a useful method for protein purification and it can be 
successfully applied for protein interaction studies. Working on my master degrees in 
chemistry and biology I synthesized three novel affinity resins with attached cap analogues 
(Fig. 11A): m7GpCH2pp-Sepharose (2), m
7GpppA-Sepharose (3) and m7GpCH2ppA-
Sepharose (4) (446). Two of these resins (2 and 4) contain methylene group replacing the 
pyrophosphate oxygen atom closest to the m7G moiety (between β and γ phosphate groups). 
This modification was introduced to specifically inhibit the decapping activity of DcpS, 
which hydrolyse pyrophosphate bond in this position. During the course of the PhD project I 
examined the properties of these resins and exploited them to develop the binding assay to 
study the interaction between CBC and NNS complexes. Results presented in this section 
were published in the RNA journal (446). 
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Figure 11. Properties of new cap analogue modified affinity resins: (A) Structures of the m7GTP-Sepharose 
(447) and affinity resins used in this study (446). DS values (degree of substitution) were determined by 
enzymatic digestion. (B) Binding of recombinant mouse eIF4E(28–217) and human DcpS to resins (1-4). Coomasie 
blue stained SDS-PAGE of input (inp, lane 1), flow-through (FT, lanes 2-5), and bound fractions eluted with 1 
mM m7GTP (lanes 6-9). (C) Western blot of eIF4E-His6/HA/ProtA and Cbp20-Myc purified from yeast extract 
using resins (1-4), eluted with 1 mM m7GTP and detected with PAP and anti-Myc antibodies, respectively. 
Western blot was performed on total lysate (Inp, lane 1), flow through (FT, lanes 2-5) and elutions from each 
resin (lanes 6-9).  
The degrees of substitution (DS) to the resin were determined as described previously 
(447). Ligands were released from matrices using two enzymes: alkaline phosphatase and 
phosphodiesterase I, and their concentration was measured spectrophotometrically at 260 nm. 
The degree of substitution for Sepharose 2 could not be calculated using this method, as this 
analogue was not cleaved by either of the enzymes. The DS values for all tested resins are 
presented in Fig. 11A. They were within the same range but lower than those described before 
(447). 
The efficiency of cap binding protein purification was evaluated using recombinant mouse 
eIF4E(28-217) and human DcpS. Proteins were incubated with equal volumes of m7GpCH2pp-
Sepharose (4), m7GpppA-Sepharose (3), m7GpCH2ppA-Sepharose (2) and control m
7GTP-
Sepharose (1), synthetized as described in (447). Bound fractions were eluted with free 
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m7GTP cap analogue (1mM) and precipitated from pooled eluates using pyrogallol red (448). 
Binding efficiency of m7GpCH2ppA-Sepharose (4) were comparable to the standard m
7GTP-
Sepharose (1) for mouse eIF4E(28-217) (Fig. 11B), while two other resins (2, 3) showed 
significantly lower binding affinities (Fig. 11B). As expected, only non-hydrolysable, 
methylene modified resins (2 and 4) bound human DcpS. However, the only resin that bound 
this pyrophosphatase with high efficiency was the m7GpCH2ppA-Sepharose (4) with a 
hexylene spacer linking the cap to the resin (Fig. 11B). 
The applicability of new resins for purification of cap binding proteins from a more 
complex biological material, such as cellular extracts, was studied before (446). To assess the 
relative efficiency of protein binding to different cap analogues more quantitatively, I 
performed similar experiments using yeast strains expressing tagged yeast cap-binding 
proteins, eIF4E and Cbp20. eIF4E was expressed from a plasmid under the control of the 
pGAL promoter as a C-terminal fusion with a triple affinity tag consisting of a His6-HA 
epitope, a protease 3C cleavage site and the IgG domain (ZZ) of protein A (450). Cbp20 was 
expressed under its endogenous promoter in fusion with the C-terminal Myc epitope (86). The 
level of eIF4E was comparable in all four eluates (Fig. 11C), which is consistent with the MS-
MS data (446), but differed significantly from binding studies with mouse eIF4E(28-217) (Fig. 
11B). This discrepancy probably results from structural differences between yeast and 
mammalian eIF4E that can affect protein-cap complex stability (451, 452). In turn, Cbp20 
bound with a comparable high affinity to the control m7GTP-Sepharose (1) and the newly 
synthesised m7GpppA-Sepharose (3). The level of Cbp20 in eluates from m7GpCH2pp-
Sepharose (2) and m7GpCH2ppA-Sepharose (4) was much lower, in agreement with the MS-
MS data (446). Resins 1 and 3 were therefore chosen for binding assays to evaluate the 
interaction between CBC and NNS complexes.  
3.2 CBC directly interacts with the Nrd1/Nab3 complex 
CBC proteins copurify with components of the NNS complex (103), but the character of 
this interaction has not been established. To confirm direct binding between these proteins I 
performed pull-down assay using yeast cellular extracts expressing Cbp80-Myc and Cbp20-
Myc and the recombinant Nrd1/Nab3 complex. To this end I purified Nrd1(1-548)-His/Nab3(191-
556)-MBP, lacking large N- and C-terminal parts of Nab3, but containing all conserved motifs 
with single RRMs in both Nrd1 and Nab3, as well as the CTD interaction domain (CID) of 
Nrd1 (274). This experiment showed that CBC copurified with the Nrd1/Nab3 complex on 
Ni-NTA-Agarose (Fig. 12A and B), whereas CBC alone was not retained on the beads (Fig. 
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12A). In contrast, Rad30-Myc, a nuclear DNA polymerase eta, used as a negative control, did 
not bind Ni-NTA-Agarose either in the presence or absence of Nrd1/Nab3 proteins (Fig. 
12C). Since both complexes contain RNA binding proteins, their copurification from the 
extract can simply result from simultaneous interaction with RNA molecules. To exclude this 
possibility, pull-down was repeated using RNase A-treated extract (experiment performed 
under my supervision by the master student Dorota Adamska). As expected, RNase treatment 
did not affect CBC-Nrd1/Nab3 interaction (Fig. 12B, compare lanes 4 and 6), strongly 
suggesting it is not mediated through RNA. 
 
Figure 12. CBC interacts with the Nrd1/Nab3 complex. (A) Pull-down assay: the mixture of Cbp20-Myc and 
Cbp80-Myc extracts incubated with or without Nrd1(1-548)-His/Nab3(191-556)-MBP and purified on Ni-NTA-
Agarose. Western blot analysis: input (Inp, lanes 1 and 5), flow through (FT, lane 2), last wash (W, lane 3) and 
elution (E, lanes 4 and 5). (B) Pull-down assay using RNase A treated extracts, description as for A. Prior to 
incubation with the Nrd1/Nab3 complex, the extract was treated with RNaseA (eluate in lane 6). (C) Control 
pull-down assay: Rad30-Myc extract incubated with or without Nrd1(1-548)-His/Nab3(191-556)-MBP and purified on 
Ni-NTA-Agarose, description as for A.  
Other putative Nrd1-interacting proteins identified in the Nrd1-TAP isolation included Pol 
II subunits and components of numerous RNA processing complexes (103). To determine 
whether CBC-NNS interaction is direct or mediated by other factors I performed in vitro 
binding using purified complexes. Because I could not obtain stable CBC expression in 
bacterial system, CBC was purified from yeast strains overexpressing Cbp20-His6-HA-3C-ZZ 
or Cbp80-FLAG-Strep-tagII2 under the control of the PGAL promoter. The isolated complex 
was contaminated with low amounts of protease 3C (Fig. 13), but no subunits of NNS, Pol II 
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or exosome complexes were detected as determined by mass spectrometry (data not shown). 
Cbp20-His6-HA-ZZ/Cbp80-FLAG-Strep-tagII2 and Nrd1
(1-548)-His/Nab3(191-556)-MBP 
complexes were incubated and purified using the m7GTP-Sepharose (1) and m7GpCH2ppA-
Sepharose (3) (446). Both complexes were present in eluates, although the Nrd1/Nab3 
complex was less abundant (Fig. 13). At the same time proteinase 3C and other contaminants 
were strongly depleted. Upon incubation of Nrd1(1-548)-His/Nab3(191-556)-MBP with both 
resins, Nrd1 itself showed only a weak binding (Fig. 13 lane 9 and 10), demonstrating that 
Nrd1/Nab3 copurifies with CBC through their interaction. The results obtained using both 
resins were comparable, although the standard m7GTP-Sepharose (1) was more efficient and 
specific. These results demonstrate that the CBC-Nrd1/Nab3 interaction is direct, not 
dependent on other proteins or RNA. Importantly, binding of the cap by CBC does not 
interfere with this process, which indicates that CBC-Nrd1/Nab3 may engage the cap-bound 
CBC in vivo. 
 
Figure 13. CBC interaction with the Nrd1/Nab3 complex is direct. Interaction in vitro using purified 
complexes: Cbp80-FLAG-Strep-tagII2/Cbp20-His-HA and Nrd1(1-548)-His/Nab3(191-556)-MBP. CBC complex, 
purified from yeast, was contaminated by Proteinase 3C, Pol II subunits or RNA, but not with the NNS complex, 
as determined by MS analysis. Interacting proteins were purified using m7GTP-(1) and m7GpppA-(3) 
Sepharoses. Control binding of the Nrd1/Nab3 complex (without CBC) is presented on the right. SDS-PAGE 
analysis: input (inp, lanes 1 and 6), flow through (FT, lanes 2-3 and 7-8) and elution (E, lanes 4-5 and 9-10). 
3.3 CBC is recruited to Pol II transcribed sn/snoRNA genes 
Recruitment of CBC at the early step of transcription was reported for protein coding genes 
but not for ncRNA genes (33, 86, 88). To determine CBC association with much shorter 
sn/snoRNA genes I optimized chromatin immunoprecipitation (ChIP) using extensive 
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sonication of formaldehyde-crosslinked chromatin to obtain fragments ~200 bp in length (10). 
The occupancy of Cpb20, Cbp80 and Pol II was analysed in Cbp20-Myc and Cpb80-Myc 
strains for chosen genes, using anti-Myc and anti-Rpb3 antibodies. Selected sn/snoRNAs 
represented different classes and gene organization and were relatively well separated from 
other transcription units or expressed at a much higher level than neighbouring genes, 
according to available high-throughput data (8, 10). This group included independently 
encoded box C/D snoRNAs snR47, snR48 and snR68, whose precursors are cleaved by Rnt1 
at their 5’ ends, and snR45 not processed by Rnt1; polycistronic box C/D snoRNA unit, 
snR41-snR70-snR51, where individual snoRNAs are separated by Rnt1 cleavage sites; box 
H/ACA snoRNAs snR30 and snR82 not cleaved by Rnt1; and U1 and U5 snRNAs processed 
by Rnt1 at their 3’ ends. Pol III transcribed box C/D snoRNA snR52 was used as a negative 
control. CBC and Pol II (Rpb3) profiles for these genes are shown in Figures 14 - 16. 
 
Figure 14. CBC is co-transcriptionally recruited to Pol II transcribed sn/snoRNA genes. Chromatin 
immunoprecipitation (ChIP) for CBC (Cbp20-Myc or Cbp80-Myc) and Pol II (Rpb3). CBC and Rpb3 profiles 
are shown along box C/D snR47 (A) and Pol III transcribed snR52 (B) genes. qPCR analysis of the ChIP output 
in CBP20-Myc (dark bars) or CBP80-Myc (light bars) strain using an anti-Myc (for Cbp20 or Cbp80 proteins) 
and anti-Rpb3 (black bars) antibodies, respectively. Data is presented as the percentage of input. The scale on 
the diagrams is adjusted to the maximal Cbp20 or Rpb3 occupancy at snR47. Error bars indicate standard 
deviation from at least three independent experiments. Schemes shown below the diagrams represent 
distribution of amplicons (marked 1-6), sn/snoRNA gene organization and adjacent transcription units. All 
symbols used here and in subsequent figures are explained in the Transcription unit legend on the bottom-right. 
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Figure 15. CBC is co-transcriptionally recruited to Pol II transcribed sn/snoRNA genes. CBC (Cbp20-Myc or 
Cbp80-Myc) and Pol II (Rpb3) profiles at box C/D snoRNA genes (A-D), box H/ACA snoRNA genes (E and F) 
and snRNA genes (G and H). Description as for Figure 14. The scale on the diagrams is adjusted to the maximal 
Cbp20 or Cbp80 occupancy at the given gene and set for 0.8% for all anti-Rpb3 IPs. 
As expected, CBC is recruited to all tested Pol II transcribed sn/snoRNAs, but not to 
snR52, for which the signal is similar to that observed for the noncoding control region (Fig. 
14-15). The slight enrichment of CBC and Pol II signals for snR52 for amplicons 2-4 may 
result from the expression of CUT that overlaps with pre-snR52 5’ end (Fig. 14B). Cbp20 and 
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Cbp80 profiles are similar (Fig. 14A and 15F), therefore for most genes only Cbp20 
occupancy was assigned. As in the case of protein coding genes, CBC recruitment occurs 
early in the transcription cycle reaching the full occupancy about 200 bp downstream of the 
transcription start site (TSS) (33). CBC profiles at the 3’ end of sn/snoRNA genes follow Pol 
II profiles with the prominent decrease downstream of the transcription termination region. 
The discrepancy between Cbp20 and Rpb3 profiles at the 3’ end of U1 snRNA may result 
from Pol II pausing at the terminator region of the SSU72 gene (Fig. 15G). Similarly, slightly 
elevated Rpb3 level at the 3’ end is observed for snR30 situated in the close vicinity of 
ADE16 (Fig. 15E). These results suggest that CBC remains associated with sn/snoRNA genes 
until termination takes place, regardless of the presence of Rnt1 cleavage site in the precursor. 
Noteworthy, CBC level at analysed genes is similar for all sn/snoRNA classes, regardless of 
the presence or absence of 5’ Rnt1 cleavage site (Fig 14-15). It is also not correlated with the 
Rpb3 level, but it has a slight tendency to reach higher values at longer transcription units 
(Fig 15C and E). 
 
Figure 16. CBC recruitment is dependent on RNA. Cbp20 profiles at snR47 (A), snR45 (B) and snR82 (C). The 
results of qPCR analysis of the ChIP output with (light bars) or without (dark bars) RNase treatment. 
Description as for Figure 14. The scale on the diagrams is set for 0.2%. 
To test if CBC presence at sn/snoRNA genes depends on RNA I performed ChIP using 
RNase-treated extracts for selected snoRNAs (snR47, snR45 and snR82) (Fig. 16A, B and C). 
ChIP signals for RNase-treated samples were near background levels, although at least two 
orders of magnitude higher than those obtained for the wild-type extract (BY4741 strain, data 
not shown). This clearly indicates that CBC is bound to nascent sn/snoRNA precursors. In 
general, observed occupancy is lower than in previous ChIP experiments (Fig. 14-15) due to 
differences in the protocol, especially shorter incubation time with the antibody. 
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3.4 Rnt1 is co-transcriptionally recruited to sn/snoRNA genes 
Association of Rnt1 with rDNA was shown to play an important role in co-transcriptional 
pre-rRNA processing (132). It has been suggested that endonucleolytic cleavage of snoRNA 
precursors by Rnt1 occurs co-transcriptionally, based on the enrichment of Rnt1 near the 
snR190-U14 gene (132). It is more likely in the case of processing in the 5’ precursor region 
that has the potential to fold early on into the hairpin structure recognized by Rnt1. On the 
other hand, association of CBC with sn/snoRNA precursors until the termination region 
indicates that the cleavage may be delayed and take place shortly before or even following 
termination. To determine whether Rnt1 is co-transcriptionally recruited to sn/snoRNA genes 
and when this event actually occurs I performed ChIP analysis using Rnt1-Myc strain for 
Rnt1-cleaved sn/snoRNAs: snR47, snR48, snR68, snR41-snR70-snR51 and U1, U5 snRNAs, 
as well as for snR45, snR30 and snR82 not processed by Rnt1 and Pol III transcribed snR52.  
For all Pol II transcribed and Rnt1-processed sn/snoRNAs, except U5, I observed 
significant enrichment of Rnt1 at the 3’ ends of genes and their termination regions (Fig. 17). 
Notably, Rnt1 remains associated with snoRNA genes until very late stages of transcription, 
with the highest occupancy observed in regions where Pol II level already drops, which is 
especially visible in the case of snR48 (Fig. 17B, compare with Fig. 15A) and snR41-snR70-
snR51 (Fig. 17D, compare with Fig. 15C). Although Rnt1-Myc signal is weaker compared to 
that of Cbp20-Myc, and there is only approximately 2 fold enrichment relative to adjacent 
noncoding regions of each gene, Rnt1 profiles for all tested Pol II transcribed snoRNAs are 
consistent. In contrast, Rnt1 profile for the Pol III transcribed box C/D snoRNA snR52 is 
significantly different (Fig. 17J), with the highest occupancy at the 5’ region of the precursor, 
where Rnt1 cleavage site is present (120), and dropping towards the 3’ end of the gene. 
Association of Rnt1 with snRNA genes was also distinct, as expected, since their precursors 
are cleaved at their 3’ termini that become accessible for recognition at the very end of their 
transcription. There is no detectable enrichment of Rnt1-Myc at U5 (Fig. 17F) and a quite 
discreet Rnt1-Myc peak downstream of U1, overlapping with the Pol II profile 3’ of the 
terminator region (Fig. 17E, compare with Fig. 15G). In addition, no Rnt1 enrichment was 
detected at box C/D snR45 and box H/ACA snR82 that are not processed endonucleolytically 
(Fig 17G and I). However, slight Rnt1 signal was observed at the 3’ end of the box H/ACA 
snR30, not reported to be cleaved by this enzyme (Fig. 17H). Rnt1 level is similar for most 
tested box C/D snoRNA genes, with the exception of snR68 (Fig. 17C) that showed three fold 
higher maximal occupancy. This gene was therefore chosen for subsequent ChIP, northern 
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blot and cRT-PCR analyses. On the other hand, Rnt1 level measured along snR48 gene was 
visibly lower (Fig. 17B), possibly due to a weaker interaction of Rnt1 with the noncanonical 
tetraloop (see 1.2.4.1).  
 
Figure 17. Rnt1 is co-transcriptionally recruited to sn/snoRNA genes. (A-J) Rnt1 profiles at different 
sn/snoRNA genes. qPCR analysis of the ChIP output in RNT1-Myc strain using anti-Myc antibodies. Description 
as for Figure 14. The scale on most diagrams is set for 0.5%, with the exception of snR68 (C), which shows the 
highest level of Rnt1 occupancy. 
Since ChIP results for Rnt1-Myc performed after RNase treatment were inconclusive due 
to the low signal and high background, to determine whether Rnt1 recruitment to sn/snoRNA 
genes depends on RNA I carried out ChIP of Rnt1-Myc in the snR68Δ strain expressing either 
wild-type or mutated copy of plasmid-borne snR68. The mutated version carries two 
substitutions in the tetraloop recognized by Rnt1 (AGGAACAA), which disable Rnt1 
79 
 
binding and endonucleolytic cleavage (124). The results of this ChIP experiment showed that 
mutations within the snR68 tetraloop (snR68mut) prevent Rnt1 recruitment to its gene, while 
the occupancy at other snoRNA genes was not affected (Fig. 18A and B). This also confirmed 
that co-transcriptional recruitment of Rnt1 involves the recognition of the tetraloop. Rnt1 
profile for the episomal copy of snR68 differs from that of genomic snR68 in the RNT1-Myc 
strain (Fig. 17C), probably due its transcription from the plasmid. 
 
Figure 18. Rnt1 recrutment depends on tetraloop recognition. Rnt1 profiles at snR68 (A) and snR47 (B). qPCR 
analysis of the ChIP output in RNT1-Myc snr68Δ pRS415-snR68WT (dark bars) and RNT1-Myc snr68Δ pRS415-
snR68mut strains using an anti-Myc antibody. The mutated version of snR68 carries two substitutions in the 
tetraloop recognized by Rnt1 (AGGA→ACAA). Description as for figure 14. The scale on the diagrams is set for 
1.5% 
Rnt1 was shown to interact directly with Sen1 and to associate with the NNS complex, 
probably via Sen1 (36, 103). To assess whether Rnt1 recruitment to snoRNA genes requires 
interactions with other protein factors, I performed ChIP for Rnt1-Myc in the sen1-K128E 
mutant, where binding between Sen1 and Rnt1 is disrupted (37, 292). As a control Rnt1-Myc 
sen1-R302W strain was used with impaired Sen1-Pol II CTD interaction, but retained Sen1-
Rnt1 connection. Rnt1 profiles in both strains showed no significant differences and were 
comparable to that for the wild-type (Fig. 19). This result indicates that Sen1 has no 
significant contribution to Rnt1 association with snoRNA genes. 
3.5 Lack of CBC delays Nrd1 recruitment to sn/snoRNA genes 
The NNS complex is recruited to sn/snoRNA genes through its interaction with Pol II CTD 
and direct binding of Nrd1 and Nab3 to RNA (272, 273, 275). It has been shown that Nrd1 
interacts with the CTD phosphorylated at Ser5 (Ser5-P), typical for Pol II at the 5’ end of 
genes (272), whereas Sen1 specifically binds Ser2-phosphorylated CTD (Ser2-P), which level 
increases towards the 3’ end of genes (37). 
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Figure 19. Rnt1 recruitement to sn/snoRNA genes does not depend on interaction with Sen1. (A-D) Rnt1 
profiles at chosen snoRNA genes. qPCR analysis of the ChIP output in the wildtype (RNT1-Myc in BY4741), 
RNT1-Myc sen1-R302W and RNT1-Myc sen1-K128E strains using anti-Myc antibodies. Description as for 
Figure 17.  
To test whether association of CBC and Nrd1 mutually affects one another I performed 
ChIP analysis for different classes of sn/snoRNAs for Cbp20-Myc in the GAL::Nrd1-HA 
strain before and after Nrd1 depletion, and for Nrd1-HA in the cbp80Δ* mutant. Nrd1 
depletion had no direct effects on CBC association with tested snoRNA genes (data not 
shown). In contrast, in the absence of CBC, Nrd1 occupancy at sn/snoRNA genes was slightly 
but significantly lower than in the wild-type strain (Fig. 20). The strongest effect was 
observed for snR68, snR45 and U1 (Fig. 20A, C and E), and it was not caused by the reduced 
transcription rate, as Pol II occupancy was comparable in both strains (Fig. 20). Also the level 
of Nrd1-HA protein was not changed (data not shown). The most visible difference in Nrd1 
association was detected along the body of the gene and upstream of the terminator region, 
whereas further downstream the Nrd1 level in cbp80Δ* cells approached the wild-type 
situation. This observation suggests that in the absence of CBC Nrd1 recruitment to 
sn/snoRNA genes is delayed. 
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Figure 20. Lack of CBC delays Nrd1 recruitment to sn/snoRNA genes. (A-F) Nrd1 (Nrd1-HA) and Pol II 
(Rpb3) profiles at different sn/snoRNA genes. qPCR analysis of the ChIP output in NRD1-HA (dark bars) and 
cbp80Δ NRD1-HA (light bars) strains using anti-HA and anti-Rpb3 antibodies. Description as for Figure 14. 
The scale on diagrams is set for 6.0 % for most anti-Nrd1-HA IPs and 0.8% for most anti-Rpb3 IPs. 
It was shown recently that CBC affects CTD phosphorylation at mRNA genes through its 
interaction with Bur1/2 and the Ctk1/2/3 kinase complexes (32, 33). In particular, the level of 
Ser2-P Pol II was markedly reduced in the absence of CBC. My ChIP analysis using Ser2, 
Ser5 and Ser7 phospho-specific CTD antibodies did not show significant differences in Ser5-
P or Ser7-P CTD at tested sn/snoRNA genes in the Nrd1-HA cbp80Δ strain (Fig. 21). 
However, although Ser2-P is generally low at relatively short sn/snoRNA genes, there was a 
slight increase in Ser2-P at some snoRNA genes in the absence of CBC, especially at snR47 
and snR48 (Fig. 21B and D). What is worth noting, Nrd1 level at these genes was comparable 
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to the wild type, however, its profile was slightly shifted towards the 3’ end. It may suggest 
some correlation between a delayed Nrd1 recruitment and Ser2-P, although these effects are 
rather subtle and may not be directly caused by the absence of CBC.  
 
Figure 21. Pol II CTD phosphorylation on sn/snoRNA genes. (A-F) Serine 7 (Ser7-P), Serine 5 (Ser5-P) and 
Serine 2 (Ser2-P) profiles at different sn/snoRNA genes. qPCR analysis of the ChIP output in NRD1-HA (dark 
bars) and cbp80Δ NRD1-HA (light bars) strains using anti-Ser7-P (24E12), anti-Ser5-P (3E8) and anti-Ser2-P 
(3E10) antibodies. Description as for Figure 14. 
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3.6 5’ end processing defect causes accumulation of 3’ extended snoRNA 
precursors 
The majority of independently transcribed box C/D snoRNAs undergoes 5’ end processing 
initiated by endonucleolytic cleavage by Rnt1 that enables further exonucleolytic trimming by 
exonuclease Rat1 (120). Rnt1 cleavage removes the cap structure associated with CBC. In 
contrast, 5’ end of snRNA and most box H/ACA snoRNAs corresponds to TSS. 
 
Figure 22. Defective processing of pre-snoRNA 5’ end results in the accumulation of 3’ extended precursors. 
(A) Northern blot analysis of snR68 in wild type (BMA64), cbp80Δ and tgs1Δ strains expressing plasmid-borne 
wild-type (lanes 1-3) or mutated (lanes 4-6) snR68. The mutated version of snR68 carries two substitutions in the 
tetraloop recognized by Rnt1 (AGGA→ACAA). Hybridization after RNase H treatment in the presence of an 
oligo specific for the sequence localized upstream the mature snoRNA. Mature snR68 (genome and plasmid 
encoded) are visible at the bottom and plasmid-derived pre-snR68 is visible on the top (lanes 4-6). (B) Northern 
blot analysis of snR68 in wild type (BMA64), cbp80Δ, tgs1Δ, rnt1Δ, rnt1Δ cbp80Δ and rnt1Δ tgs1Δ strains. 
Hybridization after RNase H treatment in the presence of an oligo specific for the mature snoRNA. 
In this case, their m7G cap becomes hypermethylated to trimethylguanosine cap (TMG) by the 
cap specific methyltransferase Tgs1 (108). TMG-capped RNAs do not further bind CBC 
whose affinity to 2,2,7- trimethylguanosine is much lower than to m7G (115). Thus, CBC 
removal from sn/snoRNPs is a common step in maturation of all sn/snoRNAs. Northern blot 
analysis of three box C/D snoRNA, snR64, snR65 and snR68, showed that 3’ extended 
snoRNA precursors with highly heterogeneous 3’ ends (3’-pre-snoRNAs) accumulated in the 
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absence of Rnt1 (Grzechnik, unpublished results). 3’ end extensions in rnt1Δ cells were even 
more dispersed than in the case of the rrp6Δ mutant, where snoRNA 3’ end processing is 
defective (251, 326, 327, 453). 
 
Figure 23. The absence of CBC or Tgs1 contributes to 3’ end processing defect. Densitometric analysis of 
autoradiographs presented on Figure 22. All bands (mature and pre-snR68) were analysed for rnt1Δ, rnt1Δ 
cbp80Δ and rnt1Δ tgs1Δ strains (A, C, E) as they were interfering with each other, while only the upper band 
(pre-snR68) was analysed for BMA64, cbp80Δ, tgs1Δ strains expressing the plasmid-borne snR68mut (B, D, F). 
For each lane a vertical line was placed manually, the relative density was measured and the diagram was 
created using the ImageQuant program. 
To further investigate this phenotype I performed similar northern blot analysis in yeast 
strains expressing plasmid-borne snR68mut carrying mutations in the tetraloop recognized by 
Rnt1 that disable Rnt1 cleavage from the plasmid. To examine the 3’ end more precisely and 
minimize the background of the wild type snR68, RNA was treated with RNase H in the 
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presence of oligonucleotide complementary to the 5’ end precursor region just upstream of the 
mature 5’ end. Tetraloop mutation caused comparable 3’ end processing defect as RNT1 
deletion (Fig. 22A), confirming that endonucleolytic cleavage at the 5’ end is important for 
efficient exonucleolytic trimming of box C/D snoRNA 3’ ends. To examine the relationship 
between Rnt1 cleavage, cap hypermethylation and CBC presence I extended this analysis for 
strains with deletions of CBC80 or TGS1, either for single mutants expressing plasmid-borne 
snR68mut or double rnt1Δ cbc80Δ and rnt1Δ tgs1Δ mutants. In the latter case, 
oligonucleotide used for RNase H treatment was complementary to the mature snR68 
sequence to obtain a better resolution of the diffused extended pre-snR68 population. 
Interestingly, additional deletion of CBC80 led to a visibly weaker accumulation of the 3’ 
extended precursor pool in both the rnt1Δ cbc80Δ double mutant and for snR68mut in cbc80Δ 
cells, whereas lack of Tgs1 caused a slightly stronger phenotype, namely an increased level of 
3’-pre-snoRNAs in the case of the rnt1Δ tgs1Δ strain or more extensive 3’ end heterogeneity 
for snR68mut in the tgs1Δ mutant (Fig. 22A and B). These observations were substantiated by 
the densitometric analysis (Fig. 23).  
These data suggest that the key element that enables proper 3’ end maturation of snoRNAs 
is the removal of CBC from the 5’ end, either by Rnt1 cleavage or by cap modification by 
Tgs1. 
3.7 snoRNA precursors that accumulate in the absence of Rnt1 are 
oligoadenylated 
It was shown before that oligoadenylation is important for the efficient snoRNA 3’ end 
processing (251). Northern blot results described above suggest that in strains where 
processing of the 5’ end is defective, 3’ ends of accumulated pre-snoRNAs are 
oligoadenylated (Grzechnik, unpublished results). To further examine the length and 
composition of these 3’ end extensions I performed circular RT-PCR (cRT-PCR) analysis 
followed by sequencing for pre-snR68 in rnt1Δ, cbp80Δ, tgs1Δ, cbp80Δ rnt1Δ and tgs1Δ 
rnt1Δ strains (Fig. 24-27). Total RNA was treated with RNase H in the presence of 
oligonucleotide complementary to the 5’ region of the precursor between two Rnt1 cleavage 
sites or Tabaco Acid Pyrophosphatase (TAP) to remove RNA 5’ cap structure (Fig. 24A). RT 
reaction on circularized total RNA was performed with a mature snR68-specific primer to 
target both mature and precursor snR68 (Fig. 24A). Different combinations of primer pairs 
were used to amplify the ligated 5’-3’ junction, with at least one complementary either to the 
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3’ or 5’ precursor sequence, to detect only pre-snR68 (Fig. 24A and pre-snR68 scheme on 
Fig. 25-27).  
 
Figure 24. cRT-PCR analysis of pre-snR68 accumulated in the wild type (BMA64), cbp80Δ, tgs1Δ, rnt1Δ, 
rnt1Δ cbp80Δ and rnt1Δ tgs1Δ strains. (A) Scheme of the cRT-PCR experiment. To remove the cap structure 
that prevent RNA ligation, total RNA was treated with Tabaco Acid Pyrophosphatase (TAP) or RNase H in the 
presence of an oligo complementary to the region located within the Rnt1-cleaved hairpin structure. After 
ligation with T4 RNA ligase, circulated RNAs were reverse transcribed using a primer specific for the mature 
snR68 (RTsp on the circular RNA diagram). Obtained cDNA was used in PCR or semi-quantitative PCR 
reactions using 3 different combinations of 4 primers (represented as green and blue arrows): pairs 1F + 1R 
(green) and 2F + 2R (blue) were used on cDNA obtained from the TAP-treated RNA, pair 2F + 1R on cDNA 
obtained from the RNaseH-treated RNA. Fragments amplified with primers 1F + 1R (collectively, DNA purified 
from both bands was pulled together) and 2F + 1R (DNA purified from different bands was treated separately) 
were cloned and sequenced. Dark rectangle corresponds to mature snR68 sequence, black dot corresponds to 
cap structure, Rnt1 cleavage site is indicated by scissors. Blue line represents sequenced 5’end, whereas green 
line represents 3’end. Primers are indicated by black (RT primer), green and blue (PCR primers) arrows. 
Packman represents TAP/RNaseH. (B) Semi-quantitative PCR of the representative experiment performed on the 
RNaseH-treated RNA using primer pair 2F + 1R. The size of the main product obtained for rnt1Δ, rnt1Δ 
cbp80Δ, rnt1Δ tgs1Δ strains (lanes 2, 4, 6) is given on the left. Coloured, numbered (1-3) bars near the first 
panel (lanes 1-2) indicate the fragments purified and sequenced separately. The smeared band in lanes 1, 3, 5 
(strains BMA64, cbp80Δ, tgs1Δ) indicated by a green bar (2) consists of 3’ end extended fragments longer than 
the lower band (blue bar, 1), while sequences of fragments that correspond to the area marked by a green bar 
(2) in lanes 2, 4, 6 are no longer that the fragments obtained from the main band (bar, 1). The upper band in 
lanes 2, 4, 6 (indicated by a magenta bar, 3) corresponds to the fragment containing multiple copies of pre-
snR68 (most often 2 copies, either identical or different). (C) Semi-quantitative PCR of the representative 
experiment performed on the TAP-treated RNA using primer pairs 1F + 1R and 2F + 2R. The size of main 
products for rnt1Δ, rnt1Δ cbp80Δ and rnt1Δ tgs1Δ strains (lanes 4-6) is given on the left. Upper bands 
correspond to the fragment containing multiple copies of pre-snR68. Lower panel shows loading control 
(TDH1). 
cRT-PCR is a more sensitive technique than northern blot, therefore 3’ extended 
precursors were detected in all tested strains, but semi-quantitative analysis showed they were 
87 
 
much more abundant in strains lacking Rnt1 (Fig. 24B and C), which is in consistent with 
northern results. The level of precursors detected with 1F+2R and 2F+2R primer pairs was 
also elevated in the tgs1Δ mutant compared to wild-type or cbp80Δ cells, although this effect 
is more subtle and therefore was not detected by northern analysis (Fig. 24B and C). 
 
Figure 25. snoRNA precursors that accumulate in the absence of Rnt1 have heterogeneous 5’ ends. 
Sequences of 5’ ends of pre-snR68 in rnt1Δ, rnt1Δ cbp80Δ, rnt1Δ tgs1Δ, cbp80Δ, tgs1Δ and wild-type (BMA64) 
strains obtained by cRT-PCR analysis. Scheme above sequences represents pre-snR68 organization, the blue 
rectangle corresponds to mature snR68, red cap represents cap structure, hairpin contains Rnt1-recognized 
tetraloop and scissors indicate Rnt1 cleavage site. The location of the two pair of primers (1F + 1R and 2F + 
2R) is shown as green and blue arrows, respectively. Sequences not shown are denoted by numbers (length) in 
round brackets; AAUG and UUGA motifs shown in red contain Rnt1 cleavage sites indicated by black scissors 
(+145 bp and +180 bp from the longest 5’end). Numbers in square brackets on the right represent the number of 
the same sequences obtained for a particular strain. Location of the sequenced fragment in the precursor is 
shown by thin lines on the pre-snR68 scheme. 
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Sequencing of pre-snR68 5’ and 3’ extensions, together with semi-quantitative analysis, 
revealed several important points. All snR68 precursors that accumulated in strains lacking 
Rnt1 were not cleaved at their 5’ ends, whereas 80-90% of 3’ end extended precursors 
detected in wild-type, cbp80Δ and tgs1Δ strains were cleaved at the first Rnt1 site (Fig. 25). 
Interestingly, most of these Rnt1-processed precursors were not further trimmed 
exonucleolytically. The majority of snR68 3’ extensions in the rnt1Δ strain were quite short, 
composed of 2-5 nt precursor sequence and additional 1-19 A residues (Fig. 26). This pool, 
amplified with the 1F+2R pair, gave rise to an abundant PCR product that was shorter than in 
the wild-type strain (Fig. 24B). Similarly short 3’ end extensions (1-5 nt precursor sequence 
plus 0-5 A residues) in the rnt1Δ strain were also observed by cRT-PCR for pre-snR68 using 
primers specific for the mature sequence (Grzechnik, unpublished results). These results were 
included in the “RNaseH 2F + 1R” set for BMA64 and rnt1∆ strains. Longer 3’ extended 
snR68 precursors were more common in wild-type, cbp80Δ and tgs1Δ strains (Fig. 27). These 
tend to reach the region containing Nrd1/Nab3 binding sites, usually upstream or within the 
first site, and probably they represent the full-length precursors that are normally present in 
the cell at a very low level. A few much longer snR68 precursors were detected in cbp80Δ 
and cbp80Δ rnt1Δ strains (Fig. 26-27) that reach into the beginning of the next FLX1 gene. 
Longer extensions above 24 nt of the precursor sequence were more rare in the rnt1Δ strain 
and were detected mainly by amplification with the primer 1R complementary to the 3’ 
precursor region. Only a small fraction of these longer 3’ ends were oligoadenylated and their 
oligo(A) tails were generally shorter (1-7 As) (Fig. 26-27). Unexpectedly, there was no 
significant difference in the length of 5’ and 3’ extensions between single rnt1Δ and double 
cbp80Δ rnt1Δ and tgs1Δ rnt1Δ mutants. And finally, this analyses revealed a considerable 
heterogeneity of precursor 5’ ends that is consistent with previous primer extension results 
(120) and is probably caused by multiple TSS (Fig. 25). 
These data strongly suggest that maturation of both snoRNA termini is synchronized, most 
likely via CBC bound to the nascent transcript 5’ end until transcription termination, resulting 
in a delay of processing at the 3’ end. However, even following the release of the transcript, in 
cases when 5’ end is incompletely or improperly matured, the processing at the other termini 
is obstructed, leading to the accumulation of 3’ extended precursors. 
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Figure 26. snoRNA precursors that accumulate in the absence of Rnt1 are oligoadenylated. Sequences of 3’ 
ends of pre-snR68 in rnt1Δ, rnt1Δ cbp80Δ, rnt1Δ tgs1Δ, cbp80Δ, tgs1Δ and wild-type (BMA64) strains. Two 
different types of experiments are indicated on the left: shorter sequences were identified using primers 2F + 1R 
(RNase H treatment), whereas longer and more heterogeneous sequences using primers 1F + 1R (TAP 
treatment). For the rnt1∆ strain, the first set (RNaseH 2F + 1R) includes initial data obtained by Dr Pawel 
Grzechnik. Sequence of the 1F primer within pre-snoRNA 3’ end is shown in green; in the case of longer 3’ ends 
only the beginning and the end of the sequence is shown, interrupted with a dash. Untemplated oligo(A) tails are 
shown in magenta, the number of A residues is in subscript (separated by + when more than one different 
species were found). Asterisk indicates the end of the longest 3’ end located within the next ORF. Sequences not 
shown are denoted by numbers (length) in round brackets. Numbers in square brackets on the left represent the 
number of the same sequences obtained for a particular strain. Location of the sequenced fragment in the 
precursor is shown by thin lines on the pre-snR68 scheme (description as for Figure 25). 
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Figure 27. Sequences of 3’ ends of pre-snR68 in cbp80Δ, tgs1Δ and wild-type (BMA64) strains. Description as 
for Figure 26. For the wild-type strain, the first set (RNaseH 2F + 1R) includes initial data obtained by Dr 
Pawel Grzechnik. 
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3.8 The contribution of the Dcp1/Dcp2 complex to snoRNA processing 
Although box C/D pre-snoRNAs accumulate in strains lacking Rnt1 activity, some amount 
of mature snoRNAs, varying for different species, is still generated (Fig. 22B) (119, 120, 131, 
149). An alternative, Rnt1-independent 5’ end maturation pathway may involve the removal 
of the 5’ cap structure by the decapping Dcp1/Dcp2 complex followed by trimming by 
Rat1/Xrn1. Although snoRNA precursors that accumulate in the rnt1Δ strain were shown to 
carry a TMG cap (119, 120, 131, 149), yeast Dcp2 is able to decap TMG-capped RNAs (188).  
The level of box C/D pre-snoRNA in strains devoid of the decapping activity has been 
analysed previously, with some effects detected only for pre-snR68, but not other snoRNAs 
tested, in dcp1Δ and dcp2Δ strains and in temperature sensitive dcp1-2 mutant at the 
restrictive temperature, especially in the poly(A)+ RNA fraction, suggesting that snR68 
precursors were polyadenylated (Grzechnik, unpublished results). 
 
Figure 28. Contribution of the Dcp1/Dcp2 complex to snoRNA processing. (A) Northern blot analysis of 
snR68 in the wild type (BY4741) and dcp2Δ strains expressing plasmid-borne wild-type (lanes 1-2) or mutated 
(lanes 3-4) snR68. Description as for Figure 22A. (B) Semi-quantitative PCR of representative cRT-PCR 
experiment performed on TAP-treated RNA using primer pairs 1F + 1R and 2F + 2R for the wild-type (BY4741) 
and dcp2Δ strains. Description as for Figure 24C. 
The level of snoRNA precursors in decapping deficient strains was much lower than in the 
rnt1Δ strain, which indicates that processing involving cap hydrolysis represents a minor 
pathway when Rnt1 is active. Attempts to generate double rnt1Δ dcp1Δ or rnt1Δ dcp2Δ 
mutants were not successful, suggesting that deletions of RNT1 and either DCP1 or DCP2 
may be synthetic lethal. To circumvent this difficulty I used a dcp2Δ strain expressing 
snR68mut with an Rnt1 binding site mutation. The level of unprocessed snR68mut precursors 
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was greatly enhanced by DCP2 deletion compared to that in the wild-type strain, showing that 
lack of the decapping activity adds to the processing phenotype induced by the inhibition of 
Rnt1 cleavage (Fig. 28A). The accumulation of pre-snR68 in the dcp2Δ mutant was also 
confirmed by the semi-quantitative cRT-PCR analysis (Fig. 28B). Surprisingly, I observed a 
significant enrichment of precursors that were not cleaved by Rnt1 (primers 2F+2R). 
Sequencing of cRT-PCR products generated with the 1F+2R pair revealed that approximately 
80% of 3’ extended precursors in the dcp2Δ strain was not processed by Rnt1, compared to 
only 10% in the isogenic wild-type strain (Fig. 29A). These results suggest that decapping 
may precede and facilitate Rnt1 processing. Unexpectedly, 5’ extensions in dcp2Δ cells were 
on average shorter than those in rnt1Δ strains (compare Fig. 25 and 29A), but it may reflect 
different genetic backgrounds. 
 
Figure 29. Contribution of the Dcp1/Dcp2 complex to snoRNA processing. (A) Sequences of 5’ ends of pre-
snR68 in dcp2Δ and wild-type (BY4741) strains. Description as for Figure 25. Rnt1 cleavage sites are indicated 
by black scissors (+130 bp and +164bp from the longest 5’end). (B) Sequences of 3’ ends of pre-snR68 in dcp2Δ 
and wild-type (BY4741) strains. Sequences were obtained using primers 1F + 1R (TAP treatment). Description 
as for Figure 26. 
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3.9 Summary 
Multiple roles of m7G cap and CBC in pre-mRNA processing are well established, whereas 
their contribution to ncRNA biogenesis was not studied that extensively. Presented data 
strongly indicate that there is a regulated connection between two termini of pre-sn/snoRNA, 
since 5’ end processing defect results in accumulation of 3’ end extended precursors in 
mutants related to RNA 5’ end status (rnt1Δ, tgs1Δ, cbp80Δ rnt1Δ, tgs1Δ rnt1Δ and dcp2Δ). 
The presence of cap and CBC on the precursor molecule acts as a signal that its 5’ end is still 
not completed and ready for further processing. A key element of this coordination 
mechanism involves cap removal (mainly through Rnt1 cleavage) or modification 
(hyperphosphorylation by Tgs1). CBC directly interacts with ncRNA-specific termination 
factors, the NNS complex, and remains bound to the nascent transcript throughout the course 
of its transcription. Early co-transcriptional recruitment of Rnt1 to snoRNAs requires specific 
stem-loop structure within the precursor, but it appears that endonucleolytic cleavage occurs 
only at the end of transcription, acting to activate both 5’- and 3’ end trimming. This 
synchronized processing of both sn/snoRNA termini may serve as an additional mechanism 
regulating error-free and well-timed expression of ncRNAs. 
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4. DISCUSION 
While the role of the 5’ cap and CBC in pre-mRNA processing and export of mRNAs and 
metazoan snRNAs is well established (reviewed in (73, 74)), their function in yeast 
sn/snoRNA biogenesis remains largely unknown. It has been previously demonstrated that 
CBC and ncRNA-specific NNS termination factors exist in a multisubunit complex that also 
contains the exosome (103), but the character and contribution of this complex to sn/snoRNA 
biogenesis has not been properly explored. Using new affinity resin with attached cap 
analogue (m7GpppA-Sepharose) and m7GTP-Sepharose I showed that the CBC-NNS 
interaction is direct, independent of RNA and other proteins. CBC is co-transcriptionally 
recruited to the nascent pre-sn/snoRNA m7G cap and remains bound until termination takes 
place. I envisage that during transcription elongation CBC contributes to Nrd1 recruitment to 
sn/snoRNA genes via its physical connection with the NNS complex. This association links 5’ 
cap and CBC to sn/snoRNA transcription termination and their 3’ end processing. Similar 
relationship was recently described in human cells, where CBC interacts with the ARS2 
protein and the CBC-ARS2 complex may be regarded as functionally analogous to the yeast 
NNS complex (95, 96).  
Although 5’ end processing of sn/snoRNAs differs between distinct groups, it always 
involves CBC removal either by combined endo- and exonucleolytic trimming or by cap 
hypermethylation. My analyses revealed accumulation of 3’ extended precursors of box C/D 
snoRNAs when their 5’end processing is inhibited, mainly in the absence of Rnt1 cleavage. 
Notably, the additional lack of CBC partially rescues this phenotype, whereas deletion of 
DCP2 or TGS1 has the opposite effect. Together, my data suggest the existence of a quality 
control mechanism that coordinates the processing at both sn/snoRNA termini, with the CBC-
NNS complex being a key factor that prevents premature maturation of either end. 
4.1 The CBC-NNS complex coordinates processing of sn/snoRNA 5’ and 3’ 
ends 
Although the existence of the CBC-NNS complex is well established, its function has not 
been conclusively demonstrated. Since the NNS complex in involved in transcription 
termination and nuclear RNA surveillance, it may be presumed that CBC-NNS may 
contribute to either of these activities. CBC in association with the exosome has been shown 
to eliminate mRNAs retained in the nucleus due to abnormal physiological conditions in the 
nuclear mRNA degradation pathway (DRN) (99–101). However, nuclear location of yeast 
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sn/snoRNAs is absolutely natural, as they are not known to leave the nucleus, so they are not 
subject to the DRN quality control. 
sn/snoRNAs as all Pol II transcripts are capped at the early stage of their synthesis. 
Although mature sn/snoRNAs do not possess m7G cap that interacts with CBC, proteomic 
analyses of sn/snoRNP composition in wild-type and tgs1Δ strains revealed CBC association 
with snoRNP complexes prior to TMG-capping (107). My ChIP analyses demonstrated that 
CBC is co-transcriptionally recruited to sn/snoRNA genes as soon as cap synthesis is 
completed, reaching full occupancy about 200 bp downstream of the TSS. This is consistent 
with a genome-wide CBC association for protein coding genes (33) and in accordance with 
the ChIP-chip occupancy profiles for sn/snoRNA genes (unpublished data provided by 
Michael Lidschreiber). CBC presence at the 5’ end of pre-sn/snoRNA persists until the 
completion of their transcription, followed by its rapid removal either by Rnt1 processing or 
by cap hypermethylation (120). In turn, Nrd1 reaches its full occupancy usually at least 100-
200 bp downstream of the CBC peak, so it appears that CBC-NNS complex formation is 
restricted to a very defined stage of sn/snoRNA biogenesis. This transient and 
substoichiometric complex assembles most likely co-transcriptionally, probably 
simultaneously with NNS recruitment, since my data suggest that CBC promotes Nrd1 
association with sn/snoRNA genes. The impact of CBC on Nrd1 recruitment is not mediated 
by changes in CTD phosphorylation status, however, it may be also connected with Pcf11 
recruitment to sn/snoRNA terminator. In the case of mRNAs, CBC promotes Ser2-P that 
stimulates productive Pol II elongation (31–33). However, this effect is not observed for short 
sn/snoRNA genes, where Ser2-P level is much lower than for protein coding genes. 
In the case of transcription termination of protein coding genes, CBC was shown to act as 
an antiterminator and prevent early termination at weak PASes by interfering with binding of 
termination factors Rna15 and Pcf11 (86). Both Rna15 and Pcf11 were demonstrated to be 
involved in NNS-dependent transcription termination. According to recent studies Pcf11, that 
is recruited downstream of Nrd1-binding sites, cooperates with Nrd1 and facilitates it release 
(41). It was also suggested that Pcf11 binding enhances Ser2 phosphorylation and promotes 
Sen1-CTD interaction necessary for its termination activity in vivo (37, 292). Slightly 
elevated Ser2-P level observed in the termination region of some snoRNA genes in the 
cbp80∆ NRD1-HA strain can be therefore explained by earlier Pcf11 recruitment and its 
stimulatory effect on CTD phosphorylation. It would also account for delayed recruitment of 
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Nrd1 to these genes. The competition between Pcf11 and Nrd1 may also contribute to lower 
Nrd1 occupancy at sn/snoRNA genes observed in cbp80∆ NRD1-HA strain. 
Three potential function of the CBC-NNS interaction should be considered: targeting to 
degradation by the exosome as proposed for mRNAs (99–101), transcription termination or 
3’end processing activity, similarly to the human CBCA complex (95, 96). Although the first 
possibility cannot be ruled out and may operate in the case of mRNA and cryptic unstable 
transcripts (CUTs), my data are more consistent with the second or third explanation.  
In humans, the main mechanism involves direct interaction between CBCA and 
transcription termination or 3’ end processing factors (such as CLP1, NELF-E, SLBP15 or 
FLASH). Thus, CBCA facilitates recruitment of these proteins and stimulates 3’ end 
processing of capped noncoding and coding RNAs (95, 96). During yeast ncRNA 
transcription CBC may prevent premature binding of Pcf11, at the same time facilitating Nrd1 
recruitment to the elongation complex. However, considering that lack of CBC does not cause 
visible sn/snoRNA termination and 3’ end processing defects, this activity is not of great 
significance, but rather has an auxiliary character. Still, evidently deficient 3’ end formation is 
observed in strains where snoRNA 5’ end processing is inefficient, especially rnt1Δ. Delayed 
CBC removal from RNA 5’ end in these cells leads to accumulation of 5’ and 3’ extended 
box C/D snoRNA precursors. This indicates that CBC-NNS interaction is not indispensable 
for sn/snoRNA transcription termination, but rather provides quality control mechanism for 
coordinated 3’ and 5’ end processing. The important condition of the proposed mechanism is 
relative instability of the CBC-NNS complex that must disassemble quite rapidly after cap 
removal or modification (Fig. 30). I envisage that premature processing of both pre-
sn/snoRNA ends is precluded by the CBC-NNS complex either by interfering with their RNP 
assembly or delaying the action of the TRAMP/exosome complex during 3’ end formation. 
Another possibility that cannot be ruled out is that the presence of extended 5’ end itself 
significantly changes RNP conformation and blocks the access to precursors 3’ ends, e.g. 
through base-pairing. Several mechanisms may operate at the same time, since CBC deletion 
alleviates, but not fully suppresses, accumulation of 3’ extended pre-snoRNAs in rnt1Δ cells. 
This may result either from delayed Nrd1 recruitment and consequently also transcription 
termination or disturbed folding of 5’ end extended precursors.  
Finally, coordination between processing of both sn/snoRNA termini may involve known 
interactions between different ncRNA transcription termination and processing factors. 
Besides Pol II and CBC, the NNS complex, physically interacts with Trf4 and Rrp6, with the 
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Nrd1 CID domain directly binding Trf4 (103, 273, 280). It is possible that NNS acts within 
larger complexes, whose dynamic rearrangements are important for synchronizing ncRNA 
transcription and processing. The connection between Pol II, Nrd1/Nab3 heterodimer (with or 
without Sen1 helicase) and CBC (forming “Pol II-NNS-CBC complex”) would be important 
to provide full Nrd1 and Nab3 occupancy required for proper ncRNA termination. Following 
Pcf11 recruitment, Nrd1 dissociates from Pol II CTD and may therefore bind Trf4. Provided 
that also NNS-CBC interaction is interrupted at this stage, this gives room for Nrd1-Rrp6 
association. The connection between NNS, TRAMP and the nuclear exosome, possibly within 
a larger complex, will then govern either ncRNAs 3’ end formation or degradation.  
Dissociation of the CBC-NNS complex may therefore play several roles: facilitating Pcf11 
recruitment to the elongating polymerase and subsequent association of Sen1 and activation 
of its transcription termination activity; enabling interaction between NNS, TRAMP and the 
exosome that directs sn/snoRNA 3’ end processing or degradation; allowing 5’ end 
processing synchronized with CBC removal. However, these events are interdependent and it 
is difficult to discern their timing or mutual impact. 
4.2 Rnt1, Tgs1 and Dcp1/Dcp2 synchronize processing of sn/snoRNA 5’ and 
3’ ends 
It is well established that pre-mRNA maturation (capping, splicing and 3’ end formation) 
takes place co-transcriptionally. The timing of sn/snoRNA processing and its association with 
transcription is less obvious, though it was shown that efficient and correct 3’ end formation 
of box C/D snoRNAs requires Nop1 snoRNP core factor (316). The assembly of box H/ACA 
snoRNPs also occurs co-transcriptionally at an early stage of biogenesis, beginning with the 
recruitment of Cbf5p and RNA binding protein Naf1 (321, 433). Components that specifically 
assemble on nascent transcripts to form functional RNPs probably impact their transcription 
and processing, but coordination of sn/snoRNA processing with transcription and RNP 
assembly has not been extensively studied. Although 3’ end trimming must occur post-
transcriptionally, 5’ end cap hypermethylation or Rnt1 cleavage may theoretically take place 
concurrently with RNA synthesis. Co-transcriptional Rnt1 processing was shown for pre-
rRNA, which primary transcript is the most abundant Rnt1 substrate in the cell but is hardly 
detectable in vivo (132). I showed that Rnt1 is co-transcriptionally recruited to sn/snoRNA 
genes but reaches full occupancy near the termination region. Consistently, CBC association 
with sn/snoRNA genes also persists until the termination region. Lack of Rnt1 activity causes 
accumulation of 3’ extended, oligoadenylated box C/D snoRNA precursors. In wild-type cells 
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pre-snoRNAs are also present albeit at a very low level and their both termini are also 
extended, with 5’ ends beginning from the Rnt1 cleavage site and not processed 
exonucleolytically. This data indicates that maturation of both snoRNA termini is 
synchronized. The cleavage by Rnt1 is rapid and efficient, since almost all precursors detected 
in strains with active Rnt1 were cleaved at 5’ end. In addition, in vitro cleavage of Rnt1 
substrates occurs extremely fast, a visible fraction of cleavage products can be observed 
within few seconds (data not shown). Also meta-analysis of native elongating transcript 
sequencing (NET-seq) data (454) strongly suggests that Rnt1 cleavage of pre-snoRNAs is co-
transcriptional (Grzechnik, unpublished). However, Rnt1 and CBC ChIP results indicate that 
snoRNA 5’ end processing is delayed until transcription termination. Rapid Rnt1 cleavage 
provides entry site for Rat1/Xrn1 to unprotected 5’ ends and at the same time activates 3’ end 
processing by removing CBC from pre-snoRNP. Exonucleolytic trimming of both ends is 
slower than Rnt1 processing, therefore a small subset of extended precursors can be detected. 
Rnt1 was also shown to interact with the NNS complex (36, 103, 455) and this may 
additionally affect sn/snoRNA transcription termination or 3’ end processing. Although our 
ChIP analysis revealed that Rnt1 recruitment to snoRNA genes is not dependent on Sen1, 
Rnt1 association profiles at snoRNA genes resemble Nrd1 profiles, suggesting that also Rnt1-
NNS connection is established co-transcriptionally. Rnt1 may therefore coordinate 5’ and 3’ 
end processing in two ways: by removing CBC through the 5’ end cleavage or via the 
interaction with the NNS complex. The second connection could act as the “NNS complex 
sensor”, preventing the cleavage until the NNS complex reaches its optimal occupancy. It is 
noteworthy that Rnt1 cleavage site at the 5’ end of Pol III transcribed pre-snR52 is not strictly 
required for its 5’ processing (120), which additionally underlines the role of Rnt1 cleavage in 
CBC removal.  
Similar, but much lower accumulation of 5’ and 3’ extended precursors is observed when 
cap hypermethylation or decapping are disrupted. It was shown before that box C/D snoRNA 
precursors that accumulates in rnt1Δ strain are TMG capped, that suggests rapid cap 
hypermethylation following pre-snoRNA transcription, but this modification does not 
additionally stabilize pre-snoRNAs (119, 120). I showed that in the absence of Tgs1 snR68 
precursors that are not processed by Rnt1 are present at a very low level. This confirms rapid 
cap modification that at least partially can occur prior to Rnt1 cleavage. Although Rnt1 
processing is hardly affected by the absence of Tgs1, cap hypermethylation may facilitate this 
process. I envisage that the role of cap hypermethylation is not pre-snoRNA stabilization, but 
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rather CBC removal from the 5’ end and probably also from the complex with NNS. 
Additional studies are necessary to establish the role of Tgs1 in this process, especially in the 
case of snRNA and box H/ACA snoRNA. Precursors of these ncRNAs are not 5’ extended 
and do not require 5’ end processing, therefore cap hypermethylation is the only step in their 
maturation that removes CBC from their 5’ ends. 
The role of the decapping complex Dcp1/Dcp2 in snoRNA processing has been suggested 
(120), but has never been demonstrated. Most box C/D snoRNA cleaved by Rnt1 at their 5’ 
end do not entirely depend on Rnt1 for their maturation ((120), this study), therefore an 
alternative pathway that enables exonucleolytic 5’ end processing must exist. It was shown in 
my laboratory that pre-snR68 accumulates at a very low level in mutants with disrupted 
decapping activity (Grzechnik, Matuszek unpublished results). Moreover, my results show 
that DCP2 deletion causes greater accumulation of pre-snR68 with mutated Rnt1 recognized 
tetraloop. Surprisingly, most of the precursors present in dcp2Δ strain was not cleaved by 
Rnt1. Collectively, this data demonstrate the role of Dcp1/Dcp2 in box C/D snoRNA 
maturation not only as a part of an alternative 5’ end processing pathway, but also in 
promoting Rnt1 cleavage. Since processing of other box C/D snoRNAs was not affected in 
Dcp1/Dcp2 deficient strains (Grzechnik, Matuszek, unpublished results), this suggests that 
additional decapping enzymes may be involved in this mechanism. Besides Dcp1/Dcp2 also 
Rai1, Dxo1 and Nudt3 have a decapping activity, although first two were shown to preferably 
hydrolyse unmethylated cap substrates (80, 161, 189, 196). It will be worthwhile to test the 
potential role of these proteins in the alternative pathway generating mature snoRNA 5’ ends. 
4.3 The model of pre-sn/snoRNA maturation 
It was suggested that 3’ and 5’ extensions in box C/D snoRNA precursors provide a way to 
prevent their degradation before completing snoRNP assembly (120, 429). snoRNP 
formation, involving RNA folding and snoRNP protein binding, begins co-transcriptionally 
and involve additional auxiliary factors (316, 321, 433, 436). Mature ends of box C/D 
snoRNAs form a stem structure, so their final folding occurs after 3’ end has been transcribed 
and released from the Pol II complex. It is quite likely that complete snoRNA assembly is 
achieved after transcription termination, but at least some factors associate during 
transcription. For example, Nop1 is recruited co-transcriptionally to nascent box C/D pre-
snoRNAs and this is probably mediated by Ref2. It is also possible that binding of Snu13 and 
Nop58 precedes Nop1 association (316, 438).  
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Figure 30. Role of CBC and Rnt1 in box C/D pre-snoRNA processing. Working model based on presented data 
and recent publications. Interaction of CBC-NNS complexes is established during snoRNA transcription. 
snoRNP proteins are recruited co-transcriptionally, beginning with Snu13 and Nop58 in the case of box C/D 
pre-snoRNAs. Rnt1 is recruited to the tetraloop, reaching full occupancy at the late phase of transcription. 
Endonucleolytic cleavage of the pre-snoRNA 5’ end releases CBC from its interaction with the NNS. NNS 
complex changes its interacting partners, recruiting the nuclear exosome (possibly through the interaction with 
Rrp6 cofactor) and TRAMP complex (interaction with Trf4) and after transcript release thanks to the action of 
helicase Sen1, pre-snoRNA 3’ end is oligoadenylated by Pap1 and TRAMP, which facilitates trimming by the 
exosome. Pre-snoRNA 5’ end lacking of the cap structure is trimmed by Rat1/Xrn1. At the same time snoRNP 
proteins are recruited and the RNA component is folded into its mature structure, which both naturally hinder 
progression of exonucleases. Interactions between proteins are indicated either by their physical contact or 
double-arrow lines. Lines with arrowheads indicate catalysed reaction, lines with bar heads indicate inhibition. 
Red bars are schematic representation of RNA-DNA hybrids. Detailed description in the text. 
Although processing of the 5’ end may begin co-transcriptionally, my data suggest that it is 
rather delayed until transcription termination. Moreover, maturation of both sn/snoRNA 
termini is coupled and synchronized by the CBC-NNS complex and Rnt1 (Fig. 30). CBC-
NNS interaction prevents premature degradation of the 5’ end and although Rnt1 is co-
transcriptionally recruited to the nascent pre-snoRNP, it probably does not cleave the 
precursor until the very end of its transcription. This is supported by indications that Rnt1 
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activity is facilitated by interactions with Sen1 and Nop1 that associate with precursors at the 
late stage during transcription.  
After cap removal (Rnt1 cleavage or decapping) CBC no longer binds the nascent 
transcript and probably is also released from its interaction with NNS. This enables further 5’ 
end exonucleolytic trimming in the case of most box C/D pre-snoRNAs and at the same time 
permits NNS to recruit 3’ end processing factors, exosome and TRAMP complexes, via direct 
binding of Rrp6 and Trf4, which activates 3’ end processing (Fig. 30). snoRNP proper folding 
and association of the remaining core proteins create natural boundaries that stop 
exonucleolytic digestion at the right place. This provides a quality control mechanism 
ensuring that snoRNAs are properly assembled and have correct, well-defined mature 5’ and 
3’ termini. 
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5. MATERIALS AND METHODS 
5.1 Materials 
5.1.1 Yeast Strains 
Name Genotype Ref or source 
BY4741 
MATa his3Δ1, leu2Δ0, met15Δ0, 
ura3Δ0 
Euroscarf 
BMA64 
MATa, ura3-1, ade2-1, his3-11,5, 
trp1Δ, leu2-3,112, can1-100 
(456) 
rnt1Δ as BMA64 but RNT1::TRP1 (131) 
cbp80Δ as BMA64 but CBP80::HIS3 This study 
tgs1Δ as BMA64 but TGS1:: HIS3 This study 
cbp80Δ rnt1Δ As rnt1Δ but CBP80::HIS3 This study 
tgs1Δ rnt1Δ As rnt1Δ but TGS1::HIS3 This study 
rrp6Δ as BY4741 but RRP6::kanMX4  Euroscarf 
dcp2Δ 
leu2-3112 his4-539 lys2-201 trp1 ura3-52 
dcp2::TRP1 
(201) 
BMA64+ pRS415-
snR68WT 
as BMA64 but pRS415-snR68WT This study 
BMA64+ pRS415-
snR68mut 
as BMA63 but pRS415-snR68mut This study 
cbp80Δ+ pRS415-
snR68WT 
as cbp80Δ but pRS415-snR68WT This study 
cbp80Δ+ pRS415-
snR68mut 
as cbp80Δ but pRS415-snR68mut This study 
tgs1Δ+ pRS415-snR68WT as tgs1Δ but pRS415-snR68WT This study 
tgs1Δ+ pRS415-snR68mut as tgs21Δ but pRS415-snR68mut This study 
dcp2Δ+ pRS415-snR68WT as dcp2Δ but pRS415-snR68WT This study 
dcp2Δ+ pRS415-snR68mut as dcp2Δ but pRS415-snR68mut This study 
GAL::CBP20 (Y258) 
 
MATa, pep4-3, his4-580, ura3-52, leu2-3, 112, 
pBG1805-GAL1::CBP20-His6/HA/ZZ (URA3, 2μ) 
(450) 
GAL::eIF4E (Y258) 
MATa, pep4-3, his4-580, ura3-52, leu2-3, 112, 
pBG1805-GAL1::CDC33-His6/HA/ZZ (URA3, 2μ) 
(450) 
GAL::CBP20 GAL::CBP80 
(Y258) 
as GAL::CBP20 but + p425GAL1-CBP80-FLAG-
2×Strep-tag II 
MSc  
D. Adamska 
Cbp20-Myc as BY4741 but CBP20-myc13::HIS3 (86) 
Cbp80-Myc as BY4741 but CBP80-myc13::HIS3 (86) 
Rad30-Myc 
his3-Δ200, leu2-3,2-112, lys2-801, trp1-1, ura3-
52, RAD30-9myc::klTRP1 
(457) 
Rnt1-Myc as BY4741 but RNT1-myc13::NAT This study 
snr68Δ  as BY4741 but SNR68::HIS3 This study 
snr68Δ + pRS415-
snR68mut 
as snr68Δ but pRS415-snR68mut This study 
Rnt1-Myc snr68Δ+ 
pRS415-snR68WT 
as snr68Δ but RNT1-myc13::NAT, pRS415-
snR68WT 
This study 
Rnt1-Myc snr68Δ+ 
pRS415-snR68mut 
as snr68Δ but RNT1-myc13::NAT, pRS415-
snR68mut 
This study 
sen1-R302W as BY4741 but sen1-R302W (37) 
sen1-K128E as BY4741 but sen1-K128E (37) 
Rnt1-Myc sen1-R302W as sen1-R302W  but RNT1-myc13::NAT This study 
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Rnt1-Myc sen1-K128E as sen1-R302W but RNT1-myc13::NAT This study 
Nrd1-HA as BY4741 but NRD1-HA3::NAT This study 
cbp80Δ* 
MATa, ade2, ade3, his3, leu2-3, 112 rp1 ura3 
CBP80::TRP1 
(84) 
cbp80Δ Nrd1-HA as cbp80Δ* but CBP80::TRP1; NRD1-HA3::NAT This study 
 
5.1.2 Bacterial strains 
E. coli BL21(DE3): fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
E. coli Rosetta (DE3): F- ompT hsdSB(rB- mB-) gal dcm (DE3) pLysSRARE (CamR) 
5.1.3 Plasmids 
Plasmid Reference or source 
pST39-Nrd1-His9-Nab3-MBP (274)  
p425GAL1 (458) 
p425GAL1-CBP80-Flag-StrepTag II MSc D. Adamska 
pRS415-snR68WT This study 
pRS414-snR68mut This study 
pFA6a-13Myc-natMX6 (459) 
pFA6a-3HA-natMX6 (459) 
pJET1.2 Fermentas 
5.1.4 Oligonucleotides and probes 
Primer 
no 
name sequence 
strains construction 
W332 3HAnrd1FA GAACATAGGAAAAAACAGAAATTATATATAGAGGTAGA
TTAGTTTTATGTGAATTCGAGCTCGTTTAAAC 
W333 5HAnrd1FA ATTCTTTGATGAATATGCTTAACCAACAGCAGCAGCAAC
AACAACAAAGCCGGATCCCCGGGTTAATTAA 
W336 FNrdHA5v CCTCGTTAGCATGACTCCC 
W337 RNrdHA5v GTACCGGGTTTGTTGCTGC 
W568 Rnt1F2 
GTGTTAAAAGATCCCTCACAAAAGAATAAGAAAAGAAA
ATTCTCAGATACAAGCCGGATCCCCGGGTTAATTAA 
W569 Rnt1R1 
TTTATGAATGACATATATGCGATAATTATATGGCTAAAG
AAAATCAATGCGAATTCGAGCTCGTTTAAAC 
W570 Rnt1_ver_F AGTGCAGAGTAGGTGATGGAAC 
W571 Rnt1_ver_R AGACGCGTTGCCATTACGC 
ChIP 
W443 snR45F1 ATCTCTCTTCATGGCAATAGAGGATG 
W444 snR45R1 CACTTCTCTACGGGTAATCCTCG 
W445 snR45F2 AGGTATAAAAAGCGAAACACTCGGTAC 
W446 snR45R2 TCCGAGAAGAATTGTTCGATTTGAAACG 
W447 snR45F3 TCGGAGCGATCTGAGGTTTTAATGG 
W448 snR45R3 GTGTACAGATGAGATGACTACTCCCAAG 
W449 snR45F4 ACTTGGGAGTAGTCATCTCATCTGTAC 
W450 snR45R4 CGGCAAGTTTCCCTGGATGTC 
W451 snR45F5 GGTCTCTGTGGAAACCAGTGC 
W452 snR45R5 GTAGTTGATGCCCGAAGGTGC 
W453 snR82F1 TGACAGCGTTATTTGAGAATAGACCTAAG 
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W454 snR82R1 GTTGAAATGTGTTGAAGAGCCATGAT 
W455 snR82F2 ATCATGGCTCTTCAACACATTTCAAC 
W456 snR82R2 TCTTGAGCTTATTTCTTAATGCGTGGG 
W457 snR82F3 ATCCCGCCTTTTTTCGCTAACAATG 
W458 snR82R3 AGGTATCGGTCAGTATCACGCTC 
W459 snR82F4 GACAGGACACATAATAGCAAGGCAAG 
W460 snR82R4 TTGTCGTCACTTGATCCCAGTTG 
W462 snR47F1 ACCTTTCGAGCATCTCTTACAGCAATGG 
W463 snR47R1 TGTTCGGAGACAGTTCTGATGCCTAG 
W464 snR47F2 CCCTAGAAGAAATACCCGAAGATGTAAG 
W465 snR47R2 ACCGTATGGAAGACGTAGAGTGGATG 
W466 snR47F3 AAGGCTTCAGCTCCATATC 
W467 snR47R3 CCTTTCTCCTACTTTGCTCAG 
W468 snR47F4 ACAACAACATGAATTTCTTCGTCCG 
W469 snR47R4 CAGCAAGAATGACGCGAAA 
W470 snR47F5 TTTCTGTTTCTGTTTCGCGTCGG 
W471 snR47R5 TCCCTGTTATCCGCCTTTCTTCTTGG 
W472 snR47F6 CAGCTAACAAACGACTAGGTCTC 
W473 snR47R6 CCTTGAAAAGTAGAAAGGGTAG 
W476 snR48F1 ACAGCCATTCCACAGATAGTGCTAC 
W477 snR48R1 TTGCTACTTATGGTAAAACTGCCGC 
W478 snR48F2 ATACCTTTGTCCGCTGTTATCATACC 
W479 snR48R2 GTTACCGTACCACTCTTGCTTATG 
W480 snR48F3 GGTACGGTAACCACAAGGCAATG 
W481 snR48R3 GATAAACGAGACGGATGAAAGGAG 
W484 snR48F4 ACTATGATTAAACAGACCGAGGGAG 
W485 snR48R4 ACGACGCGGACGAAGAGAAAG 
W486 snR48F5 TTCGTTACCCGGTGTAGTCACG 
W487 snR48R5 CGATAACTGGCTCTGCTCTTTCCTG 
W488 snR48F6 ACCGATAACAGTCAGCAACCTCAAG 
W489 snR48R6 AATAATACGACCACAGCAGAGGCG 
W492 snR30F1 ATGTCCTTCTAGCGTAGTAACC 
W493 snR30R1 GTTAAATGCACGACGATGAGAG 
W494 snR30F2 ACCATAGTCTCGTGCTAGTTC 
W495 snR30R2 CTTATGTGATGCCGTTGTCC 
W496 snR30F3n TCGGACAACGGCATCACATAAG 
W497 snR30R3n ATACACATCGTTAAGGCAACAGC 
W498 snR30F4 AAGTAGGACGCATGATCTTG 
W499 snR30R4 GGACCAACTAGGGTCATTTC 
W500 snR30F5 TCTCATAAAATGTACCCTACTTAGTGG 
W501 snR30R5 TGTAAAGTTCATCACGGCTCC 
W540 U1F1 TGGTCTTTTTGCTTCCTGGAACTC 
W541 U1R1 TATGATGGCAGCGTAGATCACCG 
W542 U1F2 GCTGCCATCATAGGGCTCATTG 
W543 U1R2 CCAATGGAAAACTCGTCGCCTTAG 
W544 U1F3 AGAAGTCCTACTGATCAAACATGCG 
W545 U1R3 CGCCGTATGTGTGTGTGACCA 
W546 U1F4 CCTTGTTTCAATCATTGGTTAATCCCTTG 
W547 U1R4 TGGTGTCAAACTTCTCCAGGCAG 
W548 U1F5 AGTTTATGATGAAGGTATGGCTGTTGAG 
W549 U1R5 ACGGGAACGAGCAAAGTTGAGAC 
W550 U1F6 CTACATTGAGACAAGACATTGTCCAGC 
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W551 U1R6 ACGTTTCTTGTTGCGGCTCTC 
W552 snR41_70_51F1 GTCAACAAGCAAGTATCCCGCAAG 
W553 snR41_70_51R1 TCCAGTTCGGGCTAAAGAGTCG 
W554 snR41_70_51F2 CTTCCTTTGTTTGCTTCTTCGTCTTC 
W555 snR41_70_51R2 ACCTACTGGTCGCTTAATCTGCCTC 
W556 snR41_70_51F3 TCTTTCTGTGTGACTCCCCTATG 
W557 snR41_70_51R3 ACCCCTCATACAAGGCTGAAAC 
W558 snR41_70_51F4 AAGGGTCGCCGTCTACTCTC 
W559 snR41_70_51R4 TGTCTTGTGACCAATCATCAATTCTCC 
W560 snR41_70_51F5 TGATAAAAGAGACTGTTGCGGACTAG 
W561 snR41_70_51R5 TTGTAGTCATCAATTAGCCCCTTCG 
W562 snR41_70_51F6 AGGAGAAAGGGTTTTGAACACATCG 
W563 snR41_70_51R6 TGTGATACCGCCAAGCAAGTAAAC 
W592 snR68F1 AGTCAGCATTCAACAACGTGAGAAG 
W593 snR68R1 AGAGCATGACCGTGTATGGTGAC 
W594 snR68F2 AGGGACCTTCAGGAGGTTACG 
W595 snR68R2n GTACAAAGCTATGACCAACCGTTCC 
W596 snR68F3 TTGAAAAGAGTTAATTATGGAACGGTTGG 
W597 snR68R3 TCGTTTGATAGCAGTAAGTCGCAG 
W598 snR68F4 TTTACTGCGTTATCGTATTGACGG 
W599 snR68R4 AGCAAATCTGTTAAGAGTCAATTTCCTCG 
W600 snR68F5 AACCAGCACGCAGCAGGAAG 
W601 snR68R5 TGGATGCACTACCAATGTGGTG 
W602 snR68F6 TCGGCGAATAGTGGACGTAGTG 
W603 snR68R6 GAAATAAACTCCCCATGCAATGGC 
 U5F1 GTTGCTGAATTTCCTGACTCTACGG 
 U5R1 CTCTACCCATTATCCCTTTGTCATCG 
 U5F2 AATGGCGGAGGGAGGTCAAC 
 U5R2 ACCTGTTTCTATGGAGACAACACCC 
 U5F3 TGTCCGTTACTGTGGGCTTGC 
 U5R3 GTTCCATGGACTCATGAATCAAATTTGTAG 
 U5F4 TGGAGCAGAAATAAGACGATCACAGG 
 U5R4 AGTTTAGTCTCAAATGTATCGAACGCG 
 U5F5 ACTCTTGTTTCATCGGTTGTTGCC 
 U5R5 AGGGGAAGCACTATTTCTCACTTG 
 U5F6 GAACCTTCTATGCAGGATTTTGACCC 
 U5R6 TCTTTTCTGTGGCATTGCTGTCTGAG 
 snR52F1 ACAACTCTAGATTTTGTAGTGCCCTC 
 snR52R1 ACTTTCACTTCTACAGCGTTTGACC 
 snR52F2 TCTAGATTTTGTAGTGCCCTCTTGG 
 snR52R2 CACCAACTTTCACTTCTACAGCGT 
 snR52F3 ACGCTGTAGAAGTGAAAGTTGGTG 
 snR52R3 TCAGAGATTGTTCACGCTAATGTCATTC 
 snR52F4 TGACATTAGCGTGAACAATCTCTGATAC 
 snR52R4 TGCGTTCCATACTGTCAGAGGTG 
 snR52F5 CTTGCTAGTTTTGCGTTGCCCT 
 snR52R5 AGTTTTTGATGTACTGTATTCCTTGCG 
hybridization probes 
W076 snR68-2 AAGAGTCAATTTCCTCGGTA 
W271 snR68 GCTTTCAGATACTATCTAGC 
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RNase H treatment 
 snR68son CCCCGTCAATACGATAACGC 
W315 cRTPCR1R AATTTATCGTTTGATAGCAG 
cRT-PCR 
 68Hlig GTATCCTTACAAACATGACG 
W091 RTsp GATAACGCAGTAAAATAAATG 
 cRTPCR1F GGTTCATCTTACAAAAAAATTG 
W315 cRTPCR 1R AATTTATCGTTTGATAGCAG 
W092 cRTPCR 2F GTACAGTCTGTTTTATAATC 
 cRTPCR 2R CCAACCGTTCCATAATTA 
 TDH1F GGTATGGCTTTCAGAGTCCCA 
 TDH1R AGACAACGGCATCTTCGGTG 
 pJET1.2F CGACTCACTATAGGGAGAGCGGC 
 pJET1.2R AAGAACATCGATTTTCCATGGCAG 
 
5.2 Methods 
Reagents used were purchased from Sigma-Aldrich unless stated otherwise. 
5.2.1 Basic techniques used in molecular biology 
Basic techniques such as electrophoresis, plasmid DNA isolation, PCR and RT-PCR 
reaction, molecular cloning etc. were performed according to (460) or manuals provided by 
the manufacturer. 
5.2.2 Conditions of yeast cultures  
Yeast strains were grown at 25°C or 30°C, either in YPD or YPGal medium (1% yeast 
extract, 2% Bacto Peptone, 2% glucose or 2% galactose, respectively) or in synthetic 
complete medium (0.77 g/l CSM medium, MP, 6.7 g/l yeast nitrogen base (YNB), Difco, 2% 
glucose, when necessary additionally supplemented with amino acids or nucleotide bases, BD 
Biosciences). For solid media agar was added to 2% concentration. Liquid cultures were 
grown to early logarithmic phase (OD600 0.2–0.6) unless stated otherwise. Cells were 
harvested by centrifugation, washed with distilled water, frozen in liquid nitrogen and stored 
at -80°C. GAL::CBP20, GAL::CBP80 and GAL::eIF4E strains were grown in l.3 l of 
complete synthetic medium w/o uracil with 2% sodium-L- lactate (0.77 g/l CSM –URA, MP, 
6.7 g/l YNB w/o amino acids, Difco, 2% sodium-L- lactate, 50 µg/ml Ampicillin), at 30°C to 
OD600 0.5–1. Induction with 650 mL of induction medium (60 g/l Bacto Peptone, Difco, 30 g/l 
Bacto Yeast Extract, Difco, 6% D-galactose, 50 mg/mL Ampicillin) was carried out for 6 h at 
30°C.  
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5.2.3 Preparation of yeast strains  
Myc- and HA-tagging was performed by one-step PCR procedure (461) using plasmids 
pFA6a-13Myc-natMX6 and pFA6a-3HA-natMX6 (459). BY4741 genomic DNA was used as 
a PCR template. Homologous sequences that determined the insertion region were added on 
primers overhangs (50 nt from the 3’ ORF upstream the stop codon and 50 nt from the 
sequence just downstream the stop codon). Transformation procedure was as described (462) 
using 15-20 OD600 units of logarithmic phase yeast. Cells were harvested, washed with 10mM 
Tris-HCl pH 7.5 and incubated with buffer LiT (10mM Tris-HCl pH 7.5, 10 mM Lithium 
Acetate) supplemented with fresh DTT (10 mM) for 40 min. Cells were centrifuged and 
resuspended in transformation buffer (5-8 OD600 units per single transformation in 50 μl LiT, 
20-100 μl purified PCR product, 5 μl of carrier DNA 10 μg/μl). After 10 min incubation in 
room temperature, 300 μl of 50% PEG 4000 (Merck) in LiT was added and incubation was 
continued for 10 min, followed by addition of 50 μl of DMSO and incubation for 15 min at 
42°C. Cells were then centrifuged, resuspended in 1-20 ml of YPD medium and incubated at 
25°C or 30°C for 1-12 h. After centrifugation, cells were plated on YPD Nat (100 mg/l, 
WERNER BioAgents). Cassette integration was confirmed using PCR and western blot 
analysis. 
5.2.4 Isolation of yeast genomic DNA  
2 ml of thick yeast culture were centrifuged and resuspended in buffer TE (10 mM Tris-
HCl pH 7.5, 1 mM EDTA) with 3% SDS and 500 l glass beads (BioSpec). Cells were 
incubated for 10 min on vortex mixer. 400 l TE and 500l phenol solution was added and 
the mixture was vortexed for another 5 min and centrifuged. Aqueous phase was twice 
extracted with cold phenol/chlorophorm/isoamyl alcohol mixture (25:24:1) and once with 
chlorophorm/isoamyl alcohol mixture (24:1). DNA was precipitated with 0.3 M ammonium 
acetate (pH 5.3) in 75% ethanol. After centrifugation and washing with 75% ethanol, DNA 
pellets were air-dried and resuspended in 50 l of deionized water. 
5.2.5 Isolation of RNA  
Total RNA from yeast cells was isolated using a hot phenol procedure (463). Yeast cells 
(10-15 OD600 units) harvested at early logarithmic phase were resuspended in 400 buffer AE 
(50 mM sodium acetate, 10 mM EDTA) with 10% SDS and 400 l of acidic phenol (pH 4-5). 
Suspension was incubated at 65°C with shaking for 5 min and then frozen in liquid nitrogen. 
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After centrifugation, aqueous phase was twice extracted with cold 
phenol/chlorophorm/isoamyl alcohol mixture (25:24:1) and once with chlorophorm/isoamyl 
alcohol mixture (24:1). RNA was precipitated with 0.3 M ammonium acetate (pH 5.3) in 75% 
ethanol. After centrifugation and washing with 75% ethanol, RNA pellets were air-dried and 
resuspended in 50 l of deionized water. 
5.2.6 Northern blot analysis 
Northern hybridization was performed essentially as described (464). 8 μg of total RNA or 
10 µg of RNA treated with 0.5 U of RNase H (Ambion) in the presence of oligonucleotide 
snR68son was mixed with the equal volume of loading buffer (98% formamide, 0.025% 
xylene cyanol, 0.025% bromophenol blue), incubated at 95°C for 5 min and separated on 6% 
denaturing polyacrylamide-urea gel in TBE buffer (89 mM Tris base, 89 mM boric acid, 
2mM EDTA) at constant power 15 W. RNA was then transferred onto N+ nylon membrane 
(GE Healthcare) by electric transfer in 0.5 × TBE at 10 mA overnight. After fixing with UV 
crosslinking (1200 kJ/cm2) blots was pre-hybridized with 5’ end γ-32P-labelled 
oligonucleotide probe (20 nt) in 20 ml of Denhardt buffer (5 × Denhardt reagent: 0.1% Ficoll 
400, 0.1% polyvinylpyrrolidone, 0.1% BSA, 6 × SSPE: 60 mM phosphate buffer pH 7.4, 1 M 
NaCl, 6 mM EDTA, and 0.5% SDS) at 37°C for 30 min. Oligonucleotide was labelled using 1 
U of PNK (NEB) and 20 μCi [γ-32P]ATP (Hartman Analytics) in manufacturer buffer. 15 μl 
reaction was carried out at 37°C for 30 min. Hybridization was performed at 37°C for at least 
8 h and the membrane was washed three times for 10 min at 42°C with 6 × SSPE buffer and 
exposed to Storage Phosphor Screen BAS-IP MS (Fuji Lifesciences). Autoradiographic 
images were obtained using laser scanner Typhoon FLA 9000 (GE Healthcare) at 650 nm 
wavelength and analysed using Image Quant (Molecular Dynamics). 
5.2.7 RNase H treatment 
20 µg of RNA was mixed with 1 pmol of specific oligonucleotide (snR68son for northern 
blot or cRTPCR1R for cRT-PCR analyses) in 10 µl of hybridisation buffer (25 mM Tris-HCl 
pH 7.5; 1 mM EDTA; 50 mM NaCl). RNA was denatured at 70°C for 10 min and slowly 
cooled down to 30°C. After that reaction buffer (final concentration: 20 mM Tris-HCl pH 7.5, 
10 mM MgCl2, 50 mM NaCl, 1 mM DTT, 30 mg/ml BSA) and 0.5 U of RNase H (Ambion) 
were added and the reaction was incubated at 30°C for 1 h. RNA was then extracted with  
phenol/chlorophorm/isoamyl alcohol mixture (25:24:1) and chlorophorm/isoamyl alcohol 
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mixture (24:1) and precipitated in 75% ethanol using 0.3 M ammonium acetate (pH 5.3) and 
20 µg of glycogen.   
5.2.8 cRT-PCR 
cRT-PCR was carried out as described (251) with several modifications. 5’ end of snR68 
with the cap structure was removed prior to circularization either by RNase H (Ambion) 
treatment of 20 µg of total RNA in the presence of oligonucleotide cRTPCR1R (see 5.2.7) or 
by Tobacco Acid Pyrophosphatase (TAP, Epicentre) treatment for 2 h at 37°C using 8 μg of 
total RNA and 2.5 U of TAP followed by purification using RNeasy MinElute Cleanup Kit 
(Qiagen). Ligation reaction was incubated at 37°C for 90 min. After ligation RNA was 
purified either by extraction with phenol/chlorophorm/isoamyl alcohol mixture (25:24:1) and 
chlorophorm/isoamyl alcohol mixture (24:1) and subsequent precipitation or using RNeasy 
MinElute Cleanup Kit (Qiagen). Circular molecules were amplified by RT-PCR using Super 
Script Reverse transcriptase (Thermo Fisher Scientific) and 0.5-2 µg of RNA, 2 pmol of 
specific primer (RTsp) or 200 ng of random primers for the loading control. RNA mixed with 
primer and 1 mM dNTPs were denatured at 65°C for 5 min. After cooling on ice, the reaction 
mix was added to each sample (1 × manufacturer reaction buffer, 50 mM DTT, 20 U 
Ribolock (Thermo Fisher Scientific) and 100 U of Super Script Reverse transcriptase 
(Thermo Fisher Scientific)). Reaction was incubated at 50°C for 1 h. cDNA obtained using 
RTsp primer was diluted 4 times and the loading control 10 times prior to subsequent semi-
quantitative PCR analysis. Products were cloned into pJET1.2 vector (Thermo Fisher 
Scientific) and sequenced at the DNA Sequencing and Oligonucleotides Synthesis facility 
(Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw). 
Preparation of plasmid DNA was carried out by MSc Katarzyna Kowalska (IBB PAS, 
Warsaw) using 96 Well Plate Plasmid DNA Mini-Preps Kit and Janus JANUS Automated 
Workstation (PerkinElmer). 
5.2.9 Expression and purification of recombinant proteins 
Mouse eukaryotic initiation factor eIF4E (residues 28–217) was expressed in Escherichia 
coli BL21(DE3) as inclusion bodies by Dr Joanna Żuberek (Division of Biophysics, Institute 
of Experimental Physics, Faculty of Physics, University of Warsaw). The guanidinium-
solubilized protein was renatured by one-step dialysis and purified by ion-exchange 
chromatography on a HiTrap SP column without contact with cap analogues by Dr Joanna 
Zuberek as described in (465). Concentration of eIF4E was determined 
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spectrophotometrically assuming ε280 = 53,400 M−1 cm−1. Human DcpS was expressed in E. 
coli Rosetta DE3 according to the procedures described previously (466) with several 
modifications by Dr Zbigniew Darżynkiewicz (Division of Biophysics, Institute of 
Experimental Physics, Faculty of Physics, University of Warsaw). His-tagged DcpS was 
purified by MSc Krystian Stoduś (IBB PAS, Warsaw) by a two-step procedure on Ni-NTA 
Superflow Cartridge (Qiagen) followed by gel filtration on Superdex 200 column (GE 
Healthcare) using the AKTA Purifier system (GE Healthcare). Proteins were eluted with 
buffer IPP150 (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% rTX100). Concentration of 
DcpS was determined spectrophotometrically assuming ε280 = 30,495 M−1 cm−1. 
Nrd1/Nab3 complex (Nrd1(1-548) with N-terminal His9 tag and Nab3
(191-556) with N-terminal 
MBP tag) was purified as described (274) with several modifications. The Nrd1–Nab3 
heterodimer was expressed in E. coli strain BL21 grown in ZYM-5052 autoinduction medium 
(10 g/l N-Z amine AS, 5 g/l yeast extract, 1 mM MgSO4, 1 × trace elements mix1, 1 × 50522, 
1 × M3, 100 μg/l kanamycin, 34 mg/l chloramphenicol) at 4°C for 3 days. The culture was 
harvested and resuspended in buffer L1 (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 20 mM 
imidazole, 10 mM β-mercaptoethanol, 10% glycerol, 0.1% Triton X100) and sonicated in a 
Bioruptor sonicator (Diagenode) using 35–30 s pulses at the high level. The lysate was then 
filtered using syringe filters (Sarstedt). Fusion proteins were purified by a two-step procedure 
on Ni-NTA Superflow Cartridge (Qiagen) followed by ion exchange chromatography on 
HiTrap Heparin HP (GE Healthcare) using the AKTA Purifier system (GE Healthcare). After 
protein loading, Ni-NTA Superflow resin was washed with buffer W1 (20 mM Tris-HCl pH 
8.0, 1 M NaCl, 10 mM imidazole, 10 mM β-mercaptoethanol). Proteins were eluted with 
buffer E1 gradient (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 600 mM imidazole, 10 mM β-
mercaptoethanol, 100% in 40 min) and then dialysed into buffer D2 (10 mM Tris-HCl pH 8.0, 
150 mM NaCl, 2 mM DTT, 1 mM PMSF, 20% glycerol). After sample loading, heparin resin 
was washed with buffer W1 (10 mM Tris-HCl pH 8.0, 150 mM NaCl) with 1 mM DTT. 
Proteins were eluted with buffer E2 gradient (10 mM Tris-HCl pH 8.0, 1.2 M NaCl, 1 mM 
DTT, 100% in 40 min). Alternatively, a second batch of the Nrd1/Nab3 complex was purified 
by MSc Krystian Stoduś (IBB PAS, Warsaw) using Ni-NTA chromatography followed by gel 
filtration on Superdex 200 column (GE Healthcare). Proteins were eluted with buffer IPP150. 
                                                 
1 1000 × trace elements mix contains: 50 mM FeCl3 × 6 H2O; 20 mM CaCl2 × 2 H2O; 10 mM MnCl2 × 4 H2O; 
10 mM ZnSO4 × 7 H20; 2 mM CoCl2 × 6H2O; 2 mM CuCl2 × 2 H2O; 2 mM NiCl2 × 6 H2O; 2 mM Na2MoO4 × 2 
H2O; 2 mM H3BO3. 
2 50 × 5052 contains: 25% glycerol; 2.5% glucose; 10% lactose. 
3 50 × M contains: 2.5 M NH4Cl; 1.25 M KH2PO4; 1.25 M Na2HPO4 × 2 H2O; 0.25 M Na2SO4. 
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Affinity tags were not removed. Concentration of the purified complex was estimated using 
Bradford method assuming 400 – 1000 μg ml−1. 
Since Cbp80 expression in bacterial system was not feasible, CBC complex was purified 
from the yeast Y258 strain expressing Cbp20-His6/HA/ZZ and Cbp80-FLAG-2×Strep-tagII 
under the control of the PGAL1 promoter from a BG1805 or p425GAL1 plasmids, respectively 
(450, 458). Cloning and tagging of Cbp80 was performed by MSc Dorota Adamska during 
the course of her MSc project. After induction (see 5.2.2) yeast were harvested, resuspended 
in an equal volume of buffer L2 (40 mM Hepes pH 8.0, 150 mM NaCl, 1 mM β-
mercaptoethanol, 0.2% Tween20, protease inhibitors (Roche), 1 mM PMSF), frozen in liquid 
nitrogen and homogenized in laboratory blender (Waring) with dry ice (4 × 2 min). The lysate 
was centrifuged at 50000×g for 20 min and at 120000×g for 1h 30 min at 4°C. The extract 
was dialyzed for 4 h at 4°C in buffer D1 (40 mM Hepes pH 8.0, 150 mM NaCl, 1 mM β-
mercaptoethanol, 1 mM PMSF, 20% glycerol). CBC was isolated on IgG Sepharose (GE 
Healthcare), after extensive washes with buffers IPP500 (10 mM Tris-HCl pH 8.0, 500 mM 
NaCl, 0.1% Triton X100) and 3C (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 10 mM Sodium 
Citrate pH 8.0, 0.1% Triton X100, 10 mM β-mercaptoethanol), proteins were eluted overnight 
by protease 3C treatment. The eluate was applied on Superdex 200 column (GE Healthcare) 
and further purified using the AKTA Purifier system (GE Healthcare). Proteins were eluted 
with buffer IPP150. Concentration of the purified complex was estimated using Bradford 
method assuming 350 μg ml−1. 
5.2.10 Preparation of whole-cell extracts 
Yeast extract for evaluation of modified cap affinity resins was prepared from 2 l of yeast 
culture (CBP20-Myc and GAL::eIF4E) at OD600 1-2. Cell pellets were resuspended in an 
equal volume of buffer L3 (40 mM Hepes pH 8.0, 250 mM NaCl, 1 mM DTT), frozen in 
liquid nitrogen and homogenized in laboratory blender (Waring) with dry ice (4 × 2 min). The 
lysate was then centrifuged for 20 min at 50000×g at 4°C. The extract was cleared by 
ultracentrifugation at 120000×g for 1h 30 min at 4°C and dialyzed for 4 h at 4°C in buffer D3 
(40 mM Hepes pH 8.0, 150 mM NaCl, 1 mM DTT, 1 mM PMSF, 20% glycerol).  
Extracts used for protein binding studies were prepared from 250 ml of yeast culture 
(CBP20-Myc, CBP80-Myc and RAD30-Myc) at OD600 0.6-0.8. Cell pellet was frozen in liquid 
nitrogen, resuspended in 1 ml of buffer L4 (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.2% 
Tween 20, 1 mM β-mercaptoethanol, protease inhibitors (Roche), 1 mM PMSF) and lysed 
with 500 µl of glass beads (BioSpec). The lysate was centrifuged at 3200×g for 5 min at 4°C 
112 
 
and the supernatant was further clarified by a 30 min spin at 16000×g at 4°C. The extract was 
dialysed for 2 h at 4°C in buffer D4 (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.2% Tween 
20, 1 mM β-mercaptoethanol, 1 mM PMSF, 20% glycerol). 
5.2.11 Purification of cap-binding proteins using cap modified affinity resins 
Yeast extract (containing Cbp20-Myc or eIF4E-His6/HA/ZZ) or protein samples (520 
µg/ml eIF4E and 200 µg/ml DcpS) were supplemented with reduced Triton X100 (0.1% final 
concentration) and GTP (100 µM final concentration). 300–500 µl of extract or protein 
sample were incubated for 2 h with 50 μl (settled volume) of resin (1–4) equilibrated with 
buffer IPP150 in 4°C. Flow through fractions were separated and resins were washed twice 
with 0. Bi; 4 × 40 µl) by incubation with the resin for 5 min. The purification procedure was 
carried out in 0.8 ml spin columns (Mo Bi Tec). 8 µl of collected fractions was separated by 
SDS-PAGE and in the case of purification from the extract were then analysed by western 
blot using anti-His and anti-Myc antibodies (see 5.2.13). 
5.2.12 Protein interaction assays 
Pull-down assays were carried out using whole cell yeast extracts prepared from CBP20-
Myc, CBP80-Myc and RAD30-Myc strains and the recombinant Nrd1/Nab3 complex. The 
mixture of CBP20-Myc (30 µl) and CBP80-Myc (100 µl) extracts or RAD30-Myc (150 µl) 
extract were incubated with or without (negative control) approximately 60 µg of Nrd1/Nab3 
proteins in buffer B (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM β-mercaptoethanol) on a 
rotating wheel for 1 h at 4°C. For RNase treatment, the reaction was incubated with or 
without 1 µg of RNase A (Sigma) for 2 h at 4°C prior to adding Nrd1/Nab3 proteins. RNase 
treatment was carried out by MSc Dorota Adamska during the course of her master project. 
The mixture was transferred to spin columns (Mo Bi Tec) and bound for 1 h at 4°C to 25 µl of 
Ni-NTA-Agarose (Qiagen) pre-blocked with 30 µg of BSA. Flow-through fractions were 
separated by centrifugation (1 min at 400×g), the resin was washed three times with 700 µl of 
buffer W2 (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 20 mM imidazole, 1 mM β-
mercaptoethanol) and bound proteins were eluted with buffer E4 (20 mM Tris-HCl pH 8.0, 
150 mM NaCl, 250 mM imidazole, 1 mM β-mercaptoethanol) for 15 min at room 
temperature. 8 µl of collected fractions was separated by SDS-PAGE and analysed by western 
blot using anti-His and anti-Myc antibodies (see 5.2.13).  
For in vitro binding, approximately 20 µg of purified CBC was incubated with 25 µg of 
recombinant Nrd1/Nab3 in 200 µl of IPP150 buffer on a rotating wheel at 4°C for 1 h. The 
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mixture was incubated at 4°C for 1 h in spin columns (Mo Bi Tec) with 1 mM GTP (Thermo 
Scientific) and 50 µl of m7GTP-Sepharose equilibrated with IPP150. Bound proteins were 
purified as described for purification of cap binding proteins (see 5.2.11). 10 µl of collected 
fractions was analysed on 10% SDS-PAGE gel and stained with SYPRO Ruby Protein Gel 
Stain (Invitrogen).  
5.2.13 Western blot analysis 
After SDS-PAGE electrophoresis, proteins were transferred at nitrocellulose membrane 
(GE Healthcare) using semi-dry blotter (Bio-Rad) in buffer Tris-glycine (25 mM Tris-HCl, 
250 mM glycine) with 20% methanol at 15 V for 1 h. Proteins were stained with Ponceau S 
dye in 3% acetic acid (the dye was then removed with distilled water). Membranes were 
blocked in 5% milk in PBST buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM 
KH2HPO4, 0.05% Tween 20) for 1 h at room temperature or overnight at 4°C. The blots were 
incubated with appropriate primary antibody: mouse anti-Myc antibody (Santa Cruz 
Biotechnology, 1:500 dilution), mouse anti-His antibody (Calbiochem, 1:3000 dilution), 
mouse anti-HA antibody (Covance, 1:1000 dilution) or PAP, peroxidase-anti-peroxidase 
antibody (1:5000). After three washes with PBST with 5% milk, membrane was incubated 
with secondary anti-mouse horseradish peroxidase-conjugated antibody (Calbiochem, 
1:10000 dilution). After two washes in PBST with 5% milk and one with PBST, visualization 
was performed using Enhanced Chemiluminescence protocol (ECL) using ECL reagent (100 
mM Tris-HCl pH 8.0, 225 μM coumaric acid, 1.25 mM luminol, 0.015% H202) and CCD-
camera (Fluorchem SP, Gel Biosciences). 
5.2.14 Chromatin immunoprecipitation (ChIP) 
ChIP assay was based on (251) with several modifications. 50 ml of yeast culture (OD600 
0.4-0.5) was crosslinked with 1% (v/v) formaldehyde at room temperature for 20 min and 
quenched with 375 mM glycine. Cells (20 OD600 units) were resuspended in 1 ml of cold 
FA1-lysis buffer (50 mM HEPES-KOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100, 0.1% sodium deoxycholate, protease inhibitors (Roche) and 2 mM PMSF) and disrupted 
with 300 µl of glass beads (BioSpec) using Fast Prep apparatus (MP Biomedicals), two times 
for 40 s at 6 m/s with 5 min rest period between runs. After glass beads separation, the lysate 
was diluted with 1 ml of FA1-lysis buffer and sonicated in a Bioruptor sonicator (Diagenode) 
using 35–30 s pulses at the high level. The lysate was clarified by 40 min spin at 16000×g at 
4°C. 500 µl of extract diluted 5 times with FA-1 buffer was incubated overnight at 4°C with 
114 
 
20 µl of Dynabeads Protein G (Invitrogen) and appropriate amount of antibodies (10 µl anti-
Myc (Santa Cruz Biotechnology), 4 µl anti-HA (Covance), 1 µl anti-Rbp3 (Neoclone), 5 µl 
anti-Ser7-P clone 24E12, 20 µl anti-Ser5-P clone 3E8 and 20 µl anti-Ser2-P clone 3E10 (CTD 
antibodies were a kind gift from Prof. Dirk Eick). 20 µl of the input sample were frozen in -
80°C. Beads were washed twice at room temperature with 500 µl of FA1-lysis buffer, FA2-
lysis buffer (50 mM HEPES-KOH pH 7.5, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 
and 0.1% sodium deoxycholate), ChIP wash buffer (10 mM Tris-HCl pH 8.0, 250 mM LiCl, 1 
mM EDTA, 0.5% Nonidet P-40, 0.5% sodium deoxycholate) and TE. All washes were 
performed at room temperature. Beads were resuspended in 100 µl of ChIP elution buffer (50 
mM Tris-HCl pH 7.5, 10 mM EDTA, 1% SDS) and samples, including 20 µl of the input 
sample, were incubated with 40 µg of Proteinase K (Bioline) for 2 h at 56°C and 5 h at 65°C 
to digest proteins, reverse cross-linking and elute DNA. For RNAse treatment, diluted extract 
was incubated with or without RNase A (10 U, Qiagen) and T1 (500 U, Roche) at 37°C for 1 
h. Extracts were then incubated for 2 h at room temperature with 10 µl of Dynabeads and 5 µl 
of anti-Myc antibody (Santa Cruz Biotechnology). Washes were performed as described 
above. Beads resuspended in elution buffer with Proteinase K were incubated 2 h at 56°C and 
12 h at 65°C. DNA was purified using the commercial clean-up kit (Axygen). Additional 
wash step was applied to completely remove traces of SDS. DNA was eluted twice with 35 µl 
of elution buffer. Prior to qPCR analysis DNA samples, except no-antibody control, were 
diluted 3 to 10 times. Reaction mixes for some experiments were pipetted using JANUS 
Integrator automated workstation (PerkinElmer). Real time PCR analysis was performed 
using Roche Light Cycler 480 with 4 to 6 primers pairs for each gene. Primers efficiencies 
were assayed in each run and were higher than 80%. Immunoprecipitation efficiency was 
expressed as percent of the input, calculated using DNA concentrations as established by the 
Light Cycler software (20). Data represent the results of at least three independent biological 
replicates. The background level of DNA non-specifically bound to magnetic beads was 
negligible as determined by immunoprecipitations without antibodies or using anti-Myc and 
anti-HA antibodies with the extract from wild-type (BY4741) cells. 
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